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Abstract
In this thesis, we develop the application of Bayes linear kinematics and Bayes linear Bayes
graphical models to problems in medical diagnosis and prognosis. In medical diagnosis
or prognosis, we might use information from a number of covariates to make inferences
about the underlying condition, prediction about survival or simply a prognostic index.
The covariates may be of different types, such as binary, ordinal, continuous, interval
censored and so on. The covariates and the variable of interest may be related in various
ways. We may wish to be able to make inferences when only a subset of the covariates is
observed so relationships between covariates must be modelled. In the standard Bayesian
framework, such a case might suggest the use of Markov chain Monte Carlo (MCMC)
methods to integrate over the distribution of the missing covariate values but this may be
impractical in routine use. We propose an alternative method, using Bayes linear kine-
matics within a Bayes linear Bayes model in which relationships between the variables
are specified through a Bayes linear structure rather than a fully specified joint probabil-
ity distribution. This is much less computationally demanding, easily allows the use of
subsets of covariates and does not require convergence of a MCMC sampler. In earlier
work on Bayes linear Bayes models, a conjugate marginal prior has been associated with
each covariate. We relax this requirement and allow non-conjugate marginal priors by
using one-dimensional numerical integration. We compare this approach with one using
conjugate marginal priors and with a Bayesian analysis using MCMC and a fully specified
joint prior distribution. We illustrate our methods with an application to prognosis for
patients with non-Hodgkin’s lymphoma in which we treat the linear predictor of the life-
time distribution as a latent variable and use its expectation, given whatever covariates
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Real world data often involve multiple variables and need complex models to reach re-
alistic conclusions. As we encounter widely applicable models, we often need advanced
computational methods to fit them. Therefore, methods such as Markov Chain Monte
Carlo (MCMC), which allow sampling from the posterior distribution when there is no
analytical solution are often used. Bayes linear Bayes models and Bayes linear kinematics
(Goldstein and Shaw, 2004) offer an alternative approach which is computationally much
simpler.
This thesis addresses the methodology of using Bayes linear Bayes network models in
the context of medical diagnosis and prognosis problems. The main aim of this thesis is
to construct a Bayes linear Bayes prognostic network. This can be done by relating T to
a latent prognostic index.
A Bayes linear analysis (Goldstein and Wooff, 2007) differs from a full Bayesian anal-
ysis in that only first and second order moments are specified in the prior. Posterior
(termed adjusted) moments are then calculated when data are observed. The introduc-
tion of Bayes linear kinematics and Bayes linear Bayes models (Goldstein and Shaw, 2004)
extends Bayes linear methods to allow the incorporation of observations of types which
are not readily accommodated in a straightforward Bayes linear analysis. For example,
beliefs about certain unknown quantities might be updated by full conditional Bayesian
inference when observations are made on conditionally Poisson or binomial variables and
then information can be propagated between these unknowns, or to other unknowns, via
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a Bayes linear belief structure. This approach avoids the need for computationally in-
tensive methods such as Markov chain Monte Carlo which are often required in standard
Bayesian analyses.
In routine clinical use, in diagnosis or prognosis, the use of methods such as MCMC
is not ideal. The methods are computationally demanding and require attention to issues
such as convergence. We aim in this thesis to investigate a method which does not have
these drawbacks and which can be used even when only a subset of covariates is available.
This proposed method is based on the new idea of using the non-conjugate prior update
to construct Bayes linear kinematic prognostic index values. In this way, we construct a
Bayes linear kinematic network.
1.2 Bayesian network models and why they are im-
portant
A Bayesian network (BN) is a representation of the joint probability distribution of a
number of variables which makes use of conditional independence relationships among
the variables. We can represent a Bayesian network as a directed acyclic graph (DAG).
Bayesian network models can be useful by combining expert knowledge with the theory
of probabilities. There are many reasons why these models are useful and important.
Firstly, they are graphical models, so we can represent the relationships between the nodes
or vertices clearly, intuitively and in an attractive way. These relationships can often be
represented as cause and effect, but this is not always the case. Secondly, these models also
can represent more complex problems in a simple graph with dependence relationships.
Thirdly, because of the rapid development of computer languages and softwares, we can
learn from “big data” and even construct very large and complex networks.
In this thesis, we investigate developing Bayesian methods for selecting, fitting and
using models with appropriate conditional independence structures, i.e. graphical models,
in the context of medical diagnosis and prognosis problems. So we fit some survival models
such as a Weibull distribution to a data set on patients with non-Hodgkin lymphoma,
with missing data values for some covariates. That leads us to follow the advice of Farrow
(2003) to elicit the structure of the covariance matrix. In some cases, especially when the
covariates are a sequence of measurements taken over time, it might be appropriate to use
a generalised autoregression model (Pourahmadi, 1999; Daniels and Pourahmadi, 2002).
2
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Bayesian networks may be constructed using expert judgement. However, we may
wish to construct a network by inference from historical data.
In order to make inference in Bayesian networks, we need first to learn about the
structure of the network. Ku laga (2006) considered that, when he had a small number of
variables such as 5, he can manage all the potential models and then calculate the posterior
probability for them and choose the best one. However, he mentioned that when the
number of variables increases, the number of models will increase at an exponential rate.
Therefore, the solution for this problem is to use Markov chain Monte Carlo (MCMC)
methods. Also he explained the idea of a Markov blanket for the BN which is defined
as a set of nodes that separates a target node from the rest of the nodes in the network
which includes its parents, its children and other nodes sharing a child. He then defined
this object for a dynamic structure.
Husmeier et al. (2005) gave some insight about how we can learn a BN from complete
and incomplete data. They used a Metropolis Hastings algorithm to construct a BN in
computational molecular biology and bioinformatics, such as sequence alignment, molec-
ular evolution and genetic networks. Scutari and Denis (2014) gave many examples of
BN in the real world. One example used data for medical diagnosis to predict the human
body composition which forms the body weight: bone, fat and lean.
Efficient algorithms are available for information propagation “inference” within cer-
tain classes of BN, where the conditional distributions are all (finite) categorical or all
Gaussian. Inference using networks with other conditional distributions can be more diffi-
cult. Furthermore, the problem of using data to inform the construction of a BN (“network
learning”), particularly the structure of the network, remains challenging. Heckerman and
Chickering (1995) use a score metric to describe learning Bayesian network from gathering
knowledge and statistical data.
1.3 Bayesian networks in medical diagnosis and prog-
nosis
An important application since the early days of Bayesian networks has been in medical
diagnosis. Diagnosis can be viewed as a decision problem and Bayesian networks can
assist physicians in making the right decisions, diagnosing the disease early and choosing
the most appropriate treatment and thereby improving the outcomes for patients in terms
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of health and, in some cases, survival. Therefore, Bayesian networks are powerful tools for
helping physicians to make important decisions that lead to the correct treatment with
low risk for patients. Similarly, among patients with a particular disease, the prognosis
may vary according to various risk factors. A Bayesian network (BN) can be used to
improve the efficient use of information in making a prognosis and informing decisions on
treatment.
In survival analysis, Langseth (1998) constructed a Bayesian network for survival
times using a proportional hazard model. The results showed that his network is useful
for qualitative observations. See also (Kjaerulff and Madsen, 2013).
Verdurmen (2003) proposed a model to predict whether clients are likely defaulters at
any time during the loan time. He demonstrated a Bayesian network with an exponential
survival model. He compared his method to a proportional hazards model and showed
that his model can represent much more complex functions than the semi-parametric
hazards model.
Jiang et al. (2014) developed a new Bayesian network with high dimensional data to
predict patient survival. They developed a new algorithm for Bayesian networks that was
used to predict the survival of a patient separately each year. Also, their results showed
that their method was better than a proportional hazard model for several reasons such as
that their algorithm can deal with data with high dimensions. Kraisangka and Druzdzel
(2014) used a BN to interpret a proportional hazards model. Then they compared the
accuracy of their BN for the proportional hazards model with Kaplan-Meier estimates
and with a BN learned from data. The results showed that constructing a BN from a
proportional hazards model is more accurate than the other methods, even if they have
a small number of data recorded.
Bayesian decision networks can combine probabilistic models under uncertainty and
utilities to help the users make decisions that maximise the expected utility. See Korb and
Nicholson (2004). Bayesian decision making requires specification of two elements. One
is “beliefs”: a probability distribution over the possible outcomes, or, at least, sufficient
judgments about the uncertain outcomes to be able to evaluate the necessary expectations.
The other is a utility function over the possible outcomes. Gosling (2014) briefly mentions
elicitation of utility functions from patients and other people, but is largely concerned
with elicitation of the probabilistic beliefs of experts rather than utilities. However, in
a decision-making context, the utility element can not be ignored and, in practice, this
requires the use of some structure which, as far as possible, does not impose assumptions
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but makes the results usable and interpretable.
Therefore, it is important to consider beliefs and utilities together. Often, if the
outcome involves different attributes, then the utility function in this case will be a multi-
attribute utility function. For instance, years of life, cost in time and inconvenience to
the patient, etc. As a result, this requires us to consider using the joint distribution of
outcomes, hence necessitating the elicitation of a belief structure involving the depen-
dencies. According to Gosling et al. (2013), the prior elicitation of such dependencies
can be difficult due to several reasons such as differences in the experimental methods
that are used to measure the outcomes and quantities of interest might be on different
scales (e.g, between body mass index Kg/m2 and blood pressure measurements mmHg).
However, analysis of the decision problem and the associated utility function can show
that decisions can be sensitive to beliefs about dependencies.
The methodology for imprecision in multi-attribute utility functions developed by
Farrow and Goldstein (2010) leads to an overall utility function involving a linear combi-
nation of various marginal utilities and various products of marginal utilities. Therefore,
evaluation of expected utility requires the evaluation of expectations of these quantities.
The expectation of a product requires consideration of dependence between the stochas-
tic quantities involved. Farrow and Goldstein (2010) did not explicitly consider this but
an extension of the methodology to allow this and, furthermore, to deal with imprecise
specification of these expectations seems to be within reach.
1.4 Bayes linear and Bayes linear Bayes methods
Farrow and Goldstein (2006) were motivated in their decision analytic work by problems
in the design of experiments using a Bayes linear approach to statistical inference. In the
Bayes linear approach, probability distributions are not fully specified but only certain
moments are required. See Farrow and Goldstein (1993); Goldstein and Wooff (2007).
In recent years an extension of Bayes linear methods, using Bayes linear kinematics and
Bayes linear Bayes graphical models, suggested by Goldstein and Shaw (2004), has allowed
the combination of Bayes linear structures describing the dependencies between quantities
with explicit use of observable quantities with non-Gaussian distributions. The original
idea in Goldstein and Shaw (2004) has been developed and applied in a number of papers,
including Wilson and Farrow (2010); Gosling et al. (2013) and Wilson et al. (2013). We
consider that Bayes linear analysis gives a good approximation to full-Bayes analysis while
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in Bayes linear analysis we do not need to specify the prior in a probabilistic way, but we
need to specify only the first and the second moments.
1.5 Project aims
The main aims of the project are
• Develop Bayesian methods for selecting, fitting and using models with appropriate
conditional independence structures, i.e. graphical models, in the context of medical
diagnosis and prognosis problems. In addition, we are looking for improvements to
some existing methods.
• Investigate methods for a wider class of conditional distributions, e.g. a survival
distribution.
• Build probabilistic models for diagnosis and prognosis with various Bayesian network
learning algorithms to help the physicians and others to make decisions about their
patients more accurately and efficiently.
• Construct a Bayes linear kinematic network which can be used when we observe
only some of the covariates. Develop methods for incorporating different kinds of
covariates in such a network.
• Make comparisons between different methods to construct Bayes linear kinematic
prognostic networks.
1.6 Outline of the thesis
The remainder of the thesis has the following structure. In Chapter 2 we describe the
data which will be used for illustration in the thesis. These include data on survival
for patients with Non-Hodgkin lymphoma and leukemia. We give an overview of the
explanatory variables in these data sets.
Chapter 3 reviews the basic ideas of Bayesian inference and Markov Chain Monte
Carlo (MCMC) methods which are used to compute posterior distributions. We also give
an introduction to generalised linear models and particularly the logistic regression model
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with the logit link function. We discuss variable selection methods and in particular
Bayesian variable selection methods. We illustrate the missing data problem and data
augmentation and give an example involving lung transplant data. We use the logistic
regression model to fit the data where the response variable represents whether the lung
is used for transplant or not.
In Chapter 4, we introduce probabilistic graphical models, concentrating on directed
acyclic graphs, and give some algorithms that are well known in the field of graphical
models. We give some important definitions and concepts related to Bayesian networks.
We explain some important and useful methods to construct Bayesian networks and learn
from the data. We introduce a method called the arc deletion method which depends on
finding the most optimal network using MCMC methods.
Chapter 5 deals with survival analysis with some important aspects and definitions
related to our work. An important feature in survival analysis is censoring. We give an
explanation for the most familiar survival models such as proportional hazard models,
piecewise constant hazard models and accelerated failure time models. We also discuss
prognostic indices and how we compute them. We mention also in this chapter some
parametric distributions in survival such as the exponential and Weibull distributions.
Part of this chapter also deals with Bayesian inference in survival analysis using MCMC
techniques and how to make inference about the coefficients in various models. We give
an example using the Non-Hodgkin lymphoma data which involves some missing data and
show how to deal with this kind of problem. We use rjags, (Plummer, 2013) a package
in R, (R Core Team, 2018) to do the analysis.
In Chapter 6, we introduce Bayes linear methods. We start the chapter by giving
some definitions and theory related to Bayes linear methods. Then we explain Bayes
linear kinematics with some aspects such as the issue of commutativity and the use of
multiple updates in Bayes linear kinematics with a number of examples. We use the idea of
transforming the parameters. We introduce a novel feature which uses the non-conjugate
marginal updates in order to find the posterior mean and variance, before the information
is propagated through other unknown quantities within a Bayes linear structure. In this
chapter, we also give different types of examples such as using binomial observations and
Poisson observations and compute the results with the posterior means and variance using
full-Bayes analysis.
Chapter 7 describes two sorts of problems. The first is illustrated using the leukaemia
example in which we use Bayes linear kinematics with non-conjugate prior updates to
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compute the posterior moments for the model parameters. Then we compare different
types of methods including log-mode and lognormal forms of Bayes linear kinematics and
full Bayes methods. Secondly, we describe the application of Bayes linear kinematics
to prognostic index calculation in survival. We illustrate this using the non-Hodgkin
lymphoma data. We introduce a novel method that uses a Bayes linear Bayes prognostic
network with different sorts of variables such as binary, ordinal, unordered categorical
and interval censored variables. We use an offline learning model to determine values
for some parameters that we need to calculate the Bayes linear Bayes prognostic index
values. We find that the prognostic index values from the Bayes linear Bayes model and
the prognostic index values that are calculated from MCMC methods are similar. We
give some results and graphs to represent the relationships between the prognostic values
for both Bayes analysis and Bayes linear methods. Our prototype prognostic network
produces prognostic index values using all, or only some, of the possible covariates almost
instantly and has the potential to be used, for example, as a Web-based calculator.
Chapter 8 describes simulation experiments to compare the methods that we use in
this thesis. We give three different examples with different ranges of ages and sexes
and compare two methods for dealing with categorical variables: the direct and indirect
methods.





In this chapter, we will look in detail at the two data sets that we have used for illustration
in this thesis, the non-Hodgkin’s lymphoma and leukemia data sets. We give general
information about the data and some important definitions for the covariates within each
data set.
2.2 Scotland and Newcastle Lymphoma Group (SNLG)
data
2.2.1 Background of SNLG data set
In 1979, there was formed a group called the Scotland and Newcastle Lymphoma Group
(SNLG) that built up a database on about 18,000 patients with lymphoma within North-
ern England and Scotland. The process of collecting the data is called Population Ad-
justed Clinical Epidemiology (PACE) and this process was used by the Northern Regional
Haematology Group (NRHG). See Proctor and Taylor (2000). The period of time that
they needed to collect the data was about 10 years, from 1992 to 2002. The lymphoma
group includes specialists from different disciplines such as medicine, pathology, surgery,
radiology and clinical oncology. The collected data have been used by various groups of
people working in individual centres in order to improve the choice of treatment, such
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as chemotherapy or radiotherapy, for the patients. In the thesis, we will focus on non-
Hodgkin’s lymphoma (NHL) which is one of the most common sorts of cancer. Particu-
larly, we use a subset of the SNLG data set.
2.2.2 Non-Hodgkin’s Lymphoma (NHL)
Non-Hodgkin lymphoma is a type of cancer that begins in the cells of the immune system.
The immune system fights infections and other diseases. The lymphatic system is regarded
as a part of the immune system. The lymphatic system includes the following
• Lymph vessels: the lymphatic system has a network of lymph vessels. Lymph
vessels branch into all the tissues of the body.
• Lymph: the lymph vessels carry clear fluid called lymph. Lymph contains white
blood cells, particularly lymphocytes such as B cells and T cells.
• Lymph nodes: lymph vessels are connected to small, round masses of tissue called
lymph nodes. Groups of lymph nodes are found in the neck, chest, underarms, groin
and abdomen. Lymph nodes store white blood cells. They trap and remove bacteria
or other harmful substances that may be in the lymph.
See Freedman et al. (2012).
There are more than 12,000 people diagnosed with NHL in the UK every year. The
chance of developing the disease increases as people get older and most cases occur in
people aged over 65 years with slightly more men than women. See NHS (2018).
2.2.3 Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common sort of non-Hodgkin lym-
phoma. It is a cancer of blood cells called lymphocytes. Nowadays, the number of patients
with the illness in the USA and Europe is approximately 15-20 cases for every 100,000
people, (Martelli et al., 2013). DLBCL is not just one disease. There are a number of
different types of DLBCL. The most common type of it is described as the “not otherwise
specified” form or DLBCL-NOS. See Miranda et al. (2013).
10
Chapter 2. Example data sets
2.2.4 SNLG data set
The NHL data set incorporates variables that are widely used by clinicians in choosing
the appropriate therapy for patients, (Lucas et al., 1998). The relevance of most of these
variables is supported by literature on prognostic factors in NHL. First, the information
that can be extracted from the clinician about NHL is divided into three groups:
• Pre-treatment information, (i.e. information that is required for treatment selec-
tion).
• Treatment information, (i.e. the various treatment alternatives).
• Post-treatment information, (i.e. side effects, and early and long-term treatment
results for the disease).
The most important pre-treatment variables are the variable “Clinical Stage”, which
expresses severity of the disease according to a common clinical classification, and histo-
logical classification, which stands for the assessment by a pathologist of tumour tissue
obtained from a biopsy. The most important post-treatment variables include the variable
“early result”, being the endoscopically verified result of the treatment, six to eight weeks
after treatment. Possible outcomes are:
• Complete remission, i.e. tumour cells are no longer detectable.
• Partial remission, some tumour cells are detectable, no change or progressive dis-
ease.
Another important post-treatment variable is “3-year result”, which represents the
patient either surviving three years following treatment or not.
2.2.5 Non-Hodgkin Lymphoma Example: General overview of
the covariates
In this section, we describe the covariates in the non-Hodgkin lymphoma data set in
detail. We have 14 prognostic variables that have been selected from the clinical research
by Professor Proctor, Dr. Sieniawski and Mrs White (Sieniawski et al., 2009). The
dependent-variable is survival time with censoring indicator coded as “1” for death and
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Stage Description
I Lymphoma is discovered in one lymph nodesite.
II
Lymphoma is discovered in two or more
lymph node regions and on the same side of
the diaphragm.
III
Lymphoma is discovered in lymph node re-
gions and on both sides of the diaphragm.
IV
Diffuse or disseminated involvement of one
or more distant extranodal organs with or
without associated lymph node involvement.
Table 2.1: Ann Arbor staging process
“0” for a censored observation. Here, we give more information about the covariates which
include binary, continuous, categorical and interval censored variables.
• Age: This variable represents the patient’s age at diagnosis. It has mean 62 years
and standard deviation 14.2 years. This variable is regarded as a continuous variable.
• Sex: This is a binary variable, taking the value 1 for male and 2 for female. In our
data we have 704 male and 687 female. It seems that the disease is slightly more
common in the male than the female.
• Clinical Stage: This is an ordinal variable with 4 levels. It represents the way
that the doctor can discover the lymphoma in the body of the patient, giving you
the number of places that show the lymphoma. See Cancer Research UK (2018a).
Knowing the stage of the illness will help the doctors to make an accurate decision
about the suitable treatment that the patient needs. The staging process used here
is Ann Arbor Staging (Carbone et al., 1971) which is widely used. The categories
are ordered from I to IV with the earlier category (I) refering to the least extent of
spread and the latter category (IV) refering to the greatest extent of spread. We
coded the stages with the values 1,2,3 and 4. See Table 2.1.
• ECOG: This is the Eastern Cooperative Oncology Group performance status,
(Oken et al., 1982). It is an ordinal variable. It has 5 states from 0 to 5 where
the status 5 refers to the death of the patient. So, in our case, we restricted this to
0 to 4. Table 2.2 shows the definitions for ECOG.
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Performance Description
scale
0 The patient is fully active and has no perfor-mance restrictions.
1
The patient has limited restriction to do
strenuous physical activity and he or she has
the ability to perform the light work.
2
The patient can take care of himself. How-
ever, he will be unable to perform any work
activities.
3
The patient has a limited capacity to take
care of himself and confined to bed or chair
with more than 50% of waking hours.
4
The patient is completely unable to perform
any work activities and can not take care of
himself and confined to bed or chair.
Table 2.2: ECOG performance
• Serum Lactate Dehydrogenase (LDH): Although this variable is actually con-
tinuous, it is often categorised and represented as an ordinal variable. Studies show
the importance of this variable in the prognosis of non-Hodgkin’s lymphoma. See
Yadav et al. (2016). The survival time of the patient has been negatively related
with the levels of Serum LDH and statistical analyses show that individuals with
lower levels of LDH, tend to have longer survival times, (Ferraris et al., 1979). For
more information about LDH in the SNLG data set, see Consul (2016). In the SNLG
data set, LDH is actually recorded as an interval censored variable. Observations
within the normal range are simply recorded as “normal”. Observations outside the
normal range are recorded as the actual values.
• Haemoglobin (HB): This variable is coded as a continuous variable. The mea-
surements of HB are in grams (g) per deciliter (dl) g/dl. It is a protein which is
located in the red blood cells and it carries the oxygen from the lungs to the body’s
tissues and returns carbon dioxide from the tissues back to the lungs. The normal
range of HB depends on the age and sex of the person. Table 2.3 represents the
normal range for different groups, (Longmore et al., 2014).
• White Blood Cell (WBC): This variable is treated as a continuous variable on
(0,∞). White blood cells are also called leukocytes and they are the cells of the
immune system that are involved in protecting the body against both infectious
13
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Patient’s Group HB (g/dl)
Adult man 13.8 to 17.2
Adult woman 12.1 to 15.1
Pregnant woman 11 to 12
Children 11 to 16
Table 2.3: Normal range for HB
disease and foreign invaders. See Maton (1997). The range of the WBC in this
thesis is between 1.1 and 27.2, where 1 unit is 50× 109/l.
2.2.6 Binary variables
Some covariates in the NHL data set are represented as binary variables, such as serum
albumin, blood urea nitrogen, etc. In fact, these variables are coded in different ways but
the way we put it in the model is using the values either -1 or 1. Below is the list of all
the binary variables with a brief description of each variable.
• Serum Albumin (Albumin): This is a binary variable. Albumin is considered to
be the most abundant protein in the blood plasma for humans and is produced in
the liver. Low albumin indicates liver disease and high albumin indicates dehydra-
tion. The albumin concentration in blood is 35-55 g/l for the normal range. Any
observation outside the above range is a sign of abnormality. In the SNLG data,
albumin is categorised as either normal or abnormal.
• Blood Urea Nitrogen (urea): This variable is also binary. Urea measures the
amount of nitrogen in the blood that comes from the waste product urea. The
normal range for urea nitrogen in blood is 5 to 20 mg/dl, see Hosten (1990). The
values outside the above range are considered to be abnormal. In the SNLG data,
urea is categorised as either normal or abnormal.
• Alkaline Phosphatase (AP): Alkaline phosphatase is an important component
in hard tissue formation, highly expressed in mineralised tissue cells. See Golub and
Boesze-Battaglia (2007). The normal range for AP for those aged over 16 years is
36-113 IU/l. Different age groups have different AP values. Any value outside the
normal range is regarded as abnormal. In the SNLG data, it is recorded as a binary
variable with value 1 refering to normal and value 2 refering to abnormal.
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Table 2.4: The percentage of missing values for several covariates in NHL
• Extranodal without Bone Marrow (extranod): This happens when the lym-
phoma spreads outside the lymph nodes. See Brooks (2008). The variable is
recorded as either “present” or “absent”.
• Bulk Disease (Bulk): This is to measure whether the patient has bulk disease or
not. It describes the tumours which are very large in size, also called bulky tumours.
See Pfreundschuh et al. (2008). This is a binary variable.
• Bone Marrow Involvement (marrow): Bone marrow is the soft tissue inside
the bones where blood cells are made. See El-Galaly et al. (2012). The variable
records whether or not the patient has shown evidence of lymphoma disease that is
in bone marrow.
• B-symptoms (Bsy): The patient with non-Hodgkin lymphoma may have some
symptoms such as sweating at night, temperature that goes and returns without any
infection, losing weight (more than one tenth of the total weight) and unexplained
itching. See Cancer Research UK (2018b). These symptoms are called B-symptoms.
The presence and absence of B-symptoms has an important significance in prognosis
exactly the same as in the staging of NHL. The variable records the presence or
absence of B-symptoms.
2.2.7 Missing data
Several of the covariates have missing values for some patients. This is summarised in
Table 2.4.
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2.3 Leukemia example
2.3.1 Introduction
In this thesis, we use also a data set on patients with leukemia. These data are taken from
the North West Leukemia Register in the UK in order to investigate the leukemia survival
time for 1043 patients between 1982 and 1998 where 879 died and 164 were censored. See
Henderson et al. (2002).
2.3.2 General overview of the covariates
In this data set, we have some covariates which we believe might have an effect on the
survival times for the individuals. These covariates are age, sex, white blood cell count
(WBC) and a measure of the deprivation of the area of residence which is called the
Townsend score (Townsend et al., 1988). We give the censoring indicator “1” for death
and “0” for censored data. The covariates are
• Age: This variable represents the age of the patient in years.
• Sex: This is the sex of the patient. We coded the variable to be “1” for the male
patient and “-1” for the female patient. We have 547 (52%) female and 496 (48%)
male.
• White blood cell (WBC): See Section 2.2.5 for more details about white blood
cell count at the time of diagnosis (with 1 unit= 50× 109/l).
• Deprivation score (Depscore): This variable measures the deprivation for the
residential area of the patient. We use the Townsend deprivation index (TDI)
(Townsend et al., 1988). The scale of the variable is from -7 to 10 with lower
values indicating more severe deprivation. Alston et al. (2007) mentioned that TDI
can vary by region and they found that deprivation affected cancer rates.
2.4 Summary
In this chapter, we have given some general and useful information about the data sets
that will be used in the thesis. An overview of the different sorts of covariates has been
16
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given in both cases, SNLG and leukemia.
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Bayesian inference and Generalised
Linear Models (GLMs)
3.1 Introduction
In this chapter, we will explain in detail what Bayesian inference is and illustrate gener-
alised linear models by introducing one of the most common models that is used widely
in medical studies, which is the logistic regression model. In Section 3.2, we give an intro-
duction to Bayesian inference, henceforth abbreviated to BI. In Section 3.3, we explain
some important methods to calculate some summary statistics related to the posterior
distribution (e.g. the posterior mean and the posterior variance) using various meth-
ods. In Section 3.4, we explain Markov Chain Monte Carlo methods (MCMC) which
are very widely used in Bayesian statistics. In Section 3.4.4, we give an explanation of
the Gibbs sampler, a common method in MCMC, which depends on the calculation of
the full conditional distribution for the parameter of interest given all the variables in
the model. Section 3.4.8 demonstrates the use of another method in MCMC which is
called the Metropolis-Hastings method. This method involves generating samples from a
proposal distribution in order to evaluate the posterior distributions. In Section 3.5, we
illustrate the generalised linear model (GLM) with some common link functions related
with GLM. In Section 3.7, we demonstrate different kinds of variable selection methods,
focussing on Bayesian variable selection methods. We introduce one type of prior which is
used with variable selection and is called a spike and slab prior, with more details about
this prior discussed in Section 3.7.5. In Section 3.8, we define the missing data mechanism
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with different sorts of missingness. We give a brief introduction to data augmentation in
Section 3.9. In Section 3.10, we have an example on lung transplants. In this example we
fit a logistic model as the response variable is whether the lung is used for transplant or
not. The lung transplant example also illustrates the missing data problem. Finally we
give the summary of Chapter 3 in Section 3.11.
3.2 Introduction to Bayesian inference
Bayesian inference has become widely used in different disciplines, such as medicine,
biology, clinical trails, bioinformatics, survival analysis, physics and so on.
The idea behind doing Bayesian inference is to infer about the “unknown” quantity of
interest, say θ, in the model and learn about it from the data. Therefore, there is always
uncertainty which is associated with this parameter and we represent this in the form
of the joint probability density for all unobserved quantities. See Gamerman and Lopes
(2006).
In a Bayesian context, we always describe the uncertainty in the values of the unknown
quantities in terms of probability distributions which represent beliefs about the values.
Therefore, we assign probabilities to the values of those unknown quantities, say θ. The
distribution before observing data is known as the prior distribution. If this is a continuous
distribution, we can write its density as π(θ). After observing the data, y, we update our
prior belief and find the posterior probability distributions π(θ | y). The information that
has come from the data is found in the likelihood function, L(θ | y) which refers to the
sampling density for the data. Multiplying the prior density with the likelihood function,
gives the posterior density as follows
π(θ | y) = π(θ)L(θ | y)∫
π(θ)L(θ | y) dθ . (3.1)
The integral in the denominator, known as the normalising constant, is often in-
tractable. In such cases we need to use numerical methods in order to evaluate posterior
distributions. The most common sort of numerical method in recent years is Markov chain
Monte Carlo (MCMC) methods. See, for example, Gilks et al. (1996). Often MCMC may
be implemented using software such as “BUGS” (Spiegelhalter et al., 1996).
20
Chapter 3. Bayesian inference and Generalised Linear Models (GLMs)
3.3 Numerical integration methods
In Chapter 6 we will discuss Bayes linear kinematics and Bayes linear Bayes graphical
models. We will see that it is necessary to revise our mean and variance of an underlying
unknown quantity when we observe and associated variable. We will deal with cases
where the observable variables are not Gaussian and, in particular, in Section 6.7, we will
introduce a new method which involves using a non-conjugate prior distribution for the
underlying quantity. We will need to use numerical integration to evaluate the revised
moments. Therefore, in the section, we review some methods of numerical integration
which may be used.
Suppose that we need to calculate the posterior mean of θ as follows




and the posterior variance of θ will be
Var(θ | y) =
∫
θ2π(θ)L(θ | y)dθ∫





Sometimes we can calculate all these integrals analytically especially when the prior
distribution is conjugate (if the posterior distribution and the prior belong to the same
family of distributions, then the prior is called a conjugate prior) to the likelihood but
this is not always the case. These integrals are often complicated when we deal with the
problem of non-conjugate prior distributions especially when there is more than a small
number of parameters in the analysis. Therefore, we need numerical methods to solve
problems of this kind.
3.3.1 Trapezoidal rule
The main idea of using numerical integration is to calculate an approximate solution for
definite integrals. One of these numerical methods is called the trapezoidal rule. See
Jones et al. (2014). This method gives an approximate value for an integral between two
values.
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xi = a+ i∆x f(xi) evaluate
x0 = a+ 0∆x f(0) 0.00000
x1 = a+ 1∆x f(0.05) 0.00214
x2 = a+ 2∆x f(0.10) 0.00729
x3 = a+ 3∆x f(0.15) 0.01382
x4 = a+ 4∆x f(0.20) 0.02048
x5 = a+ 5∆x f(0.25) 0.02637
x6 = a+ 6∆x f(0.30) 0.03087
x7 = a+ 7∆x f(0.35) 0.03364
x8 = a+ 8∆x f(0.40) 0.03456
x9 = a+ 9∆x f(0.45) 0.03369
x10 = a+ 10∆x f(0.50) 0.03125
Table 3.1: Evaluate the functions in order to compute trapezoidal rule





This can be done by dividing the interval between a and b into n subintervals of width
∆x. So, ∆x = (b− a)/n. Then, to calculate the trapezoidal approximation, we have
T = ∆x2
[
f(x0) + 2f(x1) + · · ·+ 2f(xn−1) + f(xn)
]
where xi = a+ i∆x. Now let us explain the method with a simple example.
Suppose we need to calculate the following integral,
∫ 0.5
0 θ
2(1− θ)3dθ. We have in this
case a = 0, b = 0.5 and also give n = 10 for example. Then ∆x = 0.05, and we have the
values shown in Table 3.1.
Therefore, the numerical integration for the above integral gives T = 0.01092 following
the calculations from Table 3.1. Now the exact solution for this integral 0.01094. As a
result, there is an absolute error 2 × 10−05 between the two values. Thus the solution
using the trapezoidal rule is close to the exact value. We notice that we can obtain a
more accurate result by increasing the number of subintervals, say n = 100.
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3.3.2 Laplace approximation method





where g(θ) is an arbitrary function of θ and L(θ|y) is the likelihood function and π(θ) is






where `(θ|y) = log f(y1, ..., yn|θ) is called the log likelihood function and f(θ) = log{π(θ)}
is the log of the prior density π(θ).
For instance, if θ has one-dimension, then g(θ) = θ gives us the posterior mean of the
distribution. More generally, when we have g(θ) = θp, we can gain the pth moment of the
posterior distribution. See Press (2009). Now the denominator of (3.3) is called the nor-
malising constant which is sometimes analytically intractable. So, we need approximation
methods to evaluate both integrals in (3.3).
The Laplace approximation is one of the analytical methods that is useful to compute
the integrals in (3.3). This method of approximation was introduced by Tierney and
Kadane (1986). It depends on the normal approximation in order to calculate the posterior
mean and posterior variance and so on. Moreover, recent developments have led to the use
of the integrated nested Laplace approximation (INLA) method which is a very efficient
method to give accurate approximations for the posterior marginals in seconds or in
minutes while using MCMC methods needs more time to run. See Rue et al. (2009).
Suppose that we are interested in calculating the expectation in (3.3). So we can





where n is the number of data points,
−nk(θ) = log{L(θ|y)}+ log{π(θ)}
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and
−nk∗(θ) = log{g(θ)}+ log{L(θ|y)}+ log{π(θ)}.
Now, we use Taylor expansions for k and k∗ to find the modes θ̂ and θ̂∗ respectively.
−k(θ̂) = max
θ
{−k(θ)} and − k∗(θ̂∗) = max
θ
{−k∗(θ)}



























Now let us give an example to illustrate how to use the Laplace method to obtain the
posterior moments.





Then our conjugate prior for θ is a gamma density with two parameters, the shape
parameter a and the rate parameter b, so θ ∼ Gamma(a, b) and
π(θ) ∝ θa−1e−bθ a > 0 , b > 0
So, the posterior density π(θ|y) will be
π(θ|y) ∝ θa+nȳ−1e−(b+n)θ.
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Now, we are interested in finding the approximation of the posterior mean using the











−nk(θ) = log{L(θ|y)}+ log{π(θ)}
=nȳ log(θ)− nθ + (a− 1) log(θ)− bθ
=(nȳ + a− 1) log(θ)− (b+ n)θ
=(a∗ − 1) log(θ)− b∗θ
and
−nk∗(θ) = log(θ) + log{L(θ|y)}+ log{π(θ)}
= a∗ log(θ)− b∗θ.
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By substituting θ̂ in {−nk(θ)} and θ̂∗ in {−nk∗(θ)}, we obtain



























































































































For example, let a = 2, b = 3, n = 10, ȳ = 5. We obtain E(θ|y) ≈ 4.00013 while the
exact posterior mean E(θ|y) = a∗/b∗ = 4. Therefore, the absolute error (representing the
difference between the exact value and the approximate value) is 0.00013, which is very
small.
3.4 Markov Chain Monte Carlo methods
3.4.1 Introduction
Markov Chain Monte Carlo (MCMC) techniques have become the most popular methods
for evaluating posterior distributions. These techniques allow sampling from the posterior
distribution of the unknown parameters in the model when there is no analytical solution.
The idea of using MCMC was originally proposed by Metropolis et al. (1953) as an efficient
method for simulation. There are two main algorithms in MCMC that are used in the
majority of cases, the Gibbs sampler (Geman and Geman, 1984; Gelfand and Smith, 1990)
and Metropolis-Hastings algorithms (Hastings, 1970).
The use of Monte Carlo methods in Bayesian statistics has dramatically increased
since the early 1990s. The basic idea of methods of this kind is to draw random samples
from probability distributions and, when the number of draws becomes large, Monte Carlo
methods give good approximations to properties of the distributions. These methods are
used when there is no analytic solution or there is a difficulty in finding the numerical
solution. Therefore, we obtain an approximate solution using these methods. See Jackman
(2009); Lesaffre and Lawson (2012); Gelman et al. (2014). In the following subsections,
we will demonstrate the most common direct and indirect sampling methods to evaluate
the posterior summaries in Bayesian statistics.
In Chapters 6, 7 and 8, when we introduce new ideas in Bayes linear kinematics and
Bayes linear Bayes models, we will compare our results using these ideas in examples with
real data and in simulation experiments with results obtained using standard Bayesian
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analysis and MCMC methods.
We use software called rjags (Plummer, 2013) to fit the models and do the analysis
as well as using R (R Core Team, 2018).
3.4.2 Monte Carlo integration
In this subsection, we explain the direct sampling method for Monte Carlo integra-
tion. Suppose that we have the function f(θ) and our target is to find δ = E{g(θ)} =∫






and that converges to E{g(θ)} with probability 1 as n→∞, using the strong law of large
numbers. In the case of Bayesian inference, f(θ) is the posterior distribution and δ is the
posterior mean of g(θ). As a result, in order to compute the posterior mean, we need just
a sample of size n from the posterior distribution. See Carlin and Louis (2008).
3.4.3 Importance sampling
Geweke (1989) suggested an important method for sampling indirectly from the posterior
(target) distribution. Let π(θ|y) ∝ L(θ|y)π(θ) be the target distribution and suppose that









where L(θ|y) is the likelihood function and π(θ) is the prior density.
Now, suppose we can easily sample from a density s(θ) and we define w(θ) as an





















Chapter 3. Bayesian inference and Generalised Linear Models (GLMs)
where θi iid∼ s(θ) and this s(θ) stands for the importance function. We also notice that
if s(θ) is a good approximation to the posterior density then all the weights will be
approximately equal. So the algorithm for importance sampling can be written as follows.
Algorithm 1: Importance sampling algorithm for calculating the posterior mean
of a distribution
1 for i = 1 to n do.
2 sample θi ∼ s(θ).



















See Carlin and Louis (2008); Jackman (2009).
3.4.4 The Gibbs sampler
In this section, we demonstrate the basic idea of using the Gibbs sampler method and
how to implement it in practice.
Assume that our model has n parameters, say θ = (θ1, θ2, ..., θn)
′ . This method in-
volves generating samples from the full conditional distributions, π(θi | θj 6=i, y), where
i = 1, 2, ..., n and the observed data are y.
The algorithm starts with assigning some initial values (θ(0)2 , ..., θ(0)n ) and then we apply
the algorithm as follows
Algorithm 2: Gibbs sampling algorithm
1 Initialise θi, i = 1, ..., n.
2 For k = 1, ..., K.




3 , ..., θ
(k−1)
n , y).














3 , ..., θ
(k)
n−1, y).
6 Change counter k to k + 1, and return to step 2.
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Let θ(k) = (θ(k)1 , ..., θ(k)n )
′
. Then the sequence ... θ(k−1), θ(k), θ(k+1) forms a Markov chain.
As k → ∞, the distribution of θ(k) tends to the joint distribution of θ1, ..., θn, known as
the target distribution, which in Bayesian statistics, is typically the posterior distribution.
See, e.g., Gilks et al. (1996).
3.4.5 Burn-In and convergence in MCMC samples
It is important to check whether the distribution of our sampled values is close to the sta-
tionary distribution of the Markov chain. Therefore, “burn-in” is the process of removing
the initial values which are related to the non-stationary part of the Markov chain. We
can visualise the convergence of the samples and that can be done by looking at the trace
plots of these random samples against the iterations of samples in the model particularly
if two or more parallel chains are use. For instance, if the burn-in is 1000 iterations,
and we need to make the number of iteration 10000, then we are determining 11000 of
the generated samples in order to give a summary of the posterior distribution of the
parameter of interest.
There are other tools that can help to assess the convergence of MCMC chains such as
diagnostic statistics. Some of these statistics are available when using the software rjags
in the “CODA” package which was written by Plummer et al. (2006).
We give a brief introduction to two statistics that have been used widely to assess
convergence. The first statistic is called the Brooks-Gelman-Rubin (BGR) statistic. See
Brooks and Gelman (1998); Gelman and Rubin (1992). This statistic deals with two types
of variability when we have multiple chains running. The first one is the variability of
the observations within each chain and the second is the variability between the chains.
If the variability between the chains is relatively small compare to the variability within
each chain, then the chains are judged to have converged to the posterior distribution.
See Hosmer et al. (2013).
Now before we illustrate the second statistic, let us take the case when we assume
that we have k chains where j = 1, ..., k. Each chain gives sampled values with i = 1, ..., n







where µ̄.j is the mean of the sampled parameter values in the chain j. We define the
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where µ̄.. is the mean of all the sample value from all the chains. So we can compute the







As we can see, this Ŝθ refers to the weighted mean of the two variances W and B.
Now, we introduce the second statistic which is called the “effective sample size” which





and this formula has been defined as a function in rjags as effectiveSize(). So for
example, we might consider the mixing of the chains to be satisfactory if the variability
between the chain is lower than the expected posterior variability and that makes the
quantity in (3.7) larger. Gelman and Hill (2007) suggested that the effective sample
size should be at least 100 samples in order to conclude that we have obtained sufficient
MCMC samples.
3.4.6 Thinning
Thinning is the process of discarding all-but-every k-th sample from a sequence of MCMC
samples of the posterior distribution. See Link and Eaton (2011). To illustrates the idea
of thinning in Monte Carlo methods, assume we have the following situation.
We have generated samples which are dependent. The posterior mean E(θ|y) of the
unknown quantity is approximated by the sample mean θ̄ and the accuracy of this ap-
proximation is measured by the Monte Carlo variance of θ̄. This Monte Carlo variance
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will be larger than it would be given a sample of independent draws from the posterior
distribution. This is the case when the value of the samples from successive iterations are
positively autocorrelated.
Now the autocorrelation across iterations can be reduced by thinning the chain. That
will give us the sampled values from iterations k, 2k, 3k, ... where k is an integer, k > 1.
Thinning gives a sample of n/k values and increased Monte Carlo variance. However,
when we have a positive auto correlation, this increase can be small. There are cases
where time-consuming computations are done on each sampled value after it is collected.
In such cases it may be more computationally efficient to increase n and then thin using
k > 1 before executing these post-sample computations. For instance, the computation
of the posterior predictive means. Thinning is also important to assess the convergence
and when we have a problem with storage space which is nowadays not as likely to be a
problem as computers generally have very big storage spaces. All these issues are discussed
by Geyer (1992).
3.4.7 Example: normal random sample
Suppose we have a random sample from a normal distribution with mean µ and variance
σ2. Hence, Yi | µ, τ ∼ N(µ, 1/τ), where τ = 1/σ2 and i = 1, 2, ..., n. We use a semi-
conjugate prior for µ and τ which is represented as follows
µ ∼ N(a, 1/b) and τ ∼ Ga(c, d)
with µ and τ independent, so that π(µ, τ) = π(µ)π(τ). Applying Bayes theorem here, the
joint posterior density for µ and τ is
π(µ, τ | y) ∝ π(µ, τ)L(µ, τ | y) (3.8)
where L(µ, τ | y) is the likelihood function. To find the full conditional distribution for
µ, we need to condition on the second parameter which is τ here, to obtain f(µ | τ, y).
Likewise, if we condition on µ, we get f(τ | µ, y). Therefore, the FCD (which stands for
full conditional distribution) for µ and τ can be summarised respectively in the following
expressions
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and
τ | µ, y ∼ Ga
(




s2 + (ȳ − µ)2
})
.
where s2 = ∑(yi − ȳ)2/n and ȳ = ∑ yi/n. In order to implement our algorithm, we need
to give initial values for µ and τ . So, for example we could use our prior means to be
starting values for the Gibbs algorithm, where µ(0) = a and τ (0) = c/d. We obtain new
values τ (k) and µ(k) from τ (k−1) and µ(k−1) by successive generation of values
µ(k) ∼ N
ab+ nȳτ (k−1)




τ (k) ∼ Ga
(




s2 + (ȳ − µ(k))2
})
.
A R function is written to illustrate how to generate samples from the posterior distribution
of µ and τ. See Appendix A.3.1. So the trace plots (which show the history of the sampled
parameter value across the iterations of the chain and therefore where the chain has been
exploring) and the autocorrelation plot for µ and τ using a Gibbs algorithm are shown in
Figure 3.1.















































Figure 3.1: Trace plots and the autocorrelation plots for µ and τ
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As we can see from the trace plots in Figure 3.1, there is good mixing for both pa-
rameters and the chain has converged, so these chains are stationary. We notice from
the trace plots that there is not any long term trend in our chains. As a result the local
average value of µ and τ in the chain is roughly constant. Similarly, we can see in the
autocorrelation plots, that the samples that we generated from MCMC using the Gibbs
sampler are almost independent samples.
3.4.8 Metropolis-Hastings algorithm
The Metropolis-Hastings algorithm arose when the algorithm of Metropolis et al. (1953)
was generalised by Hastings (1970). It is one of the MCMC algorithms that has been used
widely in the Bayesian framework. The aim of this algorithm is to sample realisations
from the posterior distribution π(θ|y). It is useful particularly when it is difficult to
sample from the FCDs.
Suppose we wish to sample realisations from the posterior density π(θ|y) and all of the
FCDs are non-standard. Furthermore, suppose that we have a proposal distribution with
density q(θ∗|θ), which can be easily sampled. This distribution can help us to propose
new values θ∗ from the current value θ. So the algorithm can be written as in Algorithm
3.
Algorithm 3: Metropolis-Hastings algorithm





3 α = min(A, 1).
4 sample U ∼ Unif(0, 1).
5 if U ≤ α then
6 θ(t) = θ∗.
7 else
8 θ(t) = θ(t−1).
9 end if
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3.4.9 Metropolis within Gibbs algorithm
If we have a posterior distribution with FCDs, it may be that some of these FCDs can
be sampled directly and others cannot. In the latter case we can use Metropolis-Hastings
updates. This type of algorithm is called Metropolis within Gibbs. This algorithm uses
each of the full conditional distribution in turn. In each case we either sample directly or
apply the Metropolis-Hastings update for the FCDs when direct sampling is difficult.
The selection of a suitable proposal distribution in a Metropolis-Hastings scheme for
the whole collection of unknowns could be cumbersome. Nevertheless, it is possible some-
times to sample from the FCDs for a subset of θ. Suppose that the full conditional
distribution for the jth component of θ is written as:
π(θj | θ1, θ2, ...., θj−1, θj+1, .., θn, y) = π(θj | θ−j, y) j = 1, ..., n.
A Metropolis within Gibbs algorithm is given by Algorithm 4.
Algorithm 4: Metropolis-Hastings Algorithm: Component-wise Transitions.











2. Obtain a new value θ(j) = θ(j)1 , θ
(j)
2 , ..., θ
(j)
n from θ(j−1) using consecutive values





θ1 | θ(j−1)2 , θ
(j−1)















θ2 | θ(j−1)1 , θ
(j−1)














θn | θ(j−1)1 , θ
(j−1)









3. Set j+1 and return to step 2
For the jth component of θ, if it is feasible to sample from a FCD of a known form,
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then we could do so.
3.5 Generalised linear model
3.5.1 Introduction
In Chapter 6, in the context of Bayes linear kinematics and Bayes linear Bayes models, we
will consider how non-Gaussian observable variables can be linked to corresponding vari-
ables in an underlying linear structure. This involves ideas related to those of generalised
linear models. Therefore, in this section, we introduce some basic ideas of generalised
linear models.
In a normal linear model, we typically write Yi ∼ N(µi, σ2) where




where β0, β1, ..., βp are the regression coefficients of the model and xij is the value of the
covariate j for observation i. So we can write the regression model as Yi = µi + εi, where
εi (i = 1, ..., n) have a normal distribution with a constant variance σ2 and they are
independent, i.e. Cov(εi, εj) = 0 for i 6= j. As a result, the requirements in the linear
model assume that the response variable must be continuous and normally distributed.
These requirements are not valid in many cases such as in social science research where
the outcome variable has dichotomous, ordinal or nominal outcomes. In such cases we
can often use generalised linear models (GLMs).
The GLMs are more complicated than linear models. Generally speaking, there is
not any closed form of the posterior distribution with these kinds of models so typically
MCMC methods are used to sample from the posterior distributions.
3.5.2 Linear predictors and link functions
In the linear regression model, we have
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Model Link function g(θ) Error distribution
Linear regression η = θ Normal distribution






Probit regression η = Φ−1(θ) Binomial distribution
Poisson regression η = log(θ) Poisson distribution
Complementary log-log η = log [− log(1− θ)] Binomial distribution
Table 3.2: Most common link functions with corresponding with their generalised linear models
(adapted from Lynch, 2007).
Now, we define and introduce the linear predictor as a linear combination of the model
parameters β in the following form




or, in matrix notation,
η = g [E(Y )] = g(µ) = Xβ.
As we can see, in the linear model µi = ηi whereas in a generalised linear model there
is a link function that links the mean and the the linear function: ηi = g(µi) where g(·)
is a known function called the link function. The link function must be monotonic and
differentiable. We notice that (3.11) does not have an error term and that is because the
expected value of Yi is the linear predictor.
In GLMs there are two important features: the conditional distribution of the response
variable Y, which need not be normal but it could be a member of the exponential family
and the link function which relates the mean of Y to the linear predictor. See Dobson
and Barnett (2008) or Faraway (2006).
Some common GLMs with their link functions are given in Table 3.2
3.6 Bayesian analysis for a logistic regression model
Suppose that we have the simple logistic regression model
ηi = g(xi, β) = β0 + β1xi. (3.12)
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where θ(xi) represents the probability of the event for subject i who has the covariate xi. In
the Bayesian framework, we should specify the prior density for the model parameters. If
the prior distribution for β0 and β1 is a bivariate normal distribution which is a common
selection (see for instance, Section 14.8 of Gelman et al., 2008) then our prior for the
intercept and the slope can be represented as
β = (β0, β1)
′ ∼ N(m,V ).
Now, in order to apply Bayes’ theorem, we need to determine the likelihood function


















The quantity π(1)(β0, β1|y) is called the posterior density for the parameters given the








Unfortunately, the expression in (3.13) is very difficult to evaluate, in particular the
integral in the denominator. So there are several methods which have been suggested to
compute the posterior density. One of them is use the numerical methods of approximation
such as a Laplace approximation or a quadrature method. Other methods that are widely
used in Bayesian inference are Monte Carlo methods such as MCMC methods and the
purpose of using those methods is to sample from the posterior distribution. See Section
3.4.
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3.7 Variable selection methods
3.7.1 Introduction
In most studies, we look for the prediction of a response variable using covariates in order
to explain the response. This relationship is unknown between the response and the
covariates. In a Bayesian analysis, if we have no particular reason to wish to avoid using
some covariates and we do not wish specifically to make inferences about the hypothesis
that a covariate has no effect, there is not usually any need to consider removing covariates.
This is particularly true when the sample size is large compared to the number of covariates
(eg Hoeting et al., 1999). However, in some cases, for example when the sample size is
small compared to the number of covariates or when costs associated with measurements
or computations are important, we may wish to select only a subset of covariates to use.
In this thesis, we are interested in variable selection because of its relevance to structure
learning in Bayesian networks. In the lung transplant example in Section 3.10 we have
many covariates and address the question of whether we need all of these covariates or
not. In this example, making a quick decision rather than waiting for all measurements
to become available has some benefits as the lungs deteriorate over time.
3.7.2 Bayesian variable selection methods
In the last 20 years, we have seen many approaches to tackle the area of Bayesian variable
selection (BVS). In this section we will concentrate on the principles of BVS methods. We
might use selection approaches when we have some uncertainty about the statistical model.
Assume that we have nmodelsM = (M1, ...,Mn) for data Y . UnderMn, Y ∼ p(Y |βn,Mn)
where βn is a vector of unknown parameters corresponding to the covariates in Mn.
Here, we need to use Bayesian techniques to assign a prior probability distribution
p(βn|Mn) and p(Mn) for each model. This specification can be recognised as a three stage
hierarchical mixture model to generate the data Y . See Chipman et al. (2001).
1. Sampling the model Mj from p(M1), ..., p(Mn).
2. Sampling the parameter vector βj from p(βj|Mj).
3. Sampling the data Y from p(Y |βj,Mj).
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Hence the probability that the “true” model was really Mj, conditioning on having
observed Y is the posterior model probability





We can write the marginal or (integrated) likelihood function of the model Mj averaged
over the possible values of model parameters as follows:
p(Y |Mj) =
∫
p(Y |Mj, βj)f(βj |Mj)dβj.
Depending on these posterior probabilities, the relative probability or posterior odds
between two models M1 and M2 is
p(M1 | Y )





p(Y |M1, βM1)p(βM1 |M1)dβ∫
p(Y |M2, βM2)p(βM2 |M2)dβ
. (3.14)
So, (3.14) demonstrates how we can use the data Y through the Bayes factor
∫
p(Y |M1, βM1)p(βM1 |M1)dβ∫
p(Y |M2, βM2)p(βM2 |M2)dβ
to update the prior odds p(M1)/p(M2) to obtain the posterior odds. See Chipman et al.
(2001).
In other words,
posterior odds = prior odds× Bayes factor.
3.7.3 Bayesian variable selection using Zellner’s g-prior
In variable selection, we should choose the prior distribution with care. In the linear
regression model, Y = Xβ + ε, we need to construct a family of priors in this model. So,
Zellner (1986) proposed a particular prior that belongs to the conjugate normal-gamma
family called a g-prior. In this prior
π(σ2) ∝ 1
σ2
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where βa is the prior mean of β and the prior variance−covariance matrix of β is a
scalar multiple g of the Fisher information matrix and that depends on the observed data
through the design matrix X.
3.7.4 Bayesian variable selection using reversible jump Markov
chain Monte Carlo
A reversible jump Markov chain Monte Carlo algorithm in Bayesian variable selection can
produce an MCMC chain which moves within the model space. See Green (1995). So, it
moves from model Mn to model Mn∗ by passing the choice of regression coefficients be-
cause the Metropolis-Hastings algorithm depends on f(y |Mn). Therefore after selecting
the model Mn∗ , we need to sample the parameters βn∗ .To generalise this method, the
joint sampling of the parameters βn and the model Mn should be used with a Metropolis-
Hastings approach. A proposal (βn∗ ,Mn∗) is generated from the proposal distribution
q(βn∗ ,Mn∗ | βn,Mn) (the combination of values from the space of parameter vectors and





∗ ,Mn∗ | y)q(βn,Mn | βn∗ ,Mn∗)




1, f(y | βn
∗ ,Mn∗)f(βn∗ |Mn∗)f(Mn∗)q(βn,Mn | βn∗ ,Mn∗)
f(y | βn,Mn)f(βn |Mn)f(Mn)q(βn∗ ,Mn∗ | βn,Mn)
)
where the second line follows from Bayes’ theorem. The proposal is done in 2 steps with
Step 1: A proposal for Mk∗ .
Step 2: A proposal for βk∗ which implies that
q(βn∗ ,Mn∗ | βn,Mn) = q(Mn∗ | βn,Mn)q(βn∗ | βn,Mn∗ ,Mn).
The challenge is to ensure that the detailed balance condition holds which means that
the move from model (βk,Mk) to model (βk∗ ,Mk∗) should be as easy as the opposite
move. However, it is not immediately clear how to guarantee this condition when the
dimensions of the model changes which occurs with variable selection. According to Chib
and Greenberg (1995), reversibility is guaranteed by the reversible jump MCMC approach.
See also Green (1995); Lesaffre and Lawson (2012).
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3.7.5 Spike and slab priors
3.7.5.1 Introduction
A method that combines variable selection with inference for regression parameters, makes
use of the variable selection priors known as spike and slab priors. These types of priors are
defined as a mixture of two distributions, spike and slab distributions where the spike prior
has a mass concentrated on zero and the slab prior has a possibly uniform distribution
over the range of that prior. See Walli (2010). Mitchell and Beauchamp (1988) suggested
these priors for BVS in normal linear regression models. They defined them as a mixture
of a Dirac measure concentrated at zero and a uniform diffuse component. Therefore we
can write the prior as
π(βi | δi) = δiπslab(βi) + (1− δi)πspike(βi)
George and McCulloch (1993) proposed an alternative spike and slab prior that can be
easily implemented in Gibbs sampler. This prior has the form
βi | δi ∼ (1− δi)N(0, σ2i ) + δiN(0, c2iσ2i )
where ci is large, ci > 1 and Pr(δi = 1) = 1 − Pr(δi = 0) = pi. In subsection 3.7.5.2 we
will illustrate two Bayesian variable selection (BVS) methods using spike and slab priors.
We will assume that the intercept β0 has a diffuse prior, β0 ∼ N(0, σ2β0) with σ
2
β0 large.
3.7.5.2 Gibbs variable selection using spike and slab priors
Dellaportas et al. (2002) proposed another method for BVS based on a spike and slab
prior. In their method which is called Gibbs variable selection (GVS), they introduced
variable indicators in the model. That is, the linear predictor of the model is equal to




where βk are the regression coefficients. The joint density of y, β, δ is
f(y, β, δ) = f(y, βk, β(k), δ) = f(y | β, δ)f(βk | β(k), δ)f(β(k) | δ)f(δ)
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Here, β(k) is the vector of regression coefficients excluding βk. After removing the
constant term, the full conditional distribution for the regression parameters is f(βk |
y, β(k), δ) ∝ f(y | β, δ)f(βk | δk).
Kuo and Mallick (1998) assumed that the prior of β is independent of δ, so that
f(βk | β(k), δ) = f(βk | β(k)). Now, f(y | β, δ) only contains βk when δk = 1. Removing the
constant terms then yields two expressions:
f(βk | y, β(k), δ) =
f(y | β, δ)f(βk | β(k)) if δk = 1f(βk | β(k)) if δk = 0
For GVS, it is also assumed that βk depends only on δk, i.e., f(βk |β(k), δ) = f(βk | δk).
Dellaportas et al. (2002) suggested taking
f(βk | δk) = (1− δk)N(µ0k, τ 20k) + δkN(µ1k, τ 21k) (3.16)
for suitable choices of τ 20k < τ 21k. Notice that f(y | β, δ) contains βk only when δk = 1 and,
combined with the prior in (3.16), the full conditional density for βk becomes
f(βk | y, β(k), δ) =
f(y | β, δ)N(µ1k, τ
2
1k) if δk = 1
N(µ0k, τ 20k) if δk = 0
where the distribution N(µ0k, τ 20k) is the prior when f(βk | δk = 0) and is called a pseudo-
prior, and the distribution N(µ1k, τ 21k) is the prior when f(βk | δk = 1). Finally, the full
conditional density for δk is Bernoulli with success probability πk/(1 + πk) with the odds
πk equal to
f(δk = 1 | δ(k), β, y)
f(δk = 0 | δ(k), β, y)
= f(y | β, δk = 1, δ(k))f(β | δk = 1, δ(k))f(δk = 1 | δ(k))
f(y | β, δk = 0, δ(k))f(β | δk = 0, δ(k))f(δk = 0 | δ(k))
.
See Lesaffre and Lawson (2012).
3.7.5.3 Stochastic Search Variable Selection using spike and slab priors
The Stochastic Search Variable Selection (SSVS) method was suggested by George and
McCulloch (1993) for variable selection in linear regression. The linear predictor is given
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by




where β1, ..., βd are assumed to have a mixture prior of spike and slab Gaussian com-
ponents. The spike element is a normal distribution concentrated closely around zero,
representing the real absence of the variable in the model. The slab component has a
large variance to allow for the “nonzero” coefficients to spread over a larger range of val-
ues. This kind of separation is being regulated by two tuning parameters τk and ck, where
τ 2k > 0 is the variance in the spike component and c2kτ 2k > 0 is the variance in the slab
component.
The components of the SSVS hierarchical prior are as follows:








1k, δk ∼ (1− δk)ψτ20k(.) + δkψτ21k(.),
σ2 ∼ IG(a0, b0),
δk | ωk ∼ Bern(ωk),
ωk ∼ U(0, 1).
with a0 = νδ/2 and b0 = νδψδ2 δk. Moreover, τ
2
0k = τ 2k and τ 21k = c2kτ 2k . Here, δk indicates
the component of the mixture (for δk = 0 the kth regressor is “practically zero”); ψx(.) is
the Kronecker delta concentrated at point x; νδ and ξδ possibly depend on δ and ωk is the
prior probability that βk is nonzero. For details see Lesaffre and Lawson (2012). SSVS
can be extended to GLMs without much difficulty (George et al., 1996).
3.8 Missing data
3.8.1 Introduction
In this section, we introduce some important definitions and assumptions that relate
to incomplete data. There is extensive literature which tackles the problem of missing
data from two points of view, the frequentist and Bayesian perspectives, such as Little
and Rubin (2014); Daniels and Hogan (2008); Raghunathan (2015); Molenberghs and
Kenward (2007).
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In real life applications, we do not always observe all of the planned data. Hence,
missing data are common in many applications. For example, suppose that we are aiming
to do the analysis for data that have some covariates with missing values. In this case,
reducing the number of cases by deleting those with missing values will not be an ideal
thing to do as our inference might be adversely affected. In this thesis, we will use
Bayesian inference to deal with the missing data problem.
In the case of completely observed data, it is not necessary to build the model for the
covariates. However, when there are missing covariate values, it is important to build a
model for the relationships among the covariates in the study. This is called a missing
data model. See Zhao (2010). We denote the observed data as Yobs, the missing values as
Ymiss, so Y = (Yobs, Ymiss) and θ is the parameter vector of interest.
3.8.2 Missing data mechanism
Suppose that we have the missing data indicator I which can take the value 1 if Y is
observed and 0 otherwise. So the joint probability distribution of (Y, I) is
f(Y, I|θ, ψ) = f(Y |θ)f(I|Y, ψ).
The conditional probability distribution for I given Y and the unknown quantity ψ
represents the missing data mechanism. In order to obtain the distribution of the observed
data, we need to integrate out the distribution of Ymiss as follows
f(Yobs, I|θ, ψ) =
∫
f(Yobs, Ymiss|θ)f(I|Yobs, Ymiss, ψ)dYmiss.
We can classify the missing data mechanism into different types of missingness termed
missing at random (MAR), missing completely at random (MCAR) and missing not at
random (MNAR). See Little and Rubin (2014); Tian et al. (2009).
3.8.3 Missing at random (MAR)
The missing data are said to be missing at random (MAR) if I is conditionally independent
of the missing values given the observed values, that is, if
f(I|Yobs, Ymiss, ψ) = f(I|Yobs, ψ).
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Then the likelihood function is




3.8.4 Missing completely at random (MCAR)
Sometimes we need to make a stronger assumption than MAR. We say that the missing
data are missing completely at random (MCAR) if the distribution of I does not depend
on either the missing or observed values, that is
f(I|Yobs, Ymiss, ψ) = f(I|ψ).
Notice that, in Bayesian inference, it is not usually necessary to assume MCAR. It is
usually sufficient to have MAR. The MAR assumption is more plausible when we observe
a large number of variables since the observed values are then more likely to provide
enough information to make missingness conditionally independent of the missing values.
3.8.5 Missing not at random (MNAR)
In the missing data mechanism, sometimes the MAR and MCAR conditions do not hold.
Then the probability of some quantity being missing depends upon unobserved data.
Therefore there is no simple way to represent the joint distribution. This type of mech-
anism is called missing not at random (MNAR). See Molenberghs and Verbeke (2005);
Daniels and Hogan (2008).
3.8.6 Missing data and Bayesian inference
In Bayesian inference, missing data can be treated like other unknown quantities and we
can integrate over their possible values to make inferences about model parameters. This
is often conveniently done using MCMC methods. However, if the data are missing not
at random (MNAR) then the data might not be informative about all model parameters.
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3.9 Data augmentation (DA)
3.9.1 Introduction
There are some models that have intractable likelihood functions which lead to more
difficult calculations. To make things more simple, we introduce extra variables which
are called auxiliary variables. In fact, these variables are not observed but if they were
observed that would make the likelihood more straightforward. Then we can treat these
auxiliary variables as if they were missing data. As a result, we can define the data
augmentation (DA) as the addition of unobserved auxiliary variables to the observed
data.
Tanner and Wong (1987) proposed the use of the DA method in the Bayesian context
in order to compute the posterior distribution. They introduce the term “data augmen-
tation”. See Imai and Van Dyk (2005).
3.10 Lung transplant example
3.10.1 Introduction
As an example we consider some data on lung transplants. See Andreasson et al. (2016,
2017). A lung transplant is surgery to remove a person’s diseased lung and replace it
with a healthy lung from a deceased donor. Lung transplants are used for people who are
likely to die from lung disease within 1 to 2 years. Lung transplants are not carried out
frequently in the UK, mainly due to the lack of available donors. During 2013−2014 there
were 198 lung transplants performed in England. See NHS (2016). In our data we have
30 covariates, with {X1, ..., X15} representing measurements on the inflammatory proteins
before ex vivo lung perfusion (EVLP) and {X16, ..., X30} representing the measurements
afterwards. Increasing the inflammatory proteins will deteriorate the lungs and as a result
the lungs will no longer be used in transplant. The study concerned the use of EVLP. This
is a technique for assessing and potentially reconditioning human donor lungs previously
unacceptable for clinical transplantation with the potential to dramatically push the limits
of organ acceptability. See Andreasson et al. (2014).
The response variable Y is a binary variable indicating whether or not the lung was
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used.
Suppose that we adopt the following model. We have a number of lungs n = 41 and
we have 30 covariates that might predict the use of the lungs. For illustration, we choose
some of these covariates. See the rjags model specification in Appendix A.3.2.
Then we suppose that Yi is an observation from the Bernoulli(θi) distribution. Let the
probability that the lung is used be
Pr(lung i used) = θi and Pr(lung i not used) = 1− θi.









βj(xij − x̄j) = x
′
iβ,
where β = (β0, β1, ..., β30)
′ and xi = (1, xi1 − x̄1, ..., xi30 − x̄30)
′ , xij is the value of the
covariate j for lung i and x̄j =
∑n
i=1 xi,j/n. The reason why we subtract the mean is
because it is easier to construct a prior by thinking about the middle of the covariates
rather than one of the ends.
Therefore the likelihood function for θ = (θ1, ..., θn)
′ is
L(θ | y) =
n∏
i=1













and (1− θi) = (1 + ex
′
iβ)−1.
Therefore, the likelihood of β can be written as







































Table 3.3: The prior summaries for some regression coefficients
We give β a multivariate normal prior distribution
β ∼ N(µ,Σ)
where µ is the prior mean vector and Σ is the prior variance and covariance matrix. We
set the prior mean for β0 for example, in the following way.
Suppose that we consider a lung where xij = x̄j for j = 1, ..., 30. Suppose that we
assess the probability that the lung will be used as P0. Then we use the logit function to






Now, to elicit the prior standard deviation, we can elicit assessments of the lower and















since Φ(1.35/2) = 0.75. In this way we obtain E(β0) and Var(β0).
By considering a lung where xi1 = x∗1 but xij = x̄j for j = 2, ..., 30, we can, in a similar
way, obtain a prior mean and variance for β0 + β1(x∗1 − x̄1) and hence a prior mean for
β1 and, if we judge β0 and β1 to be independent a priori, a prior variance for β1. We
can assess prior means and variances for {β2, ..., β30} similarly. The prior moments for
β0, ..., β8 are given in Table 3.3.
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In the example, some of the covariate values are missing, so we need a missing data
model. For instance, the first covariate X1 has some missing data. We adopt a normal
model for it:
X1 ∼ N(m1, V1)
with prior distributions for




For the second covariate X2, we also adopt a normal distribution, but the mean of
this covariate depends on x1 so that
X2 ∼ N(m2, V2)
where
m2 = β02 + β21(x1 −m1),




and so on. So we impose the order of the covariates in this example. In general,
Xj ∼ N(mj, Vj) where mj = β0,j +
j−1∑
k=1
βj,k(xk − mk) with β0,j ∼ N(m0j, V0j) and
βj,k ∼ N(mjk, Vjk).
3.10.2 Computing the posterior distribution in the lung trans-
plant example
The rjags software is used to compute the posterior distribution. A burn in of 6000
samples and then an additional 100000 Gibbs samples were used. Table 3.4 gives the
posterior summaries of the regression coefficient corresponding to the priors that were
mentioned in Section 3.10.1. Plots of the densities for these priors and posterior are given
in Figure 3.2.
Note that some of these posterior distributions are centred close to zero. So it may
be that we can simplify the model and the corresponding Bayesian network by setting
some of these coefficients to zero and omitting the corresponding arcs from the Bayesian
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Figure 3.2: Posterior and prior densities for coefficients in the lung transplant example (dashed
red: prior, solid blue: posterior).
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parameters mean S.D. 95% credible interval
β0 -0.444 0.451 (-1.346 , 0.458)
β1 -1.693 1.023 (-3.739 , 0.353)
β2 0.160 0.642 (-1.124 , 1.444)
β3 2.875 1.202 (0.471 , 5.279)
β4 0.631 0.699 (-0.767 , 2.029)
β5 0.906 0.452 (-0.461 , 2.274)
β6 -0.620 0.770 (-2.160 , 0.920)
β7 -2.177 1.336 (-4.849 , 0.495)
β8 -0.493 0.440 (-1.373 , 0.387)
Table 3.4: The posterior summaries for some regression coefficients
network.
The comparison of the prior and posterior standard deviation shows that all of the prior
standard deviations were bigger than the corresponding posterior standard deviations.
In fact, in this example we have many covariates with few observations, so we could
use the idea of variable selection. See Section 3.7. One possibility is that, before doing
EVLP, we might decide to use the lung straight away, on the basis of {X1, ..., X15} or a
subset of them.
Therefore, we need to use variable selection here because we might not need all the
covariates to decide whether to use the lung or not. There are two reasons why we prefer
to use variable selection in this example. One of them is making the calculations of the
probabilities easily and the other relates to time saved when we just measure some of the
covariates rather than all of them. As the lungs deteriorate over time, it may be better
to make a decision quickly rather than spend time making further observations.
3.10.3 Prior and posterior predictive distribution
The prior predictive distribution f0(y|x) is defined as the distribution of a new observation
which is marginalised over the prior and can be written as
f0(y | x) =
∫
f(y|β, x)π(β)dβ.
where π(β) is the prior density for β. The posterior predictive distribution f1(y|x) is
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where π(β|y) is the posterior density for β.
The probability that the lung is used when x = x∗ is given as







where x∗ = (1, x∗1, ..., x∗30)
′ and β = (β0, β1, ..., β30)
′
.
We can use an approximation method such as Monte Carlo integration in order to find
the posterior predictive probability. The posterior predictive probability depends on the
posterior distribution for β and the new observation of the covariates x∗i .
Therefore, the posterior predictive probability is approximately









where β(1), ..., β(N) are the samples drawn from the posterior distribution of β, π(β | y, x).






























Figure 3.3: Boxplot of the posterior predictive probability that Y = 1 for the lung transplant
example.
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3.11 Summary
In this chapter, we have given a general description of Bayesian analysis with some im-
portant terms and definitions that relate to it. We have investigated some numerical
integration methods such as the trapezoidal rule and Laplace approximation method as
we need them to compute the posterior mean and variance. We have discussed in this
chapter using different sorts of Monte Carlo integration, such as importance sampling,
Gibbs sampling and Metropolis Hastings. We mentioned some statistics that we need
to test the convergence of the samples in MCMC. We gave a motivational example to
illustrate the idea of using a Gibbs sampling algorithm to generate realisations from the
posterior distribution. We gave an introduction to GLM with the most common link func-
tions such as logit and probit. We have given some background about Bayes analysis for
logistic regression and some variable selection methods with different sorts of prior such as
spike and slab prior. We also demonstrated some concepts about missing data and data
augmentation because, in real life, we do not always observe all the observations from the
experiments. We used a logistic regression model to fit the data in the lung transplant
example. We obtained the posterior means and variances for all the coefficients in the
model and compared them with the prior distribution that we elicited. We investigated
the variable selection method from the Bayesian point of view for the lung example and
we found that it is important to use some of the covariates in this example rather than all
of them because in this case the lung deteriorates. We calculated the posterior predictive





Probabilistic graphical models (PGMs) are graphical representations of the problem un-
der research. See Pearl (1988); Lauritzen (1996); Koller and Friedman (2009). These
models have been used in a variety of applications for decades because they can be useful
to combine expert knowledge with the theory of probability. These models also have very
important aspects. First of all, we can visualise these models in an attractive way. Sec-
ondly, these models also can represent complex problems in a simple graph. Finally, we
can learn from the data and even construct a very large complex network because of the
rapid development of computer software. One of the most familiar sorts of PGMs that
we are interested in is called Bayesian networks (BNs). See Mateo Cerdán (2010).
This chapter introduces the methodology of Bayesian networks including methods for
learning both the structure and parameters from data. We will tackle the possibility
of using different methods for constructing Bayesian networks based on Markov Chain
Monte Carlo (MCMC) methods. The idea is to obtain the most optimal configuration of
the network and we review methods for choosing network structures.
We start in Section 4.2 by introducing some notation, definitions and important con-
cepts in Bayesian Networks. In Section 4.3, we give the main point for comparison between
regression models and BN models. There are two fundamental concepts in developing BNs
from data: parameter learning and structure learning. So we give a brief demonstration
about what they are in Section 4.4 and Section 4.5. We explain in detail two algorithms
to learn about the structure of the network, Grow-Shrink and Hill-Climbing, using an R
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package called “bnlearn”. See Scutari and Ness (2012).
In this chapter, we also describe different types of BNs such as the categorical, Gaus-
sian and hybrid and other types of Bayesian networks. In Section 4.11 we propose a
method called arc deletion in order to choose the most likely configuration. This de-
pends on an imposed ordering of the nodes. We apply this method to the non-Hodgkin
lymphoma data set.
4.2 The methodology of Bayesian networks
In this section, we will give some important definitions and notation related to graphical
models.
Bayesian networks (BNs) are very effective and flexible models to represent the prob-
abilistic relationship between variables. Bayesian networks also have different names:
Recursive graphical models, Bayesian belief networks, belief networks etc. The graph
G = (V,E) of a BN consists of a set of variables, nodes or vertices V = {X1, X2, ..., Xn}
and a set E of directed edges, arcs or arrows between these variables where the directed
edges represent the dependence relations between the nodes. If there is an arc from Xi
to Xj, then Xi is called a parent of Xj and Xj is called a child of Xi. If we define a path
between two nodes in the network, say A and B (i.e. A → B), then the following path
is not allowed in BN, A → B → A because it is cyclic graph. As a result, we refer to a
directed acyclic graph (DAG) as one representation of a BN. Therefore, we can write the
joint probability distribution function for all the variables as follows:
Pr(X1, ..., Xn) =
n∏
i=1
Pr(Xi | parents(Xi)) (4.1)
where parents(Xi) is the set of parents of Xi.
In order to construct a network we need to proceed in two stages. At the qualita-
tive level, we need to choose the graph (G) of the BN which satisfies the relationship
between the variables in terms of conditional dependence and independence relations. At
the quantitative level, the local probabilities are determined for the marginal distributions
at root nodes (a root node is defined as a node which has no parents) and the conditional
probability distributions for the other variables. As a result we can calculate the joint
probability distribution (global distribution) as a product of all these marginal and con-
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ditional distributions in the model. For more information, see Jensen (1996); Neapolitan
(2003); Korb and Nicholson (2004) and Scutari and Denis (2014).
Other important terms in BNs are ascendant and descendant. To explain the relation-
ship between the two concepts, suppose we have three variables X1, X2 and X3. Then, if
there is a directed path from X1 to X2 and there is a directed path from X2 to X3, we
called X1 an ascendant of X2 and X3 a descendant of X2.
As a result, in a BN, each variable is conditionally independent of its non-descendants
given its parents.
4.2.1 Causality in Bayesian networks
In this subsection, we give an explanation of a causal model in Bayesian networks. The
main feature of BNs is the directed edges between the vertices. Some networks can
represent cause and effect relationships between the nodes. So the causal model is defined
as a set of vertices K of a directed acyclic graph (DAG), where each vertex in the graph
matches to a different element of K, such as the example shown in Figure 4.1. In some
cases the relationship can be interpreted as a cause and effect relationship, where the
nodes refer to the variables in the model and the links indicate the direct causal influence
between the vertices. See Pearl and Verma (1995).
Smoking
Asthma Cancer
Figure 4.1: Causal network example.
From the network in Figure 4.1 we can infer that it could be that Asthma and Cancer
are the effect of a patient’s smoking or we can say that Smoking causes Cancer and
Asthma. It is sometimes more complicated to construct BNs with causal relationships
because we have to give the right meaning to the relations. Otherwise it does not make
sense from the scientific or medical point of view. See Margaritis (2003).
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Figure 4.2: D-separation (directed acyclic graph). Left: serial connection, Middle: diverging
connection, Right: converging connection.
4.2.2 D-separation
There are different ways to represent the relationships between the variables in a BN. Some
variables are directly related to each other and the rest are indirectly related with other
nodes in the network. Pearl (2000) introduces an important definition which is related to
a DAG called “d-separation” or directed separation. It can be defined as follows. Suppose
that we have two nodes such as A and B in a causal network, then for all the paths
between A and B, there is a middle node C which separates them in the following cases,
• if there is a serial connection or diverging connection when we observed the inter-
mediate node C. Or
• converging connection when there is no evidence about C.
See Jensen (1996); Korb and Nicholson (2004).
In order to explain Pearl’s idea of separation in a DAG, let us take the following simple
example. Suppose that we have three disjoint sets of nodes, for example, A, B and C
in a DAG (G). Then C is said to d-separate A from B, if A ⊥ B | C, i.e. Pr(A,B |
C) = Pr(A | C)Pr(B | C), where A ⊥ B | C means that A and B are conditionally
independent given C and Pr(A | C) is the conditional probability of A given C and no
evidence for its descendants.
We can represent the d-separation model in the DAGs in Figure 4.2.
The DAG on the left of Figure 4.2 can be represented mathematically as follows
Pr(A,B|C) = Pr(A,B,C)Pr(C) =
Pr(A)Pr(C|A)Pr(B|C)
Pr(C) = Pr(A|C)Pr(B|C).
since, Pr(A|C) = Pr(A)Pr(C|A)Pr(C) . So, C separates A and B.
Likewise, we can check if the node C separates A and B in the DAG in the middle of
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Figure 4.2 in the following expression
Pr(A,B|C) = Pr(A,B,C)Pr(C) =
Pr(C)Pr(A|C)Pr(B|C)
Pr(C) = Pr(A|C)Pr(B|C).
So, again, C separates A and B.
However, in the third case, on the right of Figure 4.2, there is no such simplification
and C does not separate A and B.
4.2.3 Markov blanket
A Markov blanket is defined as a set of nodes that separates a target node from the
rest of the nodes in the network which includes its parents, its children and other nodes
sharing a child. Figure 4.3 represents an example of a Markov blanket of node E when
the nodes {C,D} are the parents of the node E and the nodes {G,H} are the children of it
and the node F is the children’s other parent. The rest of the nodes such as {A,B,I} are
conditionally independent of E given the blanket {C,D, F,G,H}. See Scutari and Denis
(2014) and Ku laga (2006).
Figure 4.3: Markov blanket of node E.
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4.3 Comparison of Bayesian networks with regres-
sion models
The point of a BN is that, unlike a standard regression model where we do not specify a
distribution for the covariates, only a conditional distribution for the dependent variable
given the covariates, in a BN we specify the joint distribution of all variables so that we can
use it even when some are not observed. Specifying this full joint distribution allows us to
make predictions when only some variables are observed. There are some studies which
show that using BN models is preferable and gives an accurate results compared with
other regression models. See Witteveen et al. (2018); Gevaert et al. (2006). According to
Sesen et al. (2013), they illustrated that BNs are an efficient tool in survival studies and
able to predict the survival time for the patient more precisely.
4.4 Bayesian network parameter learning
4.4.1 Introduction
In constructing BNs, we often wish to learn about the values of parameters from data. If
we have a given DAG, G with P variables defined, then inference about the parameter θ
when we have observed some data D = {x1, x2, ..., xP} is called parameter learning. In
the case where all of the nodes in the BN are discrete or categorical variables with a finite
number of possible values, then we usually use the conditional probability table (CPT)
and this type of BN is called a multinomial Bayesian network. The main task here is to
make inference about all the values in the CPT when we have given a certain structure. If
we have the case where the CPT is unknown, then we can learn from the observed data in
order to produce the CPT. There are many algorithms that deal with parameter learning
in the case that we have complete data and the case when we observe one or some of the
variables in the data sets. See Ji et al. (2015).
We can learn about the parameters using either frequentist or Bayesian techniques.
Most of the material in this thesis deals with Bayesian methods. Therefore, we focus in
this chapter on parameter learning from the Bayesian point of view.
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4.4.2 Parameter learning with complete data set
In the case of learning about the parameters in a BN when we have complete data, there
is extensive literature. As a simple case suppose that we have a multinomial Bayesian
network. Suppose that we need to determine our uncertainty about the parameters θ =
{θ1, θ2, ..., θP} of a multinomial probability distributions using Bayesian inference, such
that ∑Pp=1 θp = 1. Therefore, the likelihood function in this case will be




where n1, ..., np are non-negative integers such that
∑P
p=1 np = n. We need to choose a
suitable prior distribution π(θ). The most appropriate and conjugate prior to use is a





As this is a conjugate prior, the posterior distribution will also be a Dirichlet distri-
bution with the hyperparameters {n1 + α1, n2 + α2, ..., nP + αP} as follows




See Buntine (1991) and Koller and Friedman (2009).
4.4.3 Parameter learning with incomplete data set
We can learn about the parameter values from the data after we specified a suitable
network and that can be done by computing the conditional probability distributions.
Many methods in statistical data analysis require complete data in order to obtain
the results. However, in real life, this condition does not always hold. Therefore, struc-
ture learning of BN and parameter learning by some methods in this case is analytically
intractable. See Riggelsen (2006). However, MCMC methods may be used.
We will focus on using MCMC methods to learn about the parameters in different
models with various types of missingness.
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4.5 Bayesian network structure learning
4.5.1 Introduction
The main idea behind a Bayesian network structure is the way that we can summarise
the conditional independence relationships among the variables graphically. In addition to
independencies, a BN structure can sometimes be interpreted as cause and effect relations
through the direction of edges. See Section 4.2.1. So, the parent node represents the
“direct cause” and the child node represents the “effect node”. See Margaritis (2003).
In some cases, the structure of a BN is chosen subjectively using expert opinion.
However, in other cases, we may wish to choose a suitable structure based on analysis of
data. In addition, learning a network may also take into account the prior information
about the independencies of the variables in the problem (for instance, obtained from
research or accumulated knowledge).
In the following sections, we explain in detail how we can develop Bayesian network
structure and learn about it from the data. The determination of BN structure is one
of the most challenging problems that people need to investigate. For example, some
causal BN can not easily be determined by experts and the structure and variables might
be changed when we add new data. We will use different types of algorithms in this
chapter in order to construct Bayesian networks. However, we concentrate on finding BN
structure using some Bayesian approaches and numerical techniques such as MCMC.
We will consider algorithms for constructing Bayesian network structure. For instance,
determining network structure is a combination of imposing an ordering of the nodes and
subsequent arc deletion. Bayesian methods such as Markov Chain Monte Carlo schemes
(MCMC) are used to pick the most likely configuration.
Some authors describe the selection of the network structure with greatest posterior
probability. Heckerman and Chickering (1995) describe the combination of prior knowl-
edge from experts with observed data in order to construct a BN with higher posterior
probability.
Suppose we have given been given data and we are aiming to find the posterior prob-
ability distribution for the structure of the network S and suppose that S∗ is the most
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likely structure that is supported by data, then
S∗ = argmaxS {Pr(S | D)} (4.2)
where S∗ is the best structure and D is the data. We apply Bayes’ theorem to (4.2) in
order to find the posterior distribution for S,
Pr(S | D) ∝ Pr(D | S)Pr(S)
where the likelihood function Pr(D | S) can be evaluated by integrating out θ, as in the
following expression
Pr(D | S) =
∫
Θ
Pr(D | θ, S)Pr(θ | S)dθ. (4.3)
For more details, see Husmeier et al. (2005).
4.5.2 Inferring causality
It is sometimes of interest to make inferences about whether one or more variables cause
other variables in the sense that a change in one or more variables brings about a change
in one or more other variables. Such a relationship is, of course, a stronger statement than
association or probabilistic dependence. A long and widely held view is that causality can
only be inferred from the results of controlled experiments in which the values of some
variables are deliberately changed and the changes in other variables are measured. More
recently the availability of network structure learning algorithms has led to the idea that
their use might allow inference about causality from observational data. However, such
an inference depends on being sure that there are no unobserved , hidden, variables which
might account for observed associations. See, for example, Section 7.1.4 of Jensen and
Nielsen (2007).
4.6 Bayesian networks for categorical variables
4.6.1 Introduction
As we know there are various types of variables that might be included in Bayesian
networks. For example, we have binary variables which can only take two values such as
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the variable sex can only take male or female. Categorical variables can take more than
two values. We can divide categorical variables into two groups, ordinal variables and
nominal variables. The ordinal variables are the variables that we can describe in ordered
categories such as patient’s condition (excellent, good, fair, poor). Nominal variables
are classified as unorderd categories such as eye colours (brown, blue, black, green). So,
constructing a BN for categorical variables requires that all the variables should contain
categorical data and the network is then described as a categorical BN. This discrete BN
can take the form of a conditional probability table (CPT).
4.6.2 Motivational example for categorical Bayesian network
Suppose we have the following Bayes network containing four nodes which is adopted
from Jensen (1996). They are Cloudy (C), Sprinkler (S), Rain (R) and Wet grass (W).
All four nodes are binary with two possibilities “TRUE” or “FALSE”. Suppose that we
have the structure shown in Figure 4.4.
Therefore, the joint probability distribution for the 4 variables in the network will be
Pr(C,S,R,W) = Pr(C) Pr(S | C) Pr(R | C) Pr(W | R,S).
So the probability that it is cloudy is 0.5. That is Pr(C) = 0.5 and Pr(not C) = 1 −
Pr(C) = 0.5. As we use a directed acyclic graph, we know that the two nodes Rain and
Sprinkler depend on whether it was cloudy or not. So, the node Rain has four possible
conditional probabilities which are
Pr(R | C) = 0.8,
Pr(R | ¬C) = 0.2,
Pr(¬R | C) = 0.2,
Pr(¬R | ¬C) = 0.8.
Likewise, the node Sprinkler also has four possible conditional probabilities as it depends
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P(C = F) P(C = T)
0.5 0.5
C P(R = F) P(R = T)
F 0.8 0.2
T 0.2 0.8
C P(S = F) P(S = T)
F 0.5 0.5
T 0.9 0.1
S R P(W = F) P(W = T)
F F 0.8 0.2
T F 0.2 0.8
F T 0.2 0.8
T T 0.2 0.8
Figure 4.4: A simple Bayesian network, adapted from Jensen (1996).
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on the node Cloudy as well and we can write these probabilities as
Pr(S | C) = 0.1,
Pr(S | ¬C) = 0.5,
Pr(¬S | C) = 0.9,
Pr(¬S | ¬C) = 0.5.
The last node in our network is Wet grass and because this node depends on both Rain
and Sprinkler, this node has 8 potential conditional probabilities which are shown in
Figure 4.4.
4.7 An introduction to the R package “bnlearn”
4.7.1 Introduction
The name of the R package “bnlearn” (Scutari, 2010) is an abbreviation of “Bayesian
network learning”. It is a R package that is used to learn about the structure of Bayesian
networks, estimate the parameters from frequentist and Bayesian perspectives, and make
some inference about the unknown quantities. There are many different algorithms that
we can use to learn about the structure. We will use one of the constraint-based structure
learning algorithms called the “Grow-Shrink (GS)” algorithm. We also use one of the
score-based structure learning algorithms called the “Hill Climbing (HC)” algorithm. See
Scutari (2010). In the following sections, we will give more details about each algorithm
with an illustrated example.
4.7.2 Grow-Shrink algorithm (GS) in bnlearn package
Margaritis (2003) suggested an algorithm called Grow-Shrink (GS) which depends on the
Grow-Shrink Markov blanket algorithm which we can describe as a simple Markov blanket
detection algorithm to learn about the structure of a Bayesian network. The main idea of
this algorithm is based on finding the structure for each Markov blanket say for example,
MB(b) in the network, where the node b ∈ V. Then for each b the GS algorithm works
to determine MB(b) in two phases: the grow phase and shrink phase. See Edera et al.
(2014).
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Algorithm 5: Grow-Shrink Algorithm, adapted from Margaritis (2003).
1 Ω ← ∅.
2 While ∃ F ∈ Z − {E} such that F 6⊥ E | Ω, do Ω ← Ω ∪ {F}. [Growing phase]
3 While ∃ F ∈ Ω such that F ⊥ E | Ω − {F}, do Ω ← Ω − {F}. [Shrinking phase]
4 B(E)← Ω.
In Algorithm 5, we start the growing phase with the empty set Ω. Then we add
variables to Ω unless they are dependent on E given the current contents of Ω. In this
case, we might add some variables which are actually outside the blanket which can be
identified and removed from the Bayesian network at the shrinking phase. See Margaritis
(2003).
4.7.3 Hill-Climbing algorithm (HC) in bnlearn package
This algorithm is one of the score-based structure algorithms which simply learn about the
structure of a BN based on heuristic optimisation methods. We can assign a network score
for each selected BN that reflects its goodness of fit and then the algorithm attempts to
maximise this score. See Scutari (2010). An example of this type of algorithm is a greedy
search algorithm such as the Hill-Climbing algorithm. The algorithm usually starts with
no arcs. At each iteration we can add an arc, delete an arc or reverse an arc provided
that we do not create a directed cycle. The most common score which is used in this
algorithm is the Bayesian Information Criterion (BIC).
Then we choose the structure that gives us the highest values of the score function.
The algorithm ends when no further increase can be made.
Algorithm 6: Hill-Climbing algorithm, adapted from Scutari (2010).
1 Select a network structure N which is usually empty but that is not necessary.
2 Calculate the score of N , defined as ScoreN = Score(N).
3 Put maxscore = Score(N).
4 If maxscore increases, repeat the following steps
5 (a) for every possible arc addition, deletion or reversal not resulting in a cyclic
network:
6 (i) Calculate the score of the modified network N∗, ScoreN∗ = Score(N∗).
7 (ii) If ScoreN∗ > ScoreN , set N = N∗ and ScoreN = ScoreN∗ .
8 (b) Set the new value of ScoreN in order to update maxscore.
9 Return the DAG N.
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work tenure response <30 31-45 >45 <30 31-45 >45
skilled
rent yes 18 15 6 34 10 2no 15 13 9 28 4 6
own yes 5 3 1 56 56 35no 1 1 1 12 21 8
unskilled
rent yes 17 10 15 29 3 7no 34 17 19 44 13 16
own yes 2 0 3 23 52 49no 3 2 0 9 31 51
office
rent yes 30 23 21 22 13 11no 25 19 40 25 16 12
own yes 8 5 1 54 191 102no 4 2 2 19 76 61
Table 4.1: Danish do-it-yourself
Another possibility is to use the Laplace approximation score function in order to
compute the posterior distribution for the parameters in the model structure. Using a
Laplace approximation can provide us with more efficient results but it is less accurate as
it uses approximate integrations. See Needham et al. (2007); Chickering and Heckerman
(1997).
Clearly the Hill-Climbing algorithm could be adopted to use other scores such as the
expectation of a utility function.
4.7.4 Motivational example
In this example, the data represent a sample of employed men in Denmark aged between
18 and 67. See (Hand et al., 1994). They were asked a question about whether they had
carried out work on their home. The response variable is yes or no, with four categorical
explanatory variables: Age: under 30, 31-45 and over 45, Accommodation type: apart-
ment or house, Tenure: rent or own, Work of respondent: skilled, unskilled, office. These
data are represented in Table 4.1.
We use the Grow-Shrink and Hill-Climbing algorithms with the BIC score function to
construct a Bayesian network for this example. The resulting DAGs are shown in Figures
4.5 and 4.6.
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Figure 4.5: Bayesian network structure learning based on Grow-Shrink algorithm.
Figure 4.6: Bayesian network structure learning based on Hill-Climbing algorithm.
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4.8 Bayesian networks for Gaussian variables
4.8.1 Learning the parameters in Gaussian Bayesian network
In this section, we discuss cases where we do not have a multinomial distribution network.
For instance, suppose we have a network where all the nodes are continuous random
variables and a multivariate normal distribution is considered to be appropriate. Let us
explain the idea how we can model a simple Bayesian network with three nodes A, B and
C. Suppose we have decided to use the network in Figure 4.7.
C
A B
A ∼ N(µA, σ2A) B | A,C ∼ N(µB|A,C, σ2B)
C | A ∼ N(µC|A, σ2C)
Figure 4.7: Gaussian Bayesian network for three variables.
Then, we have E(A) = µA = β0,A, since A = β0,A + εA and Var(A) = Var(εA) = σ2A.
Similarly, the mean and variance for the node C given that we have observed A are
E(C | A) = µC|A = β0,C + βA,C(A− µA).
and
Var(C | A) = σ2C|A = β2A,Cσ2A + σ2C.
and so on for the node B. In order to learn about the parameters in this network, we need
to make inference about the coefficients β0,A, β0,B, β0,C, βA,C, βA,B, βC,B and the conditional
variances σ2A, σ2B, σ2C in this simple model. We could use MCMC methods to fit this model
and evaluate the posterior mean and variance where we can use a multivariate normal
prior distribution for all β = (β0,A, β0,B, β0,C, βA,C, βA,B, βC,B)
′ and writing τG = 1/σ2G for
G = A,B,C, we give τG a gamma prior distribution with some parameters αG and λG.
70
Chapter 4. Bayesian networks
4.9 Other sorts of Bayesian networks
We have discussed simple multinomial and Gaussian networks represented by directed
graphs. There are other kinds of Bayesian networks. Here we briefly discuss some of the
most common types.
4.9.1 Hybrid Bayesian networks
In BNs, if we combine discrete variables, continuous variables and any other type of
variables such as interval censored variables in the network, such a network is called
a hybrid BN. Unfortunately, learning about the structure and the inference about the
parameters in hybrid BN needs special methods as the inferential problems for these
networks are less tractable. See Scutari and Denis (2014).
4.9.2 Dynamic Bayesian network models
The main difference between BN models and dynamic Bayesian network (DBN) models
is that the latter incorporate time series structure. We suppose in DBN that each time
slice is dependent on the previous time. There is extensive literature on DBN such as
Murphy and Russell (2002); Russell and Norvig (2016).
4.9.3 Influence diagrams
An influence diagram is a Bayesian network that includes decision nodes and a node
representing a value or utility function. See Kjaerulff and Madsen (2005). So we can
select the optimal decision based on maximising the expected utility function. The random
variables in an influence diagram can be represented with circles while the decision nodes
are represented with rectangles. See Howard and Matheson (2005).
4.9.4 Chain graphs
This type of graph is a mixture of directed and undirected networks, where the directed
networks represent the Bayesian networks and the undirected graphs represent Markov
networks. See Lauritzen and Wermuth (1989); Studenỳ (1998); Buntine (1995). Graphs
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Figure 4.8: Chain graph for 5 variables {A,B,C,D,E}.
of this type represent more complex probability distributions. Figure 4.8 represents an
example of a chain graph with 5 variables in the network. The components of this chain
are {A},{B} and {C,D,E}.
4.10 Information propagation in Bayesian networks
In this section, we describe briefly the problem of making inferences about the unknown
quantities in Bayesian networks using algorithms such as information propagation and
the Lauritzen-Spiegelhalter algorithm. See Lauritzen and Spiegelhalter (1988).
The Lauritzen-Spiegelhalter algorithm for a categorical network exploits the structure
of the network in computing the marginal distributions. The idea of this algorithm is that
the we have a structured joint tree which is basically a join tree. Then the information is
propagated through this joint tree. See Lepar and Shenoy (1998).
Now, for the Gaussian networks, all the variables in the network have Gaussian dis-
tributions. Therefore, the joint probability distribution for all of these variables is a
multivariate normal distribution. See Section 4.8 for an example of a Gaussian network.
We can write the joint probability distribution in a Gaussian network as a product of the
conditional distributions when each conditional density is independent normal as follows
f(xk|x1, ..., xk−1) ∼ N(µk, τk)
where µk = mk +
∑k−1
j=1 βjk(xj − x̄j). Notice that mk refers to the unconditional mean
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of xk and τk = 1/Vk, where Vk is the conditional variance of xk given we have observed
x1, ..., xk−1. See Geiger and Heckerman (1994).
However, in more complicated cases, simple tractable methods are not usually avail-
able. We can either use computationally intensive numerical methods or approximations.
See Needham et al. (2007); Wilkinson (2007).
In this thesis, Chapter 7, we propose a new method for such networks. This network
is called a Bayes linear Bayes prognostic network.
4.11 Proposed technique to construct a Bayesian net-
work
The main idea for this method is to construct a BN using arc deletion and an imposed
ordering of the nodes.
We use as an example, a subset of the variables in the non-Hodgkin lymphoma data.
So we are starting our model by assuming that the observational covariates such as Sex
and Age are independent and the lifetime distribution T depends on both of them.
The assumption of independence is acceptable since Sex and Age are always observed
so that we are always conditioning on both of them.
Bayesian methods such as Markov Chain Monte Carlo (MCMC) schemes are used to
pick the most likely configuration. The algorithm starts with:
Step 1: Fit the life time distribution which in this case the Weibull distribution.
Step 2: We then introduce the presence indicator I with I = 1 if the arc is present
and 0 otherwise.
Step 3: We have the product of those indicators. E.g.
IA(1− IB)IC
where A and C are present, B is absent. In general, for a network with N nodes, the




i (1 − Ii)1−Ii where Ii is the indicator for
node i.
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Step 4: Finally we calculate the posterior mean of the indicators which is the posterior
probability that those coefficients are non-zero. We also calculate the poste-
rior mean of a product of indicators which is the posterior probability of the
corresponding network structure.
See Appendix A.4.1 and Appendix A.4.2 for rjags specification and R code to apply this
algorithm.
4.11.1 Example: non-Hodgkin lymphoma
We apply this method to the non-Hodgkin lymphoma example, with the possibility of
fitting all the covariates at once and we find the most likely configuration as follows.
For illustration, we use six variables in the non-Hodgkin lymphoma example which are
Age, Sex, T, Wbc, Hb and Albumin. As we can see from the original BN in Figure 4.9, we
have 14 edges among all the nodes. After applying the MCMC approach, we obtain a BN
which is shown in Figure 4.10 which has 8 edges representing the relationships between
the nodes. This is because the posterior probabilities of some of the coefficients are very
close to zero. As a result, we dropped some of the edges.
We suppose that the log of survival lifetime has a normal distribution with
log(Ti) | xi,1, xi,2 ∼ N(µi, σ2)
where
µi = β0t + βx1,tx1,t + βx2,tx2,t
and
β0t ∼ N(µ0t, σ20t)
βx1,t ∼ N(µ1t, σ21t)
βx2,t ∼ N(µ2t, σ22t).
Suppose the indicator for Sex is Xi,1. Then
Xi,1 ∼ Bern(p) , p ∼ Beta(2, 3)
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Figure 4.9: Fully-connected (apart from Age and Sex) Bayesian network for non-Hodgkin lym-
phoma data with imposed ordering of the nodes.
Figure 4.10: Most likely configuration which depends on the posterior probability of the coeffi-
cients which are non-zero.
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Arcs Net1 Net2 Net3 Net4 Net5 Net6
Age → Wbc 0 0 1 0 1 0
Hb → Wbc 0 0 0 0 1 1
T → Wbc 1 1 0 1 0 1
T → Hb 1 0 1 1 1 1
Age → Hb 1 1 0 0 0 1
Sex → Hb 0 0 0 0 0 0
Age → T 1 1 1 1 1 1
Sex → T 1 1 1 1 1 1
Sex → Wbc 1 1 1 1 1 1
T → Albumin 0 0 0 0 0 0
Age → Albumin 0 0 0 0 0 0
Sex → Albumin 1 1 1 1 1 1
Hb → Albumin 1 1 1 1 1 1
Wbc → Albumin 0 0 0 0 0 0
Table 4.2: The posterior probabilities for the first six most likely configurations based on the
original network that have been chosen from all possible configurations.
Suppose that the Age is represented by Xi,2. Then




, τage ∼ Gamma(3, 2)
The bar chart in Figure 4.11 demonstrates the contribution of each arc in the network
by taking the mean of all the nodes which are represented in Table 4.2.
From Figure 4.11, we notice that we have eight arcs with posterior probability greater
than 0.5. For instance, there is an arc from Age to T since the posterior probability for
this arc is 1, etc.
Finally, we conclude that there is not an arc from T to Albumin since the posterior
probability for this arc is 0.
76


































































































Figure 4.11: Bar chart representing the posterior probabilities that the arcs are present.
4.12 Summary
In this chapter, we have demonstrated some methodology about probabilistic graphical
models, especially Bayesian networks. We have defined some concepts that relate to BNs.
We compared Bayesian networks with the other models such as regression models. We
explained in detail the two key phases in constructing Bayesian networks from data which
are parameter learning and structure learning. We described the R package “bnlearn”
which is used to learn about the structure of the network and make inference about the
parameters using both frequentist and Bayesian analyses. We explained two algorithms
that can be used to construct Bayesian networks, the Grow-Shrink and the Hill-Climbing
algorithms and we gave a motivational example to apply these algorithms. We talked in
brief about different sorts of Bayesian networks. We demonstrated the use of MCMC to
select Bayesian network structure in order to choose the most likely configuration in terms
of the posterior probability. This method can reduce the number of nodes or edges and
that led to making the calculation for the network simpler than for the fully connected
network. We applied this method to the non-Hodgkin lymphoma example and obtained
the new proposed configuration.
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In this chapter, we explain some basic features of survival analysis and some important
definitions that are related to our work. Generally speaking, in survival, we regard the
starting point as “fixed” and we observe the time until some end point. For example,
birth to death, time from cancer remission to recurrence and the time from first heart
attack to second. An important aspect for this type of analysis is censoring. For more
details, see Clark et al. (2003); Aalen (2008); Collett (2015); Ibrahim et al. (2001); Cox
and Oakes (1984); Moore (2016).
In Section 5.2, we give a short outline of the general background of survival models
including some features of those models and the important definitions that we need to deal
with that type of data. In Section 5.3, we explain some important features that relate to
survival analysis. We give a general overview of the most common survival models which
for example allow the hazard function to be related to some predictive variables. These
kinds of models include proportional hazard models which we illustrate in Section 5.5. In
Section 5.6, we explain prognostic indices and how we can calculate an index based on a
survival analysis. In Section 5.7, we demonstrate with details the most familiar parametric
models in survival analysis, such as the exponential and Weibull distributions. In Section
5.8, we refer to using Bayesian inference in survival analysis using MCMC techniques to
make inference about the coefficients of the covariates in the model. In Section 5.9, we
use Bayesian survival analysis and particularly a R package called rjags with the model
specification to make inference about the coefficients and apply that to the leukemia data
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set and show some results.
5.2 General background on survival analysis
There are some reasons why the survival models are different from standard regression
models. The main reason is that survival distributions are restricted to (0,∞) and typ-
ically not symmetric but are positively skewed while often, in other regression models
we assume that the data follow the Gaussian distribution. Moreover, survival data often
include censored observations. There are two possibilities to deal with this sort of data.
First, we can resolve the problem of asymmetry in survival data by transforming the data
using, for example a logarithmic transformation and secondly, we can adopt other suitable
distributions that fit the survival data such as the exponential and Weibull distributions.
5.3 Some important aspects of survival data
5.3.1 Censored time
Let T be the time from a well-defined point known as the starting point until the oc-
currence of an event of interest. Then we refer to T as either a survival or failure time.
These survival times are often censored and it is known as a censored time C. There are
three common types of censoring in survival analysis.
Right censoring (happening frequently in survival analysis) occurs when we do not
observe T but know that (T ≥ C). It might occur often for different reasons, such as
the patient is still alive after the study ends or failure to keep in contact with him/her
because he/she moved to another country.
Left censoring (less common than right censoring in survival) occurs when we do not
observe T but we know that the event occurred before a particular time (recruitment)
(T < C). For example, suppose that a study was conducted to investigate the time to
tumour recurrence following surgical resection of the original tumour from its primary
site. During periodic six-month surveillance to detect tumour recurrence, certain patients
were found to be positive for new tumour masses at the original or metastatic sites. Since
such recurrence might have occurred before the patients attended the follow-up sessions,
their actual recurrence time should therefore be less than six months. See Collett (2015).
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Interval censoring was explained in depth in Zhang and Sun (2010). It occurs when
T is known to lie between two times C1 and C2, (C1 < T < C2) but the precise value is
unknown. This type of censoring is more unusual in survival data. For methods to deal
with these data, see Andreas (2011).
5.3.2 Independent and non-informative censoring
There are a large number of statistical methods that use failure time data with the
assumption that the censoring is noninformative of the failure time. This means that the
observation that the patient is censored at time c, can tell us only that T > c. Suppose
that we have the possible censoring time Ci, so the noninformative censoring can be
achieved by saying that Ci is independent of Ti, i = 1, 2, ..., n. So if we have a group of
patients who have the same values of prognostic variables, the patient that has a censored
survival time c, should be considered as representative of all other patients in that group
who survive to time c. See Collett (2015); Klein and Moeschberger (2005); Kalbfleisch
and Prentice (2011) for more detail.
5.4 Survival function, hazard function and cumula-
tive hazard function
Let Ti be the survival time which is measured from the start date, for example the date
of the diagnosis of patient i. The lifetime distribution function is
Fi(t) = Pr(Ti < t).
The survival function is
Si(t) = Pr(Ti > t) = 1− Fi(t)
which represents the probability that patient i will survive at least until time t. Notice
that, since T is non-negative, therefore, Si(0) = 1 and lim
t→∞
Si(t) = 0.
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We can specify the relationship between the hazard function and the survival function
























du = − logSi(t).
Hence,
Si(t) = exp[−Hi(t)]
where Hi(t) is the cumulative hazard function, which measures the sum of the risks that
the patients face between 0 and t.
5.5 Survival models
5.5.1 Proportional hazard models
In survival analysis, we might be interested in building models which allow the hazard
function to be related to some explanatory or predictive variables. Therefore, the hazard
function hi(t) depends upon the values of the variables that we measured or observed for
the patient i. For instance, if we have three variables, (X1, X2, X3), the values taken for
patient i are, (xi,1, xi,2, xi,3). If X3 is the age in years of the patient at diagnosis, so for
patient i, we might have xi,3 = 65.
The proportional hazard model was suggested by Cox (1972). It is a regression model
which is commonly use in medical research to investigate the relationship between the
survival time for patients and one or more predictive variables. The proportional hazard
assumption is very common in survival data analysis. Although the Cox regression model
involves a semi-parametric model, we can also have a parametric proportional hazards
model. This model can be formulated as follows. Suppose we have values of the variables
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(xi,1, xi,2, ..., xi,p) taken from the patient at diagnosis. Then the hazard of death of patients
at a specific time depends upon (xi,1, xi,2, ..., xi,p). We can write the proportional hazard
model as
hi(t) = h0(t) exp(ηi)
where h0(t) is the baseline hazard which is the same for all patients and ηi is a linear
predictor (combination) of the p explanatory variables in xi where xi = (xi,1, ..., xi,p)
′ . So,
ηi = β0 + β1xi,1 + β2xi,2 + · · ·+ βpxi,p
The linear predictor ηi is also called the risk score or prognostic index of the patient i.
The coefficients (β0, ..., βp) have unknown values and we use our data to make inference
about these values.
Suppose we have two patients i and j, who have different x−values. Therefore, the
hazard function for patient i is
hi(t) = h0(t) exp(β1xi,1 + β2xi,2 + · · ·+ βpxi,p)
and, the hazard function for patient j is
hj(t) = h0(t) exp(β1xj,1 + β2xj,2 + · · ·+ βpxj,p).
As a result, the ratio of hazards for patients i and j is
hi(t)
hj(t)
= h0(t) exp(β1xi,1 + β2xi,2 + · · ·+ βpxi,p)
h0(t) exp(β1xj,1 + β2xj,2 + · · ·+ βpxj,p)
= exp(β1xi,1 + β2xi,2 + · · ·+ βpxi,p)exp(β1xj,1 + β2xj,2 + · · ·+ βpxj,p)
= exp(β1[xi,1 − xj,1] + β2[xi,2 − xj,2] + · · ·+ βp[xi,p − xj,p]) (5.2)
Based on (5.2), it is obvious that hi(t)/hj(t) does not depend on t.
In order to use a parametric hazard model, we should give h0(t) a particular functional
form which may involve one or more unknown parameters. For example, if we use a
Weibull distribution, then the hazard function is
hi(t) = γλitγ−1
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where λi = exp(ηi) and where ηi = β0 + β1xi,1 + · · · + βpxi,p and β0, ..., βp and γ are
unknown parameters.
Directed acyclic graphs (DAGs) are a very attractive and flexible way to represent the
(in)dependence relationships between the variables in the model. Figure 5.1, shows the
case when we know all the values of the parameters in the survival model (the coefficients
of the predictive variables and any other unknown parameters). The lifetime variable T is
stochastically dependent on the linear predictor η which in turn depends deterministically
upon the predictive variables (X1, X2, · · · , Xp). The double ring around η indicates that
it has deterministic dependence on its parents.
T
η
X2X1 Xp. . .
Figure 5.1: Basic survival model
5.5.2 Piecewise constant hazard model
We will use a piecewise constant hazard model for the leukaemia data later in Chapter
7 to illustrate Bayes linear kinematics. We are interested in making inferences about
the model parameters using different methods such as full Bayes and non-conjugate prior
methods.
We can define a piecewise constant hazard model (PCH) as a model in which the time
is divided into disjoint intervals, and then we specify a constant hazard in each interval.
However, those hazards are allowed to be different from interval to interval.
So, we choose fixed time points s0, s1, ..., sk, where s0 = 0 and sk → ∞. We can also
define the kth interval as [sk−1, sk). Therefore, the baseline hazard function for interval
sk−1 ≤ t < sk will be
h0(t) = λ0,k
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and the hazard function for patient i is
hi(t) = λi,k = φi,kλ0,k = eηi,k .
where ηi,k = x
′
iβk is the linear predictor, x
′
i = (1, xi,1, ..., xi,J) and βk = (βk,0, ..., βk,J)
′
.
As a result, the integrated hazard function Hi(t) =
∫ t




λi,r(sr − sr−1) + λi,k(t− sk−1),
for r = (1, ..., k − 1).
Now, we can write the survival function and the probability density function for patient
i at time sk ≤ t < sk+1 conditioning on T ≥ sk respectively as
Si(t | T ≥ sk−1) = exp[−λi,k(t− sk−1)],
and
fi(t | T ≥ sk−1) = λi,k exp[−λi,k(t− sk−1)].
If we fix βk for all k and k = 1, ..., K then this is a proportional hazards model.
5.5.3 Accelerated failure time model
An accelerated failure time or accelerated life model is the same as the usual linear
regression models except that the response variable in the accelerated failure model is
just the log of the survival times. See Zhou (2015); Wei (1992).
This model has a survival function which differs from the survival function in a pro-
portional hazard model. In a proportional hazard model, we scale the hazard function
while, in an accelerated life model, we scale time in the following method.
Suppose that we have the base line survival function S0(t). Then we assume that the
survival function for patient i takes the form
Si(t) = S0(ζit)
where ζi is a positive constant called the acceleration factor for patient i. Therefore, we
can make ζi depend on the covariates for each patient. So, in order to specify the model
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we need to specify the baseline S0 and constants ζi. We set log(ζi) = ηi = β0 + β1xi,1 +
· · ·+ βpxi,p where xi,1, ..., xi,p are the covariate values for patient i.
5.6 Prognostic index
5.6.1 Introduction
We use prognostic indices to predict the outcome in patients with a certain disease. The
value of the prognostic index depends on the clinical information about patients. A
prognostic index can be useful to make a decision about the appropriate treatment for
the patients. Henderson et al. (2001) mentioned the significance of using the prognostic
indices in different situations. These included its use in the selection of treatments by
clinicians, especially for a fatal disease, and its importance for the patients and their
families to know and think about the future scenario in the remaining years for their
patients by supporting and giving them the hope for the best in their lives.
The prognostic index is defined mathematically as a linear predictor based on the
explanatory variables in the model. In a proportional hazards model, the prognostic index
of patient i represents the logarithm of the multiplier of the hazard function of patient i.
(i.e., if hi is the hazard function, then hi(t) = h0(t)eη̃i , where h0(t) is the baseline hazard,
so the prognostic index η̃i = log[hi(t)/h0(t)]. A greater value for it corresponds to worse
prognosis.
5.6.2 Computing the prognostic index
A prognostic index is an index of the prediction of the survival time for the patients
with a certain disease. In order to calculate this index, we might fit one of the survival
models, say a Weibull distribution. Suppose that we have a survival lifetime distribution,
Ti ∼Weibull(α, eηi), where α is the shape parameter in the model and λi = eηi is the scale
parameter. So, ηi = log(λi) is the prognostic index for patient i, where (i = 1, 2, ..., n).
We can write the prognostic index in the following way
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where (β0, β1, . . . , βJ) are the regression coefficients of interest and xi,j are the covariates
in the model.
Given a set of data on past patients, we can find the posterior distribution of the
coefficients β0, β1, ..., βJ . Since the index η is linear in these coefficients, the predictive
mean of η for a new patient with given covariate values can be found using the posterior
means of β0, ..., βJ .
To make the index more interpretable for users, we can convert it to a [0, 100] scale.
If we have a large data set of past patients from the same or a similar population, we
can compute the index for all patients in this data set. Then, if these past index values,
in increasing order, are η(1), ..., η(n) and the values for a new patient is η∗, we base a
transformed index on the rank within this data set I = 100[R(η∗) + 0.5]/(n + 1) where
R(η∗) = max(j : η(j) < η∗) where η(0) → −∞ and η(n+1) →∞.
Alternatively, if the distribution of past η values is approximately normal, perhaps
after transformation, we might find the sample mean mη and sample standard deviation
Sη and calculate I = 100Φ ([η∗ −mη]/Sη), where Φ() is the standard normal cumulative
distribution function.
5.7 Parametric models in survival analysis
5.7.1 Exponential survival model
The exponential distribution has an aspect that its hazard function does not depend on t.
It is a special case of the Weibull distribution. Suppose we have observations (t1, t2, ..., tn)
′
which are independent and identically distributed (i.i.d.) from the survival model. This
model is an exponential model with one parameter λ which has the probability density
function, f(ti | λ) = λe−λti . Let (δ1, δ2, ..., δn)
′ be the censoring indicators, where δi = 0
if ti is a censored observation and δi = 1 if ti is a survival time observation. The survival
function for an exponential distribution is S(ti | λ) = e−λti . The hazard function is







The likelihood for patients i = 1, . . . , n with death or right censoring times t1, . . . , tn
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where δi = 1 for a patient whose death time ti is observed and δi = 0 if the lifetime is
censored at time ti.














5.7.2 Weibull survival model
We will use a Weibull model with Bayes linear kinematics in a Bayes linear kinematic
prognostic network in Chapter 7.
The Weibull distribution has an additional parameter, α, called the shape parameter.
The survival function for a Weibull distribution is
S(ti | λ) = exp(−λtα).
Therefore the probability density function is
f(ti | λ) = αλtα−1 exp(−λtα),
and the hazard function is
h(ti | λ) = αλtα−1.
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5.8 Bayesian inference in survival analysis
5.8.1 Introduction
There is literature that deals with using frequentist methods in survival analysis. However,
we are interested in this thesis to use Bayesian methods such as MCMC method. We can
also use Bayesian inference in survival analysis in order to make some inferences about
the unknown parameters in the model. We can fit different sorts of models in survival
such as exponential, Weibull and Weibull mixture models, etc. We use rjags to fit
all these models with different types of data sets such as the non-Hodgkin lymphoma
data and leukemia data. In the following sections we illustrate how we can find the
posterior distribution for the parameters of interest using Bayesian methodology. For
further information, see, for example, Ibrahim et al. (2001).
5.8.2 Bayesian analysis for exponential lifetime distribution
The likelihood function for the exponential distribution is given by (5.5).
The conjugate prior for λ is a gamma density with two parameters. The first parameter
α is called the shape parameter and the second parameter β is called the rate parameter.
The prior density is
π(λ | α, β) ∝ λα−1e−λβ (5.6)
Hence, combining the prior density and the likelihood in (5.5) and (5.6) respectively,
we obtain the posterior density as follows
π(λ | t, δ, α, β) ∝ π(λ | α, β)L(λ | t, δ)






Based on (5.7), the posterior density is a gamma (α1, β1) distribution, where α1 = α+d
and β1 = β +
n∑
i=1
ti. The posterior mean and posterior variance are given respectively as
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and







Likewise, in order to calculate the posterior predictive density of a future observation
tf , we have
f(tf | t, δ, α, β) =
∫ ∞
0
f(tf | λ)π(λ | t, δ, α, β)dλ
where f(tf | λ) = λe−λtf . Therefore, the posterior predictive density is

































Γ (α + d) ×
























where (5.8) represents the kernel of the posterior predictive density when tf > 0.
5.8.3 Bayesian analysis for Weibull lifetime distribution
Suppose X is a design matrix with dimension n× (j+ 1) where the ith row of X indicates
the covariate values of patient i, Xi = (1, xi,1, xi,2, ..., xi,j), n is the number of patients
and j is the number of covariates that are used in the model. Let T be the survival times,
T = (t1, t2, ..., tn)
′ . The censoring indicator δi (as in Section 5.8), represents whether a
patient’s death time ti is observed or right censored.
Suppose that the lifetime random variable T has a Weibull distribution with two
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parameters (γ, λ) and the data we use are subject to right censoring. Therefore, the
probability density function for a patient i is given by
f(ti | λi, γ) = λiγtγ−1i exp(−λit
γ
i ).
Let the number of patients whose death time ti is observed be nd and the number of
patients who had right censoring be nc. The scale parameter λi of a patient i depends on
the covariates,
λi = exp(ηi) = exp(x
′
iβ)
where β = (β0, β1, ..., βp)
′
, β0 is the intercept and βj is the regression coefficient for the
jth covariate.
The linear predictor ηi for the ith patient is given by




So the survival function for the ith patient is
S(ti | λi, γ) = exp(−λitγi )




fi(ti | λi, γ)
][∏
i∈c
























where c and d are sets representing the censoring and the observed times respectively.




log λi + (γ − 1) log ti
]






To apply Bayesian inference, we need the prior density for the unknown parameters.
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In this case, suppose that γ and λ have independent prior distribution.
Our prior distribution for the regression coefficient β will have a multivariate normal
prior distribution β ∼ Np+1(µ, V ) and we use a gamma prior distribution for γ. The





(β − µ)′V −1(β − µ)
]}
.
Here µ is the prior mean vector µ = (µ0, µ1, ..., µp)
′ and V is a covariance matrix with
dimension (p+ 1)× (p+ 1).
Suppose γ ∼ Gamma(a, b), so the prior density will be





The joint posterior density for γ and β is given by
π(γ, β | D) ∝ π(γ, β)L(γ, β | D).
So













− bγ − 12(β − µ)
′
V −1(β − µ)
} (5.9)
We notice that (5.9) does not have a closed form, so there is need for numerical
integration or MCMC methods. As a result, a Metropolis-Hastings algorithm should be
used to evaluate the posterior distribution for γ and β. See Consul (2016).
5.8.4 Example: inference about the two parameters of Weibull
distribution in the non-Hodgkin lymphoma example
In this Bayesian analysis for the Weibull distribution, we use a Metropolis-within-Gibbs
algorithm and apply it to the non-Hodgkin lymphoma data.
Suppose the random variable T has a Weibull distribution with two parameters α and
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λ. Then the likelihood function will be














where δi is the event indicator. Let t = (t1, ..., tn)
′ and δ = (δ1, ..., δn)
′
.
Now, in order to make inference about α and λ, we need to specify the prior for the two
quantities. So, we suppose that α and λ are independent. In addition, α ∼ Gamma(a, b)
and λ ∼ Gamma(r, s).
Therefore, the posterior distribution will be
π(α, λ|t, δ) ∝ π(α)π(λ) L














Then the full conditional distribution (FCD) of α is
π(α|λ, t, δ) = π(α, λ|t, δ)
π(λ|t, δ)
∝ π(α, λ|t, δ)














and the FCD of λ is














We notice that, the posterior distribution of λ has a closed form. However, the poste-
rior distribution of α does not have a closed form, so we can use MCMC methods to draw
samples from that distribution using a Metropolis within Gibbs algorithm. A R function
is written in Appendix A.5.1 to generate samples from the posterior distribution of α and
λ.
To sample α in this case, we have to use a proposal distribution of α, say α∗ ∼ N(α, σ2α)
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α∗(a+nd)−1 exp[−bα∗] exp [(α∗ − 1)∑ni=1 δi log(ti)] exp [−λ∑ni=1 tα∗i ]
αa+nd−1 exp[−bα] exp [(α− 1)∑ni=1 δi log(ti)] exp [−λ∑ni=1 tαi ]
The results in Figure 5.2 show that our samples for both parameters using Metropolis
with Gibbs algorithm are mixing well and the chains converged.
Figure 5.2: Trace plots, the autocorrelation plots and posterior densities for α and λ.
5.9 Bayesian survival analysis using rjags
5.9.1 Introduction
In this section, we explain how to fit a lifetime distribution using rjags. The MCMC
algorithm uses data augmentation (see Section 3.9) to deal with censored lifetimes. The
censored lifetimes are sampled at each iteration of the Gibbs sampler. While, in this case,
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this is less computationally efficient than writing code to evaluate the exact likelihood, it
is convenient especially in more complicated models.
5.9.2 Leukaemia example
As an example we use the leukemia data set, and an exponential distribution for the
lifetime Ti. So
Ti ∼ exp(λi)
where i = 1, ..., n. Therefore, the probability density function (pdf) for the lifetime distri-
bution Ti is
f(ti|λ) = λe−λti .
The data were collected by North-West Leukemia Register in the UK for n = 1043
patients from 1982 to 1998. These are right censored data where 879 patients died and
164 were censored. The variable of interest in this study is the time in days until a patient
dies.
There are four covariates in this study. See Section 2.3.2. We code them as follows.
1. The age, Ai in years of patient i. We define xi1 = Ai − 60.
2. The sex of the patient. We have, xi2 = −1 if the patient is female and xi2 = 1 if the
patient is male.
3. White blood cell count (WBC) Wi at the time of diagnosis with 1 unit= 50× 109/l.
We use xi3 = Wi − 8.
4. The Townsend score, used directly as the covariate xi4.
The time for patient i is ti and the event indicator is δi where δi = 1 if it is an observed
death time and δi = 0 if it is a censoring time.
5.9.3 Model specification for leukemia data
The model specification for the exponential survival time for the leukemia data has been
written in rjags in Appendix A.5.2.
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We have then 4 coefficients in this model, β = (β0, β1, β2, β3, β4)
′ , where β0 is the
intercept, β1 is the coefficient of age , β2 is the coefficient of sex, β3 is the coefficient of
wbc and β4 is the coefficient of the deprivation score in our model. These coefficients are
given independent normal prior distributions. The prior means, prior standard deviations,
posterior means and posterior standard deviations are given in Table 5.1. The likelihood
is given in (5.4) and (5.5).
5.9.4 Results
We fitted the exponential survival model to the leukemia data set with 100000 iterations
and two chains. Figure 5.3 shows the trace plots and the densities for the coefficients.
Table 5.1 shows the posterior means and standard deviation for these coefficients. We
can say that all the coefficients in this model show good mixing. Therefore, the local
averages of all β = (β0, βage, βsex, βwbc, βdepscore)
′ in the chains are roughly constant.
Prior Posterior
Parameter Mean SD Mean SD
β0 -6.90 0.12 -6.52 0.048
βage 0.040 0.030 0.039 0.002
βsex 0.050 0.150 0.148 0.061
βwbc 0.080 0.173 0.004 0.001
βdepscore 0.120 0.110 0.021 0.009
Table 5.1: Prior and posterior means and standard deviations for each of the coefficients in the
exponential survival model.
Now, suppose we consider new patients. That means we are interested in plotting the
survival function for these particular patients, for example, male and age 63, etc. There-
fore, we have λ for that patient denoted λ∗. If the posterior median for λ∗ is λ∗m and the
lower and upper limits of the 95% interval are λ∗0.025 and λ∗0.975 respectively, then the cor-
responding quantities for the survival probability at time t are exp(−λ∗mt), exp(−λ∗0.025t)
and exp(−λ∗0.975t). These are plotted against t in Figure 5.4. We apply this technique
with eight different patients. The values of the covariates for each patient are presented
in Table 5.2.
Figure 5.4 shows the predictive survival probability for these patients. For instance,
we use the patients 1 and 2 in Table 5.2 to produce the graph on the top left of Figure
5.4 and we use patients 3 and 4 in the Table 5.2 to produce the graph on the top right
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Figure 5.3: Trace plots and the densities for the coefficients, β0, βage, βsex, βwbc, βdepscore.
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Patient Age Sex WBC Deprivation
1 63 male 6.8 2.02
2 63 female 197 7.66
3 61 male 13.3 -1.96
4 83 female 160 -2.59
5 48 male 1.4 -1.7
6 87 female 1.4 -3.47
7 61 male 3.8 4.35
8 84 female 30.5 4.35
Table 5.2: Eight different new patients in the leukaemia example.
of Figure 5.4, etc. We notice that we have narrow credible intervals. See Appendix A.5.3
for the rjags code.
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Figure 5.4: Predictive survival probability for eight different patients in the leukemia example.
Top left: Patient 1 (blue) and patient 2 (pink). Top right: Patient 3 (blue) and patient 4 (pink).
Bottom left: Patient 5 (blue) and patient 6 (pink). Bottom right: Patient 7 (blue) and patient
8 (pink).
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5.10 Summary
We have given general background information on survival analysis in this chapter. We
illustrated some useful model that relate the survival lifetime distribution to some co-
variates in the model. These models are proportional hazard models, piecewise constant
hazard model and accelerated failure time model. We discussed prognostic indices which
are used to predict the outcome in patients with a certain disease. We showed for ex-
ample, how to calculate this index by fitting the Weibull lifetime distribution. In this
chapter, we demonstrated how we can calculate the posterior distribution for the param-
eters in the survival analysis for exponential and Weibull distributions. We used rjags
to compute all the posterior means and variances for the parameters of interest in the
model. We showed some results and graphs which show that the sampler mixed well and
the chains converged. We found that for different new patients in the leukaemia example,
we predicted the survival probability with narrow credible intervals.
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Bayes linear kinematics and Bayes
linear Bayes graphical models
6.1 Introduction
In Chapter 7, we will describe some novel applications of Bayes linear kinematics to
survival data. In this chapter we describe and illustrate Bayes linear methods which
are the basis for Bayes linear kinematics. We then describe and illustrate Bayes linear
kinematics and Bayes linear Bayes models and introduce some novel developments of the
theory.
In Bayesian analysis, we need to specify the prior distribution as our prior beliefs.
Therefore, we need to specify our prior distribution with uncertainty and that can be
expressed using probability. After observing some data, we calculate the likelihood func-
tion and finally, compute the posterior density which is proportional to the prior density,
multiplied by the likelihood. With many dimensions in our analysis, probably, we need
intensive calculations in order to obtain the results and so we depend on numerical integra-
tion methods. One common method that is used in many different fields is Markov chain
Monte Carlo (MCMC), which requires intensive and often time-consuming calculations.
However, the Bayes linear kinematics (BLK) method can obtain the results faster than
MCMC. Furthermore, the BLK method depends only on a second order prior specifica-
tion, which does not require any assumption about artificial probability distributions. In
this chapter, we explain Bayes linear methods in Section 6.2. In Section 6.3, we describe
the methods of Bayes linear kinematics. We introduce a novel feature which is the use of
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non-conjugate marginal updates in Section 6.7, so we can compute the posterior moments.
In Section 6.10, we consider some special types of observational variables, especially those
which may be relevant to our prognostic index application. Finally, we give some theory
about the BLK direct and BLK indirect methods which we shall use later in Chapter 7.
6.2 Bayes linear methods
6.2.1 Basic theory
In the standard Bayesian paradigm, we should specify the full joint prior distribution
for all unknown quantities. By using Bayes’ theorem, we update our prior beliefs by
conditioning on the observations and then calculating the posterior distributions. A Bayes
linear analysis is distinct from the full Bayesian approach in that we only need to specify
the first and the second-order moments for the prior and then calculate posterior moments.
For instance, if we have a random quantity X then we specify the prior expectation and
variance of X respectively as follows E0(X) and Var0(X). Furthermore, for two quantities
X1 and X2, we also need to specify a prior covariance Cov0(X1,X2).
Suppose that we have two vectors α = (α1, ..., αp)
′ and β = (β1, ..., βk)
′ where α is the
observed quantities and β is the inferential quantities. Assume that we have made a full
second-order prior specification for the set A = α ∪ β. Bayes linear methods (Goldstein
and Wooff, 2007) suggest a way to update beliefs about β by a linear fitting on α which
can be done using the Bayes linear updating equations for β | α
E1(β) = E0(β) + Cov0(β, α)Var−10 (α)[α− E0(α)]
Var1(β) = Var0(β)− Cov0(β, α)Var−10 (α)Cov0(α, β)
(6.1)
where E1(β) and Var1(β) are the adjusted expectation and adjusted variance for β | α.
Alternatively, we can express the relationship as





where Hβ|α = Cov0(β, α)Var−10 (α) and the random vector Uβ|α has mean zero and variance
Var(Uβ|α) = Var0(β)− Cov0(β, α)Var−10 (α)Cov0(α, β).
If Var0(α) is not invertible, we need to use a suitable generalised inverse, for instance
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a Moore-Penrose inverse. The idea of using a Moore-Penrose inverse was introduced by
Moore and Barnard (1935) and Penrose (1955) to obtain the inverse of the matrix even
when the matrix is rectangular or singular. So, this sort of inverse can be defined using
the following four properties in the definition
Definition The Moore–Penrose inverse of the p × n matrix V is the n × p matrix
which is denoted by V + and that satisfies the conditions
V V +V = V,
V +V V + = V +,
(V V +)′ = V V +,
(V +V )′ = V +V.
Schott (2016) mentioned that this Moore–Penrose inverse has one important aspect
that can distinguish it from other generalised inverses. He showed that the Moore–Penrose
inverse is uniquely defined.
6.2.2 Bayes linear adjusted expectation
Suppose that we are interested in an unknown quantity θ. Our prior expectation for θ
is E0(θ). We observe a collection of data y = (y1, y2, . . . , yn)
′
. Consider that E(θ | y),
our adjusted expectation of θ, is a linear function of the observed data y which can be
represented as
E(θ | y) = α + β1y1 + β2y2 + · · ·+ βnyn
We choose α, β1, β2, ..., βn in order to minimise the following quantity
E
[
(θ − α− β1y1 − β2y2 − · · · − βnyn)2
]
So, the adjusted expectation for θ | y is E(θ | y).
Now, let A = α+ β ′Y . To find the constant α and the vector β ′ , we need to minimise






Chapter 6. Bayes linear kinematics and Bayes linear Bayes graphical models
Hence, we can write A as
A = α + β ′Y = α + β ′
[
Y − E(Y) + E(Y)
]
= α + β ′E(Y) + β ′ [Y − E(Y)]
= α∗ + β ′ [Y − E(Y)]










+ Var(θ − A)
=
[
E(θ − α∗ − β ′ [Y − E(Y)])
]2
+ Var(θ − α∗ − β ′ [Y − E(Y)])
= (E0(θ)− α∗)2 + Var(θ − β
′Y).
If we choose E0(θ) = α∗ then the first term will be zero. We need to differentiate the
second term with respect to β.
∂
∂β
Var(θ − β ′Y) = ∂
∂β
[
Var(θ) + β ′Var(Y)β − 2Cov(θ,Y)β
]
= 2β ′Var(Y)− 2Cov(θ,Y)
Equating this to 0, we obtain β ′ = Cov(θ,Y)Var−1(Y). The adjusted expectation of
θ | y is
A = α∗ + β ′ [Y − E(Y)]
where α∗ = E0(θ) and β
′ = Cov(θ,Y)Var−1(Y). Hence,
A = E1(θ) = E0(θ) + Cov(θ,Y)Var−1(Y)[Y − E(Y)].
6.2.3 Bayes linear adjusted variance
In this subsection, we illustrate the derivation of the adjusted variance in Bayes linear
analysis. This adjusted variance can be obtained from the error terms from the Bayes
linear fit R(Y |D), where D = (D1, ..., Dn)
′ represents the subset of the values that have
been observed.
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Therefore,
R(Y |D) = Y − E(Y |D)
where E(Y |D) = E(Y ) + Cov(Y,D)Var−1(D)[D−E(D)]. The adjusted quantity also has
two important properties:
E [R(Y |D)] = 0
and
Cov [R(Y |D),E(Y |D)] = 0.
Hence, we can write Y = R(Y |D) + E(Y |D), so that
Var(Y ) = Var(R[Y |D]) + Var(E[Y |D]).
We also have
Var(Y |D) = Var(R[Y |D]) = E
[
(Y − E[Y |D])2
]
.
To evaluate Var(Y |D), we need to specify our prior variances and covariances so that
Var(Y |D) = Var(Y )− Cov(Y,D)Var−1(D)Cov(D, Y ). (6.3)
For more detail, see Goldstein and Wooff (2007).
6.2.4 Bayes linear approach: motivational example and compar-
ison with full-Bayes analysis
Suppose we have a simple linear regression model, yi = β0 + β1xi + εi. Suppose that we
want to predict the height (Y ) in inches of a student from the student’s shoe size (X) using
this relationship. Suppose that we have collected some data (y1, x1), (y2, x2), ..., (yn, xn)
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So, we can write our linear regression model in matrix form
Y = Xβ + ε
where X represents the design matrix, β refers to the parameters in the model and the
error term ε ∼ N(0, σ2). We assume that σ2 is known.
We have
E(Y ) = XE(β)
and
Var(Y ) = XVar(β)X ′ + Var(ε)
To apply Bayes theorem, we need to specify our prior distribution.
















and it is known that σ2 = 2.
We can update our beliefs about β0 and β1 after observing some data, in this case
n = 52 students. The data are shown in Figure 6.1. Bayes theorem is used to update
these beliefs and the posterior distribution is calculated.

















Now to do Bayes linear method, we start with the Bayes linear equations
E∗(β|y) = E0(β) + Cov0(β, y)Var−10 (y)[y − E0(y)]
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Figure 6.1: Plot of shoe-size and height data.
and
Var∗(β|y) = Var0(β)− Cov0(β, y)Var−10 (y)Cov0(y, β).
In order to calculate the posterior moments [E∗(β|y),Var∗(β|y)] in a Bayes linear
approach, we have to specify our partial prior belief about β.
We use the same prior mean and prior variance as in the full-Bayes analysis,
Hence,












We also have Cov0(β, y) = Var0(β)X
′ and Var0(y) = XVar0(β)X
′ + σ2In, where, In
is the identity matrix with dimension 52×52.
Substituting all of this information into the Bayes linear equations we obtain posterior
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As we can see from the results that we have obtained from applying Bayes analysis
and from using Bayes linear method are exactly the same for the posterior mean vector
and posterior variance and covariance matrix for β. For further information, see Appendix
A.6.1.
6.3 Bayes linear kinematics
6.3.1 Probability kinematics
Jeffrey (1965) supplied a method known as probability kinematics for revising a proba-
bility specification which depends on new probabilities over a partition.
Suppose that we have a partition K = (K1, ..., Kn) and corresponding probabilities
Pr0(Ki) = pi and
∑n
i=1 pi = 1. Suppose that we have obtained some information which
can cause us to update our probabilities of these events to Pr1(K1), ...,Pr1(Kn). Then we
can impose the condition that, for any future event L
Pr0(L |Ki) = Pr1(L |Ki), ∀i. (6.4)
Therefore, the new marginal probability of L can be found by probability kinematics





However, successive revisions of this kind might not necessarily be commutative. There
is some good literature which addresses the condition for commutativity. See Field (1978);
Diaconis and Zabell (1982) and a simple example was given by Wilson (2011) explaining
the case when we have a lack of commutativity.
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6.3.2 Bayes linear kinematics
In a full-Bayes analysis, we need to specify the full joint prior density for all the unknown
quantities. Then our beliefs adjusted by observing the data can be represented by the
posterior distribution and we can obtain the posterior means and posterior variances.
Bayes linear kinematics is defined as a special form of Bayes linear analysis where,
instead of observing α = (α1, α2, . . . , αp)
′ as we mentioned in Section 6.2, we simply
update our beliefs about this set by obtaining some information. Then those changes in
our beliefs can be propagated through other unknown quantities within a Bayes linear
structure.
Named after probability kinematics proposed by Jeffrey (1965), Bayes linear kinemat-
ics was suggested by Goldstein and Shaw (2004) with the idea that, instead of observing
α directly in equation (6.1), we observe some information about another quantity I and
that changes our beliefs about α to E(α|I) and Var(α|I). Then we wish to propagate
these updates to β.
In order to propagate these changes in our beliefs, we could use a full-Bayes analysis
which requires a full probabilistic specification and more intensive calculations such as
MCMC methods. However, we can use Bayes linear kinematics by adjusting the expec-
tation vector and variance matrix based on (6.2) and therefore, we can adjust our mean
and variance of A = α ∪ β as
Eα|I(A) = E0(A) + Cov0(A,α)Var−10 (α)
[




0(A,α) +W0(A,α)Var(α | I)W
′
0(A,α)




where W0(A,α) = Cov0(A,α)Var−10 (α). Therefore, the equations (6.5) are called Bayes
linear kinematics equations.
6.3.3 Commutativity
Now suppose we wish to make multiple updates. First we receive information Iα and
that can update our beliefs about A to Q1(A; Iα), where Q1(A; Iα) = [E(A|Iα),Var(A|Iα)]
using equations (6.5). Now afterwards, we observe some information Iβ which changes
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our beliefs about A to Q2(A; Iα, Iβ). Again we can use Bayes linear kinematics to gain
Q2(A; Iα, Iβ).
Consider the opposite case of observing the two parts of information. Firstly, we ob-
serve Iβ and update our beliefs about A to Q1(A; Iβ) and we apply Bayes linear kinematics
to gain Q1(A; Iβ). Then later we receive information Iα which changes our beliefs about
α to Q2(A; Iβ, Iα). Then we use Bayes linear kinematics to gain Q2(A; Iβ, Iα).
Now for commutativity of these two updates we should have
Q2(A; Iα, Iβ) = Q2(A; Iβ, Iα)
There are some necessary and sufficient conditions for a unique commutative solution
in Bayes linear kinematic updates which were introduced by Goldstein and Shaw (2004).
In this paper, they proposed a sufficient condition which states that, if
Var(α|Iα) < Var0(α) or Var(β|Iβ) < Var0(β), (6.6)
then, there is a unique commutative solution. If this condition holds, the Bayes linear
kinematic update equations can be written as
E(2)(A) = Var(2)(A)
[








Var−11 (A; Iα) + Var−11 (A; Iβ)− Var−10 (A)
]−1
. (6.8)
The equations (6.7) and (6.8) give the commutative solution even if we swap the
updates in those equations.
6.3.4 Multiple updates in Bayes linear kinematics
Suppose we have n collections of random quantities, Q1, ..., Qn where
Qi = (Qi1, ..., Qini)
′
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for i = 1, ..., n. We define a full second order prior specification for Q = Q1 ∪ ...∪Qn and




and we receive some information Di and





obtain the Bayes linear kinematic update for Q which depends on (6.5), we have






Var1(Q|Di) =Var0(Q)− Cov0(Q,Qi)Var−10 (Qi)Cov0(Qi, Q)
+ Cov0(Q,Qi)Var−10 (Qi)Var1(Qi|Di)Var−10 (Qi)Cov0(Qi, Q).
(6.10)
These Bayes linear kinematic changes might not have a unique commutative solution.
Goldstein and Shaw (2004) give conditions to make these updates have a unique solution.
We deal with Qi as scalar. Therefore, the sufficient condition will be
Var−10 (Qi)Var1(Qi|Di) < 1 (6.11)










Var−11 (Q|Di)− (n− 1)Var−10 (Q)
−1 (6.13)
where D = (D1, ..., Dn)
′
, or alternatively we can write (6.12) and (6.13) in general in the
following form
P(X | I) =
J∑
j=1
P(X | Ij)− (J − 1)P(X), (6.14)
P(X | I)E(X | I) =
J∑
j=1
P(X | Ij)E(X | Ij)− (J − 1)P(X)E(X). (6.15)
where, [P(X | I)]−1 is the adjusted variance and E(X | I) is the adjusted expectation,
I = (I1, ..., IJ)
′ and P(X) = Var(X)−1 is the prior precision matrix.
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I1X1X2I2
Figure 6.2: Bayes linear Bayes graphical model with two variables
6.4 Bayes linear Bayes graphical models
A Bayes linear Bayes graphical model is a combination of fully Bayesian and Bayes linear
graphical models allowing conditioning on marginal distributions of any form and to take
advantage of Bayes linear kinematics to involve full conditional updates within Bayes
linear adjustments. See Goldstein and Shaw (2004).
In complex models, experts often make full marginal probabilistic specifications, but
they are not able to assess the full joint probability distribution for all unknown quantities
in the model. Goldstein and Shaw (2004) developed a formalism for updating their beliefs
about these quantities which depends on Bayes linear kinematics. They introduced a
directed graphical model which is a directed graph G = (V,E) where V = (X1, X2, ..., XJ)
is a collection of nodes and E is a collection of edges. A Bayes graphical model is the model
when the generalised conditional independence relationship is probabilistic conditional
independence (Lauritzen, 1996; Cowell et al., 2007) and by taking second-order belief as
the generalised conditional independence, we obtain a Bayes linear graphical model. See
Goldstein and Wilkinson (2000); Goldstein and Shaw (2004).
Bayes linear Bayes graphical models are similar to Bayesian networks, where the nodes
represent the parameters in the model or the random variables, and the arrows represent
the relationships or the association between the parameters. In Bayesian networks, we
make use of the property of conditional independence between variables given other ran-
dom variables. Goldstein and Wilkinson (2000) proposed the idea of using belief separa-
tion. To demonstrate this idea, let us take the following simple example.
Suppose we have unknown quantities X1, X2, I1, I2. We can present our beliefs about
(X1, X2) as a Bayes linear belief structure and present our beliefs about each of (X1, I1)
and (X2, I2) as a full-Bayes specification. Figure 6.2 shows a simple way to represent the
relationships between all the unknown quantities in a Bayes linear Bayes graphical model.
We notice from Figure 6.2 that the undirected edge between the pair (X1, X2) with
magenta colour represents a Bayes linear structure and the directed blue arrows refer to
the conditional distributions which have a full-Bayes specification.
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Suppose that we have multiple unknowns X1, X2, . . . , XJ . Let X = (X1, X2, . . . , XJ)
′
.
First of all, we need to give the second order prior specification in terms of the expectations
and the variances of each Xi and the covariance matrix between the variables. In addition,
we have variables I1, I2, . . . , IJ that shall be observed where the conditional distribution
of (Ij | X) is specified probabilistically. Each Ii is associated with an element Xi of X and
is conditionally independent of the rest given Xi. Then, a Bayes linear Bayes graphical
model can propagate the information using full Bayes and Bayes linear kinematics. The
mechanism is that, if we observe Ii, then Bayes theorem is used to calculate the E(Xi | Ii)
and Var(Xi | Ii). These changes are passed through the rest of the network using the
Bayes linear kinematic equations in (6.5).
We can see from Figure 6.3, that we have three main conditions here.
• If we have a set of unknown quantities, say K = {Z,X1, X2, ..., XJ , I1, I2, ..., IJ},
where Z = XJ+1, then the collection of quantities (Z,X1, X2, ..., XJ) has a Bayes
linear belief structure.
• We specify a full-Bayesian analysis for each (Xi, Ii), for i = 1, 2, ..., J.
• Each Ii is conditionally independent of K \ {Xi, Ii} given Xi.
In the case where we have m = 4, a Bayes linear Bayes graphical model might be repre-












Figure 6.3: Bayes linear Bayes graphical model
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6.5 Transformation of the parameters
6.5.1 Introduction
Suppose we have some distribution with a bounded parameter such as a binomial distri-
bution, 0 < θi < 1, (i = 1, 2, ..., n) or Poisson with θi > 0. We can link the parameters
θ1, ..., θn using a Bayes linear structure exactly as in Section 6.4 where θ1, ..., θn corre-
spond to X1, ..., Xn. However, there are some benefits in using a transformation for these
parameters. For example we might use the logit function in the binomial case or log in
the Poisson case. Then the transformed parameter for a Poisson distribution will be
ηi = log(θi)






The transformed parameters η1, ..., ηn are then linked in a Bayes linear structure. After
observing Ii that changes our prior mean and variance for ηi, these changes are propagated
by using Bayes linear kinematics.
One of the reasons why we should use the transformation is that θi has a bounded
scale and this boundary makes the use of the Bayes linear method less attractive. There-
fore, doing the transformation can guarantee that we can use the linear updates without
worrying about crossing the boundary. Secondly, If the parameter is bounded between 0
and 1, that means the variance will depend on the mean and in a Bayes linear analysis the
variance should not depend on the mean. Thirdly, when we do not transform, the variance
for θi might increase when we observe the data. Transforming the parameter ηi can avoid
this problem and lead to a reduction in the variance when the data have been observed.
For instance, suppose I|θ ∼ Poisson(θ), θ ∼ Gamma(1, 5). Hence, the variance is 1/25.
Now suppose that we observe I = 2. Therefore the posterior density will be Gamma(3, 6).
As a result, the posterior variance is (1/12) > (1/25). For more information, see Wilson
and Farrow (2010); Wilson et al. (2013); Wilson and Farrow (2017).
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6.5.2 Guide relationship
Following West et al. (1985), Wilson and Farrow (2010, 2017) use a guide relationship
to suggest how we should relate the moments of ηi to those of λi. For example, when λi
is the mean of Poisson distribution, we can use, as a guide, ηi ≈ log(λi). In this case,
Wilson and Farrow (2017) discuss three methods to determine the moments of ηi given
those of λi, and vice versa. They refer to these as the log-mode method, the log-moment
method and the lognormal method. Wilson and Farrow (2017) show that, in each case, if
λi ∼ Ga(αi, θi), then, for some functions h1 and h2, we have E(ηi) = h1(αi)− log(θi) and
Var(ηi) = h2(αi).
6.5.3 Mode and log-curvature method
Once the parameters have been transformed from a bounded scale to the whole real line
we hope that the posterior distribution will be close to symmetric. However, the distribu-
tion may not be straightforward. We might choose to use a conjugate prior distribution
for the untransformed parameter, for example, a gamma distribution for a Poisson pa-
rameter. We then need to relate the hyperparameters of this distribution to moments on
the transformed scale. Wilson and Farrow (2017) discuss three methods in the Poisson
case. In this section we explain the principal idea of using one of these, the mode and
log-curvature method (“log mode”) for the transformed parameters. Suppose we obtain
the mode of the posterior distribution which can be done by finding the first derivative of
the log posterior density with respect to our parameter of interest. We will consider the
case when we have a single mode, say η̂ and we fit the normal distribution based on the
second derivatives of the log posterior density at η̂.
Let the transformed parameter be η = g(θ). Suppose
π(η | y) ∼ N(η̂,Var(η))










This second derivative can be calculated numerically using Newton’s method as we
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shall illustrate in Section 6.7.3. See Gelman et al. (2014).
We give an example explaining the method using binomial observations. Suppose we
have a random variable, Yi ∼ Bin(n, θ), so θ is restricted, 0 < θ < 1. For Bayes linear
fitting, it is better to have an unrestricted range for the parameter. Therefore we use a







A conjugate prior for θ is a beta density, i.e. θi ∼ Beta(ai, bi). The idea is to find
the mean of ηi which is equal to the mode of log[θi/(1− θi)] and the variance of ηi is the
inverse of the curvature of the log density at the mode η̂.
We have
π(θi) =
Γ (ai + bi)
Γ (ai)Γ (bi)
θai−1i (1− θi)bi−1


































Taking log of (6.16), we have









The first derivative of log[g(ηi)] with respect to ηi is
d log [g(ηi)]
dηi
= ai(1 + eηi) −
bieηi
(1 + eηi)
Putting the first derivative equal to 0, we obtain E0(ηi) = log(ai/bi). In order to find
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the variance of ηi, we should find the second derivative of the log density of g(ηi) with




















See Wilson and Farrow (2010).
6.5.4 Log-moment method
Suppose that we have an exponential survival time with probability density function
fi(t) = λi exp{−λit}, (6.17)
and survival function
Si(t) = exp{−λit}. (6.18)
Now to make inference about the unknown parameter λ, we could give λ a gamma
prior distribution and that is conjugate to the density and the survival function in (6.17)
and (6.18).
The likelihood function for the individual i is
Li = λδii exp{−λiti}.
where δi = 1 if individual i dies and δi = 0 if individual i is censored. The prior distribution
of λi is gamma distribution with shape parameter αi and scale parameter θi, so λi ∼
Ga(αi, θi). Therefore, the posterior density for λi will be Ga(αi + δi, θi + ti).
As in the case where we have Poisson observations, X|λ ∼ Po(λ), a suitable conjugate
prior will be a gamma distribution. Wilson and Farrow (2017) proposed η = g(λ) = log(λ)
in order to make η unbounded rather than use the bounded parameter λ. See Section
6.5.1.
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If we use the guide relationship with the conjugate update of a gamma distribution,
then the mean and the variance of ηi as those of log λi gives
E0(ηi) = g1(αi, θi) = fi = h1(αi)− log(θi)
Var0(ηi) = g2(αi, θi) = qi = h2(αi).
(6.19)
In the log-moment method, we can calculate the mean and the variance of ηi and that
gives us
h1(αi) = ψ(αi) and h2(αi) = ψ1(αi)
where ψ(·) is the digamma function and ψ1(·) is the trigamma function. See Wilson and
Farrow (2017). These are the exact moments of ηi if ηi = log(λi) and λi ∼ Ga(αi, θi).
6.5.5 Lognormal method
In this method we equate the first and second moments of the gamma prior distribution for
λ to those of a lognormal distribution and use the mean and variance of the corresponding
normal distribution for η. We put αi/θi = exp(fi+qi/2) and αi/θ2i = exp(2fi+qi)[exp(qi)−







and h2(αi) = log(1 + α−1i )
So,
αi = [exp(qi)− 1]−1 and θi = [exp(qi)− 1]−1 exp(−qi/2) exp(−fi).
See Wilson and Farrow (2017).
In this thesis, we use the lognormal method in the leukaemia example to compare the
three methods, full-Bayes method, Bayes linear kinematic methods using conjugate prior
update and BLK using non-conjugate prior update.
6.6 Example: Sulfinpyrazone
The Anturane Reinfarction Trial Research Group (1980) reported a clinical trial on the
use of the drug sulfinpyrazone in patients who had suffered myocardial infarctions (“heart
118




Table 6.1: Sulfinpyrazone example
attacks”). The idea was to see whether the drug had an effect on the number dying.
Patients in one group were given the drug while patients in another group were given a
“placebo”, that is an inactive substitute. Table 6.1 gives the number of all “analysable”
deaths up to 24 months after the myocardial infarction and the total number of eligible
patients who were not withdrawn and did not suffer a “non-analysable” death during the
study. We present the data in Table 6.1 as a bar graph in Figure 6.4.



























































Figure 6.4: Bar plot for the two groups in sulfinpyrazone example.
We have Xi out of ni die in group i. Hence, Xi | θi ∼ Bin(ni, θi) and in our beliefs we
do not regard θ1, θ2 as independent.
Let θ = (θ1, θ2)
′
. For illustrative comparison with the Bayes linear kinematic approach
we first show a full-Bayes analysis. Let η = (η1, η2)
′ where η1 = log[θ1/(1− θ1)] and η2 =
log[θ2/(1− θ2)]. We give η1, η2 a bivariate normal prior distribution with E(η1) = E(η2).
Suppose that θ2 has probability 0.95 of being in the interval 0.05 < θ2 < 0.20. The
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corresponding interval for η2 is −2.944 < η2 < −1.386. Therefore, E0(η2) = −2.165 and
the prior variance of η2, Var0(η2) =
[
(−1.386 + 2.944)/(2 × 1.96)
]2
= 0.3972 = 0.158.
In order not to prejudice the analysis, we set E(η1) = E(η2). The prior variance of η1,
Var0(η1) = 4 × Var0(η2) = 0.7942 = 0.630 and the reason behind increasing the prior
standard deviation ση1 = 2ση2 is because we have less uncertainty about the death rate
when the placebo is given. As a result, we have a 95% symmetric prior interval for η1,
−3.721 < η1 < −0.609 and thus, 0.02 < θ1 < 0.35 which is a wider interval than that for
θ2.
As we mentioned earlier, in this example θ1 and θ2 are dependent in our prior beliefs.
We suppose that in our prior beliefs, η1 and η2 are correlated with ρ = 0.5. Then the




Now, in order to use a full-Bayes analysis, we need to transform the parameters in
the model θi to the new parameters ηi for i = 1, 2. It is more convenient to work with an
unbounded scale than work with a (0,1) scale. See Section 6.5 for more detail. We give
η1,η2 a bivariate normal distribution with density






























θxii (1− θi)ni−xi .
Then we transform the parameter θi to ηi = log[θi/(1− θi)] where ηi ∈ (−∞,∞). The











i = 1, 2. (6.21)
Therefore, by applying Bayes’ theorem, the marginal posterior density of η1 is ex-
pressed by combining (6.20) and (6.21). We have
π(η1 | xi) =
∫
π(η1, η2)L(η1, η2;xi)dη2∫ ∫
π(η1, η2)L(η1, η2;xi)dη1dη2
i = 1, 2. (6.22)
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From (6.22) , we find the posterior moments for η1 respectively using numerical inte-
gration as E(η1 | x1, x2) = −2.452 and Var(η1 | x1, x2) = 0.0231. Likewise, the posterior
moments for η2 are E(η2 | x1, x2) = −2.074 and Var(η2 | x1, x2) = 0.0162.
Figure 6.5 and 6.6 show the posterior densities for θ and η respectively. See the R


































Figure 6.5: The prior (black) and posterior
(blue) density of θ1 and θ2. The dashed line
































Figure 6.6: The prior (black) and posterior
(blue) density of η1 and η2. The dashed line is
when η1 = η2.
We can see from the contour plot in Figure 6.5 which represents the posterior density,
that most of the probability lies in the side where θ2 > θ1 and that means that the death
rate is probably higher with the placebo than with sulfinpyrazone. As a result we conclude
that using sulfinpyrazone has a good effect on the patients. Likewise, we notice also from
Figure 6.6 that most of the probability for η1, η2 lies in the side where η2 > η1 which
corresponds with the results from Figure 6.5.
Now we describe a Bayes linear kinematic analysis of the sulfinpyrazone example. We
give θi a beta prior distribution; θi ∼ Beta(ai, bi). We need to specify the parameters
a1, a2, b1 and b2. In order to find ai and bi to specify the prior mean and variance for θi,
we will use the prior moments given to η1, η2 in the full-Bayes analysis and work backward
using the mode and curvature method as demonstrated in Section 6.5.3.
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Hence, a1 = 1.77, b1 = 15.42, a2 = 7.07 and b2 = 61.61.
By applying Bayes’ theorem, our posterior density of θi is Beta(ai + xi, ni + bi − xi),
where (x1, x2) =(44,62) and (n1, n2) =(560,540) as shown in Table 6.1. The summary of
the results is given in Table 6.2.
θi E0(θ) E1(θ) Var0(θ) Var1(θ)
1 0.103 0.079 0.0051 0.00013
2 0.103 0.113 0.0013 0.00017
Table 6.2: The prior means and variances for θ and the posterior means and variance using the
conjugate prior
After observing xi, we need to update our prior beliefs about ηi. Therefore, we calcu-
late the posterior mean and variance for η1 given x1 as
E1(η1) = log(A1/B1), where A1 = a1 + x1 = 45.77 and B1 = b1 + n1 − x1 = 531.42.




Similarly, the posterior mean and variance for η2 given x2 are, E1(η2) = log(A2/B2),
where A2 = a2 + x2 and B2 = b2 + n2 − x2. So, E1(η2) = −2.056. Also, Var1(η2) =
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ηi E0(η) E1(η) Var0(η) Var1(η)
1 -2.165 -2.452 0.630 0.0237
2 -2.165 -2.056 0.158 0.0163
Table 6.3: The prior means and variances for η and the posterior means and variance based on





) = 0.0163. Table 6.3 summarises the above calculations.
We now carry on and apply the Bayes linear kinematic equations to the results that
we have made. So, the Bayes linear kinematic equations for η2 after observing x1 are











and also, the Bayes linear kinematic equations for η1 after observing x2 are












E1(η2;x1) = −2.237, E1(η1;x2) = −2.056,
Var1(η2;x1) = 0.1199, Var1(η1;x2) = 0.4883.
So, this information is propagated through η1 and η2 using Bayes linear kinematics
and we evaluate the unique commutative Bayes linear kinematic solution, as
E(2)(η1;x1, x2) = Var(2)(η1;x1, x2)
[
Var−11 (η1)E1(η1)+




Var−11 (η1) + Var−11 (η1;x2)− Var−10 (η1)
]−1 (6.25)
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and
E(2)(η2;x1, x2) = Var(2)(η2;x1, x2)
[
Var−11 (η2)E1(η2)+




Var−11 (η2) + Var−11 (η2;x1)− Var−10 (η2)
]−1 (6.26)
That gives us,
E(2)(η1;x1, x2) = −2.439, E(2)(η2;x1, x2) = −2.071,
Var(2)(η1;x1, x2) = 0.0234, Var(2)(η2;x1, x2) = 0.0158.
These results differ only slightly from those obtained by the full-Bayes analysis. Alter-
natively, we can write (6.25) and (6.26) as a vector η = (η1, η2)









Var−11 (η|xi)− Var−10 (η)
−1 (6.28)
where x = (x1, x2)
′
.
Therefore, the following algorithm is to find the Bayes linear kinematic adjusted mo-
ments of η1, η2.
1. Find a1, a2, b1, b2.
2. Find A1 and B1 and A2 and B2 using the data x1 and n1 and x2 and n2.
3. Find E1(η1 | x1) and Var1(η1 | x1) from A1 and B1 and E1(η2 | x2), Var1(η2 | x2)
from A2 and B2.
4. Use BLK formulae in (6.27) and (6.28).
So, the information is propagated through η1 and η2 to update our beliefs having
observed x1 and x2 , as we can see from Figure 6.7.
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Figure 6.7: Bayes linear Bayes graphical model to update our belief about η1 and η2.
6.7 Bayes linear Bayes models with non-conjugate
marginal priors
6.7.1 Introduction
In Chapter 7, we will describe a novel Bayes linear Bayes prognostic network. This
will be able to use data from covariates of many types, including those where there is no
convenient conjugate prior. Furthermore, even when there is a convenient conjugate prior,
we will see that there can be advantages in using a prior of a different, non-conjugate,
form. Therefore, in this section we introduce a new extension to the theory of Bayes linear
kinematics to allow the use of non-conjugate marginal priors.
It is well known that, in the Bayesian framework, if the posterior density and the
prior density have the same family of distribution such as normal or beta or gamma, then
we denote this prior as a conjugate prior. However, in many applications, the prior and
the posterior do not belong to the same family. In other words, the prior has a different
type of distribution from the posterior, so this prior is called a non-conjugate prior. This
thesis aims to use non-conjugate priors in order to apply Bayes linear kinematics and that
can be done using one-dimensional numerical integration and we compare this approach
with one using conjugate priors and with a Bayesian analysis using MCMC and a fully
specified joint prior distribution.
Wilson (2011), in his thesis, explained in detail how to use Bayes linear Bayes analysis
with conjugate marginal priors and he tackled two distributions of observations, binomial
and Poisson. However, sometimes this conjugacy condition does not hold. For example,
in the case where we have a binomial likelihood, we might use a logit-normal prior. This
kind of marginal posterior distribution does not have a closed form. Therefore, we need
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to use some numerical integration method such as quadrature or Laplace approximation
method to evaluate the posterior mean and the posterior variance. Those posterior means
and variances are very important to calculate Bayes linear kinematics.
The use of non-conjugate marginal updates in Bayes linear kinematics is a new feature
which is introduced for the first time in this thesis. As well as extending the range of types
of variable which can be accommodated in a Bayes linear Bayes model, it avoids the need
to pass updated hyperparameters through a link function, or guide relation, by instead
updating moments of unknown quantities directly on the Bayes linear scale. Although
numerical integration is required, this is typically one-dimensional.
In this thesis we aim to compare the posterior means, variances and covariances using
three methods, full-Bayes analysis, Bayes linear kinematics with conjugate prior and Bayes
linear kinematics with non-conjugate marginal prior distributions. We will demonstrate
in Subsection 6.7.3 how to calculate the posterior using a Laplace approximation method.
6.7.2 Non-conjugate marginal priors
While there are advantages in using a link function, as in Wilson and Farrow (2010, 2017),
the use of a conjugate prior and then calculation of the change in mean and variance of a
transformed parameter is a somewhat restrictive arrangement. Removing the requirement
for a conjugate prior allows many different kinds of observational distributions. The price
to be paid for this is that we need to use a numerical integration to find the adjusted mean
and variance of Xj given Yj = yj. However this is typically a one-dimensional integration
and suitable fast approximation methods can often be used. Suppose that we give Xj a
prior distribution with density fj(x) and that the likelihood from observing Yj = yj is
Lj(x; yj). Then the posterior density of Xj is proportional to gj(x) = fj(x)Lj(x; yj).
For example, in the Poisson case, we might give a normal prior distribution to η = log λ
and the likelihood is proportional to exp(−λ)λyj .
In suitable cases, particularly where the support is unbounded, we might use a simple
normal approximation. Let Gj(x) = log gj(x). Then we can finding the maximum m
of Gj(x) as an approximation to the posterior mean and use v = −[∂2Gj(x)/∂x2]−1
evaluated at x = m as an approximation to the posterior variance. Alternatively, we
write the posterior mean as
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and then use Laplace approximations (Tierney and Kadane, 1986) for the integrals in
the numerator and denominator. Another possibility would be to use Gauss-Hermite
quadrature (e.g. Naylor and Smith, 1982).
6.7.3 Finding the marginal posterior by Laplace approximation
As a first step in summarising a posterior density, we might seek the posterior mode. In
practice, we look for one single posterior mode and, if the posterior density is symmetric
and unimodal, this locates the centre of the distribution. However, if the posterior density
is not symmetric and unimodal then the posterior mode is a poor point summary. In order
to make sure that our posterior mode is unique, we should run a mode-finding algorithm
with different initial values.
We can use the Newton-Raphson method to find the posterior mode. See Gelman
et al. (2014). It is an iterative method which depends on a quadratic Taylor series ap-






where f(θ|y) = k−1π(θ)f(y|θ) is the posterior density and k =
∫
π(θ)f(y|θ)dθ and k does
not depend on θ. Then,





In order to to find the posterior mode of θ, we should find the first derivative of q(θ)
with respect to θ and set the first derivative equal to 0.
q′(θ) = dq(θ)
dθ









Sometimes (6.29) does not have a closed form solution for the posterior mode which
means that there is no analytical solution for this equation. Therefore, we have to use a
numerical optimisation method such as Newton’s method as follows.
We start with an initial value θ = θ0 and carry on iterating:
θi+1 = θi −
q′(θi)
q′′(θi)
, i = 1, 2, ... (6.30)
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where q′′(θ) is the second derivative of q(θ). The sequence θ0, θ1, θ2, ... finally converges
to the optimal solution θ̂.
As we mentioned in Section 3.3, there are different techniques to compute the pos-
terior mean E(η|x) in the one-dimensional case. For example, we could use a Laplace
approximation to approximate the posterior mean. Using (3.4) we obtain
−nk∗(η) = log(η) + log [L(η|x)] + log [π(η)] .
by using the steps that we explained in Subsection 3.3.2. See Tierney and Kadane (1986).
6.7.4 Binomial observations
Suppose we have a random variable X which has a binomial distribution with parameter
θ which represents the probability of success, so X ∼ Bin(n, θ). It is better to transform
θ ∈ (0, 1) to η ∈ (−∞,∞), for the reasons that we mentioned in Section 6.5. The
likelihood function will be






So, the likelihood function for the transformed parameter η using the logit link function
is











Suppose that, the prior density for η has a normal distribution with mean µ and
precision τ = 1/σ2. Then its density is
π(η) ∝ e− τ2 [(η−µ)2].
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The log posterior density of η can be written as





− τ2 [(η − µ)
2] + ηx








− τ(η − µ) + x.
Putting the first derivative equal to 0, we have, x − neη/(1 + eη) − τ(η − µ) = 0.
This equation does not have a closed form solution for the posterior mode for η, so we
should use the Newton-Raphson method to obtain the mode η̂mode. After obtaining the
posterior mode, we have to substitute it in log [f(η|x)] because we need it to evaluate the
denominator of (3.4).





(1 + eη)2 − τ = −
(








−1 = (1 + eη̂mode)2
τ(1 + eη̂mode)2 + neη̂mode .
Likewise, we repeat the calculations above to approximate the numerator of (3.4). We
have,









where, f ∗(η|x) = ηf(η|x). Hence, log [f ∗(η|x)] = log(η) + log [f(η|x)] .
Finally, finding the first derivative w.r.t. η and equating it to 0, we have









− τ(η − µ) + x = 0
Again, we have to solve this numerically to find η̂m, the posterior mode for f ∗(η|x).
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(1 + eη)2 − τ.
To calculate the variance of η we use the second derivative. So
Var∗(η) = −







(1 + eη̂m)2 − τ
−1.















because exp{log [f(η̂m|x)]} = f(η̂m|x).
Similarly, we can find the posterior expectation for η2, E(η2|x) and the posterior
variance, Var(η|x) = E(η2|x)− [E(η|x)]2 .
Alternatively, we could use a simple method based on finding the mode and the cur-
vature of log [f(η|x)] and use these to approximate the mean and variance, i.e., the mean









Suppose we have a random variableX which has a Poisson distribution with the parameter
θ, X ∼ Poisson(θ). The probability density function will be
f(x|θ) = θ
xe−θ
x ! θ > 0.
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It is more convenient to transform the parameter of the Poisson distribution θ using
ηi = log(θi).
As in the case of binomial data, we explain the method of applying the non-conjugate
prior to obtain the marginal posterior mean using a Laplace approximation. We have data
which is given by Davies and Goldsmith (1972) and reproduced in Hand et al. (1994). The





Table 6.4: Piston ring Failures in two compressors
We specify our prior mean and variance for η1 to be E0(η1) = 3.384 and Var0(η1) =
0.0340. So the Poisson likelihood function for compressor 1 is
f(x1|η1) ∝ e46η1e−e
η1
and the prior for η1 is
η1 ∼ N(3.384, 0.0340).
We also suppose that E0(η2) = E0(η1) = 3.384 and Var0(η2) = Var0(η1) = 0.0340 and
the covariance between η1 and η2 is Cov0(η1, η2) = ρ
√
Var0(η1)Var0(η2) = 0.008475 where
ρ = 0.25.
So the prior mean vector and the prior variance covariance matrix for η are respectively
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Consider the log of the numerator of the posterior mean,
L∗(η1) = log(η1)− 14.75(η1 − 3.384)2 + 46η1 − eη1 ,
where L∗(η1) is the log of the numerator for the expectation. We need to differentiate
L∗(η1) with respect to η1 and put that derivative equal to zero in order to find the mode
η̂∗1. So, we obtain η̂∗1 = 3.6493 numerically, and substituting η̂∗1 in L∗(η1) to evaluate this
log likelihood function, we have L∗(η̂∗1) = 129.6765.
Now to find the variance, we should obtain the second derivative of L∗(η1) with respect







So the approximate value for the numerator for the expectation is
σ∗eL
∗(η̂∗1) = 2.520404× 1055
where σ∗ =
√
Var(η∗1). Now we can repeat the similar steps to approximate the integral
in the denominator. As a result, we have
E(η1|x1) '
2.520404× 1055
6.921637× 1054 ' 3.6413
and
Var(η1|x1) ' E(η21|x1)− [E(η1|x1)]2 = 0.0144
Table 6.5 shows the posterior means and the posterior variances for η = (η1, η2) using
the Laplace approximation method.
Compressor i = 1 i = 2
E(ηi|xi) 3.641 3.439
Var(ηi|xi) 0.0144 0.0160
Table 6.5: Posterior means and posterior variance using Laplace approximation
Now these changes are propagated through to the other group using Bayes linear
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kinematics and that gives us





Var1(η|xi) =Var0(η)− Cov0(η, ηi)Var−10 (ηi)Cov0(ηi, η)
+ Cov0(η, ηi)Var−10 (ηi)Var1(ηi|xi)Var−10 (ηi)Cov0(ηi, η).
So that our solution is a unique commutative solution, the condition Var−10 (ηi)Var(ηi|xi) <
1 should hold. Clearly it does.
So, having observed x = (x1, x2)









Var−11 (η|xi)− Var−10 (η)
−1
So, we have







6.8 Example 1: Sulfinpyrazone with non-conjugate
marginal priors
We return to the sulfinpyrazone example which we described in Section 6.6. We have
the prior means and prior variances-covariance, E0(η1) = E0(η2) = −2.165, Var0(η1) =
0.630,Var0(η2) = 0.158 and Cov0(η1, η2) = 0.158. This time we simply give η1 and η2
normal prior distributions.
Now, in order to do BLK, we need to obtain E1(η1|x1),E1(η2|x2),Var1(η1|x1) and
Var1(η2|x2). To obtain these posterior means and variances, we use a non-conjugate
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marginal prior with one-dimensional numerical integration. Therefore, we can use a
Laplace approximation. The posterior means and variances for η1 and η2 are shown
in Table 6.6.
Group i = 1 i = 2
E(ηi|xi) -2.4527 -2.0561
Var(ηi|xi) 0.0234 0.0164
Table 6.6: Posterior means and variances for η.



































We notice that E2(η|x) and Var2(η|x) are very close to those obtained by the full-Bayes
analysis.
6.9 Example 2: Surgical deaths
6.9.1 Data and model
The data in this example were introduced by Mosteller and Tukey (1977) and reproduced
in Hand et al. (1994). The data are collected from two areas in the United States and
describe the number of patients classified by sex and age. Table 6.7 shows the number of
patients under the surgical operations and the patients who die in one area. The plot of
the data is given in Figure 6.8.
In this model, we denote the number of deaths in age group g, area a and sex s as
Yg,a,s.











P̂ = number of deathsnumber of patients ,
i.e. P̂ = yg,a,s/ng,a,s. We also define the covariate xg to be x̄g − 40 where x̄g is the
age-group midpoint.
We need to specify the prior mean vector and prior variances and covariances matrix
for η, S0(η) = [E0(η),Var0(η)].
We follow Farrow (2003) to construct a more structured model.
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for both males and females in area 1 against age [Top Right]. Proportion of




for both males and females in area 2 against age [Bottom Right].
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Age Males Females Males Females
0-4 2104 1952 34 22
5-14 4272 3911 9 11
15-24 2835 2989 23 5
25-34 2785 2606 19 8
35-44 1930 1886 16 15
45-54 1497 1524 59 40
55-64 960 1013 101 52
65-75 652 855 185 118
76-83 186 287 97 108
>83 69 125 68 103
Table 6.7: Death rates amongst subjects classified by age and sex
Therefore,
ηg,a,s = βa,s + γa,sxg + wg,a,s (6.32)
where wg,a,s is a specific uncertainty factor for group g, a, s.
We construct the coefficients β and γ respectively as follows:
β1,1 = β0 + βa + βs + δ1,1,
β2,1 = β0 − βa + βs + δ2,1,
β1,2 = β0 + βa − βs + δ1,2,
β2,2 = β0 − βa − βs + δ2,2,
γ1,1 = γ0 + γa + γs + κ1,1,
γ2,1 = γ0 − γa + γs + κ2,1,
γ1,2 = γ0 + γa − γs + κ1,2,
γ2,2 = γ0 − γa − γs + κ2,2.
We give prior means and variances to β0, βa, βs, δ, γ0, γa, γs, δ1,1, ..., δ2,2, and κ1,1, ..., κ2,2,
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all of which are mutually independent. We also define w in the following expression
wg,a,s = w(a)g,a + w(s)g,s + w(a,s)g,a,s (6.33)
where, for g = 2, ..., 10,
w(a)g,a = φ w
(a)
g−1,a + ε(a)g,a
w(s)g,s = φ w
(s)
g−1,s + ε(s)g,s (?)
w(a,s)g,a,s = φ w
(a,s)
g−1,a,s + ε(a,s)g,a,s
The autoregressive structure in (?) describes our prior beliefs about deviations of the
regression lines from the straight-line model in (6.32). The random variables ε(a)g,a, ε(s)g,s and
ε(a,s)g,a,s are all given zero means. For g = 1, ..., G, where G = 10 is the number of groups,
Var(ε(a)g,a) = τ−1a ,Var(ε(s)g,s) = τ−1s and Var(ε(a,s)g,a,s) = τ−1a,s . Furthermore, ε
(d)




unless g = g′ and d = d′ and d, and d′ are each one of a, s and a, s. The autoregressive
parameter φ is chosen to reflect the degree of smoothness we expect to see in deviations
from the straight-line. We choose |φ| < 1 and set Var(w(d)g,d) = τ−1d /(1 − φ2), so that the
process is stationary, we then choose the variance τ−1a , τ−1s and τ−1a,s to give a suitable
marginal variance to wg,a,s and suitable covariances between areas and sexes. This leads
to the prior means, variances and covariances for the elements of η.
We regard areas as exchangeable and sexes as exchangeable so the marginal distribu-
tion for each subvector ηa,s is the same for each a, s.
The prior mean for ηa,s is
E0(ηa,s) = (−9.312,−8.382,−7.142,−5.902,−4.662,−3.422,−2.182,−0.880, 0.298, 1.042).
The marginal prior variance for ηg,a,s is 1.006 for g = 1, ..., 10 and the prior autocor-
relations are as follows
Lag 1 2 3 4 5 6 7 8 9
Correlation 0.912 0.833 0.762 0.697 0.640 0.587 0.540 0.498 0.460
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6.9.2 Bayes linear kinematic analysis
We combine full-Bayes marginal updates, using the Laplace approximation and Bayes
linear kinematics in order to obtain S1(η) = [E1(η|x),Var1(η|x)]. Then, we propagate
these changes in beliefs to other age groups using the Bayes linear kinematics equations
(6.12) and (6.13).
6.9.3 Results
For comparison with the BLK analysis we also present the results of a full-Bayes analysis
in which posterior summaries are computed using MCMC.
First we do an analysis for each area-sex group separately. We use Bayes linear kine-
matics on η. We use R to do all these updates and produce some graphs which show
how BLK is close to the full-Bayes analysis. Figure 6.9 represents the adjusted means
for ηg,1,s (red) using BLK with the non-conjugate prior and the corresponding posterior
means from the full Bayes analysis. We notice that the posterior means are close to each
other. In addition, we can see that our posterior expectations using BLKs are closer to the
corresponding data for age group g, area 1 and sex s than the prior expectations. That
is an indicator that our prior variance and covariance structure that we used allowed the
inference to reflect the relationships between the variables very well. Figure 6.10 shows









Tables 6.9, 6.11, 6.13 and 6.15, show the posterior means for η from BLK, full-Bayes
analysis and the values of η̂ for the four combinations of area and sex. We can see that,
almost all of these posterior means are very close to each other in both methods full-Bayes
and BLK. Therefore, the non-conjugate method produces similar results to MCMC but
much more quickly. This is also shown in Figure 6.11.
The posterior variances using full-Bayes analysis and the marginal posterior variances
using BLK are shown in Tables 6.8, 6.10, 6.12 and 6.14 for the four combinations of sex
and area. We can see that most of these marginal posterior variances from BLK and
full-Bayes are very close to each other. For example, the posterior variances using BLK
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BLKs with non−conjugate prior
Figure 6.9: Adjusted means for ηg,1,s using Bayes linear kinematics with the non-conjugate prior









































Figure 6.10: Adjusted means, ±2 standard deviation limits for males in area 1.
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Table 6.8: Posterior variances of η from BLK and full-Bayes analysis for the males in Area 1.
g, s E1(η) (BLK) E1(η) (full-Bayes) η̂ (observations)
(1,1) -4.5358 -5.1039 -4.1089
(2,1) -5.4083 -5.7371 -6.1605
(3,1) -4.9401 -4.9809 -4.8062
(4,1) -4.9048 -4.9211 -4.9807
(5,1) -4.5093 -4.5458 -4.7844
(6,1) -3.2192 -3.2200 -3.1935
(7,1) -2.1401 -2.1401 -2.1406
(8,1) -0.9262 -0.9252 -0.9260
(9,1) 0.1902 0.2195 0.0861
(10,1) 2.2184 2.2268 4.2195
Table 6.9: Posterior means of η from BLK, full-Bayes analysis and the values of η̂ for the males
in Area 1.
for males and females in Area 1 are slightly less than the posterior variances using full-
Bayes analysis. However, some of the posterior variances using BLK for both males and
females in Area 2 are slightly bigger than the marginal posterior variances using full-Bayes
analysis.
Now, we expand the analysis so that the data from both areas and both sexes are
analysed together. In fact, we have 4 groups in this example (2 areas × 2 sexes). So, to
do that we give a vector of 10 prior means (for the 10 age-groups for males in Area 1).
Then the mean vector for the whole data set is just this vector repeated 4 times.
We also give a 10 × 10 variance matrix for the males in area 1, V0. Now we should
have a 40 × 40 variance matrix
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Table 6.10: Posterior variances of η from BLK and full-Bayes analysis for the females in Area 1.
g, s E1(η) (BLK) E1(η) (full-Bayes) η̂ (observations)
(1,2) -5.0447 -5.0211 -4.4742
(2,2) -6.0085 -5.8132 -5.8708
(3,2) -5.7111 -6.0258 -6.3916
(4,2) -5.5102 -5.6181 -5.7831
(5,2) -4.7927 -4.7759 -4.8262
(6,2) -3.6784 -3.6621 -3.6136
(7,2) -2.9699 -2.9022 -2.9167
(8,2) -1.9175 -1.8190 -1.8319
(9,2) -0.4554 -0.4544 -0.5053
(10,2) 1.3058 1.3335 1.5437
Table 6.11: Posterior means of η from BLK, full-Bayes analysis and the values of η̂ for the
females in Area 1.











Table 6.12: Posterior variances of η from BLK and full-Bayes analysis for the males in Area 2.
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g, s E1(η) (BLK) E1(η) (full-Bayes) η̂ (observations)
(1,1) -5.1069 -5.0346 -4.0532
(2,1) -5.5059 -5.4175 -5.8487
(3,1) -4.4720 -4.7241 -4.4667
(4,1) -4.5038 -4.7009 -4.8091
(5,1) -4.3459 -4.3733 -4.5917
(6,1) -3.4048 -3.4342 -3.4624
(7,1) -2.2176 -2.2194 -2.2070
(8,1) -1.0685 -1.0503 -1.0448
(9,1) -0.1349 -0.1276 -0.1804
(10,1) 0.9413 0.9757 1.0609
Table 6.13: Posterior means of η from BLK, full-Bayes analysis and the values of η̂ for the males
in Area 2.











Table 6.14: Posterior variances of η from BLK and full-Bayes analysis for the females in Area 2.
g, s E1(η) (BLK) E1(η) (full-Bayes) E1(η) (observations)
(1,2) -7.8966 -7.6528 -5.4323
(2,2) -7.2931 -7.1886 -6.7776
(3,2) -6.4877 -6.5292 -7.1253
(4,2) -5.5623 -5.6222 -5.8101
(5,2) -4.4997 -4.5046 -4.2474
(6,2) -3.9025 -4.0223 -4.1442
(7,2) -2.9437 -2.9917 -2.9430
(8,2) -2.0936 -2.2280 -2.2762
(9,2) -0.6615 -0.7188 -0.8309
(10,2) 1.9224 2.0961 3.1697
Table 6.15: Posterior means of η from BLK, full-Bayes analysis and the values of η̂ for the
females in Area 2.
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Figure 6.11: Posterior means for η using full-Bayes analysis, BLK with non-conjugate prior and
the empirical data. Top left: Posterior means for η for males in Area 1. Top right: Posterior
means for η for females in Area 1. Bottom left: Posterior means for η for males in Area 2.
Bottom right: Posterior means for η for females in Area 2.
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V0(η) =

V0 ρAV0 ρSV0 ρ0V0
ρAV0 V0 ρ0V0 ρSV0
ρSV0 ρ0V0 V0 ρAV0
ρ0V0 ρSV0 ρAV0 V0

where the first row and the first column of V0(η) represent the males in Area 1, the second
row and the second column of V0(η) represent the females in Area 1, the third row and
the third column of V0(η) represent the males in Area 2 and the fourth row and the
fourth column of V0(η) represent the females in Area 2 and ρ0, ρA and ρS are correlation
coefficients, where
ρ20 is the proportion of uncertainty shared by all 4 groups,
ρ2S is the proportion of uncertainty shared by 2 groups which are the same sex, and
ρ2A is the proportion of uncertainty shared by 2 groups which are the same area.
So,
0 < ρ20 + (ρ2S − ρ20) + (ρ2A − ρ20) < 1
In this example, we give ρ20 = 0.64, ρ2A = 0.81 and ρ2S = 0.68. We also have assigned
values to Var(β0),Var(βA) and Var(βS), where Var(β0) = ρ20Var(β11), Var(βA) = (ρ2A −
ρ20)Var(β11), Var(βS) = (ρ2S − ρ20)Var(β11), and Var(δ11) = (ρ2A + ρ2S − ρ20)Var(β11) and so
on. So, the posterior mean using BLK in (6.27) for η is E1(η) as follows
Area Sex g = 1 2 3 4 5 6 7 8 9 10
1 1 -4.603 -5.445 -5.009 -4.919 -4.487 -3.222 -2.137 -0.921 0.282 2.691
1 2 -4.754 -5.493 -5.018 -4.921 -4.488 -3.222 -2.137 -0.921 0.282 2.691
2 1 -4.754 -5.493 -5.018 -4.921 -4.488 -3.222 -2.137 -0.920 0.282 2.691
2 2 -4.754 -5.493 -5.018 -4.921 -4.488 -3.222 -2.138 -0.924 0.190 1.727
The posterior correlation matrix for η using Bayes linear kinematics is shown in Ap-
pendix (A.6.4).
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6.10 Categorical and censored variables
6.10.1 Introduction
In a Bayes linear analysis we might observe variables which, typically, we might suppose
have approximately normal distributions, perhaps after transformation. In some prob-
lems, such as the survival applications in Chapter 7, we observe variables which could not
be given a normal distribution even after transformation, for example discrete or cate-
gorical variables. In a Bayes linear Bayes model we relate such an observable variable to
an underlying latent variable Z. Thus we typically have a latent vector Z = (Z1, ..., ZT )T
where in an analogous full-Bayes analysis, Z might be given a multivariate normal distri-
bution. In this section we consider some particular types of observable variables.
6.10.2 Binary variables
A categorical variable which can take only two values is a binary variable. Typically the
values may be labelled 0 or 1.
Two possibilities arise in the case of a binary variable X. The first method, called the
direct method, is to let X = 1 if the corresponding Z ≥ 0 and X = 0 if Z < 0 and, for this
reason, we assign Z a normal prior distribution. In this case the support of the posterior
distribution is bounded at zero and we need to use a quadrature method rather than the
normal or Laplace approximation.
A second possibility, which we call the indirect method, is often appropriate in appli-
cations such as a prognostic index. Suppose that Pr(X = 1|Z) = θ = h−1(Z) where h−1()
is the inverse of a suitable link function h(), for instance, logit, Z = log{θ/(1 − θ)}, or
probit, Z = Φ−1(θ), where Φ is the standard normal cumulative distribution function. In
this case the likelihood function is θX(1−θ)1−X and the posterior support is not bounded
so we can use methods such as a Laplace approximation.
6.10.3 Ordinal variables
Ordinal variables are categorical variables where the values are ordered. A suitable model
to use with an ordinal variable is an ordinal logistic regression.
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Let X be an ordinal variable with K categories. One of the simplest ways to model
that is to obtain
Pr(X = 1) = θ1,
Pr(X = 2|X 6= 1) = θ2,
Pr(X = 3|X 6= 1, X 6= 2) = θ3,
and so on. These conditional probabilities are not constrained to sum to one.
We consider the case of ordinal variables as a generalisation of the case of binary
variables. Suppose that we have ordered categories labelled {1, ..., K}. Then we need
K − 1 cut points {c1, c2, ..., cK−1} for Z. For example, in the non-Hodgkin lymphoma
data set, we have an ordinal variable called Stage. This variable can take the values
(0, 1, 2, 3). We relabel these (1, 2, 3, 4). Then we should have in this case three cut points.
To avoid non-identifiability, we need to fix two cut points. This is because the distribution
of Z has two parameters, the mean and the variance.
Again, as in the case of binary variables, using the direct method, X = k if and only
if ck−1 ≤ Z < ck for a set of thresholds {c1, ..., cK−1} where c0 → −∞ and cK → ∞. In
this case the posterior distribution support is bounded, often both below and above, so
we might use a quadrature method to find the posterior moments.
We can also apply the indirect method. Suppose that Pr(X ≤ k) = h−1(ck − Z) for
a suitable link function h(). It is convenient to use h() = Φ−1(). In this case we might
suppose that there is a latent variable Z∗ which has a normal distributionN(Z, 1), given Z.
Therefore, the likelihood is h−1(ck−Z)−h−1(ck−1−Z), for example Φ(ck−Z)−Φ(ck−1−Z).
In this case the posterior support for Z is unbounded.
6.10.4 Unordered categorical variables
Dealing with a categorical variable with K > 2 unordered categories labelled 1, ..., K,
other than by conditioning the whole model on the categories, requires the use of an
underlying vector variable with K − 1 elements. This can be handled within the general
Bayes linear kinematic and Bayes linear Bayes framework since the elements Z can be
vectors. For example in an indirect approach we can set
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and this provides the likelihood. We can then give each Zj,k a normal distribution with
variance 1. A constraint, such as Zj,1 = 0 or
∑K
k=1 Zj,k = 0 is applied for identifiability.
In a direct approach, observing Xj = k corresponds to observing Zj,k ≥ 0 and Zj,i < 0
for all i 6= k.
6.10.5 Interval-censored variables
A variable subject to interval censoring may be handled by methods similar to the direct
and indirect methods in the case of ordinal variables. In the direct case, if X is not
censored, then Z = X and we make a direct observation. If the observation is censored,
then we observe that ck−1 < Z < ck for lower and upper bounds ck−1 and ck and the
posterior support is bounded. In the indirect method we suppose that, when X is not
censored, we observe Z∗ = X and, when X is censored, we observe that ck−1 < Z∗ < ck ,
where, Z∗ ∼ N(Z, 1). Hence, in the latter case, the likelihood is Φ{(ck−Z)}−Φ{(ck−Z)}.
6.10.6 Marginal update calculations for ordinal observations
Consider an ordinal variable X, using the direct method. Suppose that Z has prior mean
E0 and prior variance V0. Let S0 =
√
V0 be the prior standard deviation. Suppose
that we use probits. Let Φ() be the standard normal distribution function and Φ−1()
be its inverse. Let W = Φ{(Z − E0)/S0}. Then W has a prior uniform distribution on
(0,1). We can also transform the cut points in the same way: Cx = Φ{(C − E0)/S0}.
The observation X selects the observed interval. The posterior distribution of W is then
simply a uniform distribution over that interval, U(Cl, Cu), where Cl represents the lower
cut point and Cu refers to the upper cut point. We use a trapezium rule to integrate over
that interval by setting up a grid of W values over the interval and then calculate the
values of Z = E0+S0Φ−1(W ). Finally we find the average value of Z and the average value
of Z2 over the interval. We used a R function to make the adjustment for both binary
and ordinal variables in the non-Hodgkin lymphoma example, since a binary variable is
equivalent to an ordinal variable with just two categories. See Appendix A.6.5.
When we use the indirect method, we can obtain unbounded support for the posterior
rather than obtain bounded support in the direct method.
In the case of binary variables in the model, such as albumin in the non-Hodgkin
lymphoma data, our likelihood in this case will be θX(1 − θ)1−X . We transform the
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parameter θ here, so that we can use, for example, logit, Z = log[θ/(1 − θ)]. Then the









and the prior for Z in this case is Z ∼ N(m, 1) where m is the prior mean of Z and we
fix the variance of Z to be 1.
Therefore, the posterior density of Z is
π(Z|x) ∝ f(Z)f(X,Z)
∝ 12 exp(Z −m)
2 exp(Zx)[1 + exp(Z)]−1.
Then the support of the posterior density π(Z|x) in this case is unbounded so we can
use a Laplace approximation to calculate the posterior means and variances for Z when
we update these moments using BLK.
6.11 Summary
In this chapter, we have investigated Bayes linear methods with some theoretical aspects
of this approach. Bayes linear analysis is different from full-Bayes analysis as Bayes linear
methods specify just the first and second order moments and then calculate the posterior
moments. So we do not need to specify the prior in a probabilistic way as in a full-Bayes
analysis. We explained the idea of Bayes linear analysis using a motivational example.
We explained Bayes linear kinematics and mentioned the concept “commutativity” and
how to do multiple updates using BLK.
We also described Bayes linear Bayes graphical models as a combination of Bayesian
networks and Bayes linear structure. We use the idea of transformation of the parameters
for different reasons. However, the most important one is that θ may have a bounded
range and this boundary makes the use of Bayes linear methods less attractive.
After transforming the parameters, we can use the mode and log-curvature method
that we explained in Section 6.5.3. We apply the mode and curvature method to con-
struct the prior mean and variance for the transformed parameters. We use an example
concerning the use of sulfinpyrazone.
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This chapter has some proposed ideas including the use of non-conjugate updates
in order to calculate Bayes linear kinematics. An example is when we have a binomial
likelihood and logit-normal prior. In the case of a non-conjugate prior, we need to use
some numerical integration methods such as a Laplace approximation or the trapezoidal
rule. However, these integrations are low-dimensional, often one-dimensional, in contrast
to the high-dimensional integrations required by a full-Bayes analysis.
We have done two examples in this chapter and the results show that using a non-
conjugate prior distribution gives posterior moments closer to those obtained with a full
Bayes analysis. The ability to use non-conjugate marginal updates also widens the range
of types of observations which can be incorporated in a Bayes linear Bayes model.
We finish this chapter by considering how different types of variables can be handled
in a Bayes linear Bayes model. In addition, we have proposed two methods (the direct




Application to survival data
7.1 Introduction
This chapter deals with the application of Bayes linear Bayes models and Bayes linear
kinematics to survival data. We divide this chapter into two parts. The first part deals
with the leukaemia example with investigation and comparison of the full-Bayes method,
the BLK method with conjugate prior and our proposed method which is BLK with non-
conjugate prior update. This example applies BLK to a data set to make inferences about
the values of model parameters. In this part, we start with the introduction of piecewise
constant hazard (PCH) models in Section 7.2.2. Then we give a brief description of the
leukaemia data set in Section 7.3. In Section 7.3.3, we illustrate in detail the Wilson and
Farrow approach which depends on using BLK in a PCH model. Section 7.3.4 uses the
idea of non-conjugate prior updates in order to produce posterior means and the posterior
variance-covariance matrix for the parameters of interest β using BLK. We compare the
results from using the non-conjugate method with full Bayes methods and BLK with a
conjugate prior in Section 7.3.6. In Section 7.3.7, we do some diagnostic plots for the
leukaemia example to check the validity of the assumptions.
The second part tackles another type of application with data on patients with non-
Hodgkin lymphoma. The idea here is to construct a Bayes linear kinematic network to
compute a prognostic index value for a patient given observations on some or all of a set
of covariates. The calculation will be fast and relatively simple. The use of Bayes linear
kinematics eliminates the problem of non-commutativity which has been experienced in
some related work. We start the second part by outlining the novelty of using a latent
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prognostic index and how it relates to survival time for patients. In Section 7.4.3, we
explain how we can construct a Bayes linear kinematic prognostic network with various
sorts of covariates. In Section 7.5.1, we give an explanation of the general strategy for
constructing the prognostic network, including the use of the offline learning model.
We propose the BLK method with non-conjugate prior update and investigate its
application to a rapid computation of prognostic index values in survival analysis when
a patient’s values may only be available for a subset of covariates. We explain the offline
learning in Section 7.6.3 which simply uses a full-Bayes analysis and MCMC to learn
about the values of the parameters. As in the leukaemia example, in Section 7.6.6, we
give diagnostic plots for the non-Hodgkin lymphoma in order to assess the validity of our
assumptions and to support model selection. In Section 7.6.8, we show the summary of
the results for our proposed method using the non-conjugate prior updates in order to
evaluate the Bayes linear kinematic approach and compare it with the full-Bayes analysis
using MCMC methods. We identify important differences between the direct and the
indirect methods and compare the results of using these methods in Section 7.7. In
Section 7.8, we explain the prototype calculator for the prognostic index for patients and
how it works. Finally, we give a summary of the chapter in Section 7.9.
7.2 Bayes linear Bayes retrospective analysis
7.2.1 Introduction
As our first illustrative example, we will show a retrospective analysis. Here we have a
data set with data on a collection of patients and we wish to use Bayes linear kinematics to
learn about the values of model parameters. Specifically, we will use a piecewise constant
hazard model. Such models will be described in more detail in Section 7.2.2. Briefly, time
is divided into a number of intervals and the log hazard for patient i in interval k has the
form




where xi,j is the value of covariate j for patient i. We wish to learn about the values of
the coefficients βk,0, ..., βk,J for each interval k and we use Bayes linear kinematics to do
this.
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7.2.2 Piecewise constant hazard models
In a piecewise constant hazard (PCH) model, we do not assume a particular form for the
baseline hazard function h0(t). Instead we relax the parametric assumption about the
baseline hazard. Time is divided into different time intervals. Then we assume that the
hazard is constant within each interval. However, the hazards are allowed to vary from
interval to interval. See Section 5.5.2.
Suppose that we have patients i = 1, ..., n and patient i has the covariates xi =
(1, xi,1, ..., xi,J)
′
. A hazard function hi(t) is associated with patient i at time t. The hazard
functions of patients when we assume a proportional hazards model (Cox, 1972) are related
as hi(t) = φih0(t), where φi is a constant and h0(t) is the baseline hazard function. We




for some parameters β = (β0, β1, ..., βJ)
′
.
In this scenario, we assume that the parameter values β are constant over time, which
means that the effect of the covariates for the patient is constant over time. Sometimes
this is not the case, so if we wish to allow for this possibility we need to use a dynamic
model which allows changes in the effects of the covariates over time. This dynamic model




Now the piecewise constant hazards model, (see, for example, Ibrahim et al., 2001;
Wilson and Farrow, 2017) uses some fixed cut-points s0, s1, ..., sk such that s0 = 0 and
sk → ∞ is greater than the largest death time. Therefore, the time can be divided into
intervals. We define the interval Ik as [sk−1, sk). So the baseline hazard will be
h0(t) = λ0,k, for sk−1 ≤ t < sk
and the hazard function for patient i is
hi(t) = λi,k.
More detail about the integrated hazard function Hi(t), the survival function Si(t) and
the probability density function for patient i is given in Section 5.5.2.
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In order to apply Bayesian analysis for the dynamic model, first we need to introduce
the likelihood function allowing for right censored observations. The likelihood for patients








Li,k = (λi,k)δi,k exp{−λi,k(ti,k − sk−1)} (7.4)
where δi,k = 1 if the patient i dies in the interval Ik, δi,k = 0 if the patient i is censored
or survives in Ik and ti,k = ti if patient i dies in interval Ik, ti,k = tk if patient i survives
in interval Ik or ti,k = t∗i if patient i is censored at time t∗i in interval Ik.
7.2.3 Full Bayes analysis for piecewise constant hazard model
In this section, we give a brief description of the full-Bayes analysis to compute the
posterior means and posterior variances for all the parameter values β in a piecewise
constant hazards model.
Given that the patient survives to the beginning of the interval Ik, the conditional
lifetime distribution is an exponential distribution with parameter λi,k for patient i in
interval Ik. In each interval, our beliefs about λi,k are updated when we observe the data
in that interval. These changes in belief are propagated to the quantity ηi,k (the linear
predictor) as follows
log(λi,k) = ηi,k = xTi βk.
To compute the posterior distribution of ηi,k, we need to combine the likelihood func-
tion in (7.4) with a suitable prior distribution, for example, a normal prior distribution
for β = (βT1 , ..., β
T
k
)T . Since the prior is not conjugate to the likelihood, we need numer-
ical methods to compute posterior summaries and Markov chain Monte Carlo (MCMC)
methods are usually used.
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7.3 Example: Leukaemia
7.3.1 Introduction
This example refers to the data of Henderson et al. (2002) which are described in Section
2.3. In this example, we have 1043 patients. The dependent variable in this study is the
time T measured in days until the event (death) occurs. Of the 1043 patients, 879 died
and 164 were right censored. See Section 2.3 for more details.
We have a number of covariates that were thought to have an effect on survival with
this disease. We manipulate these covariates as follows:
• The age Ai represents the age of patients in years. So we use xi,1 = Ai − 60.
• The sex of the patients. We give xi,2 = 1 if the patient is male and xi,2 = −1 if the
patient is female.
• White blood cell count Wi at the time of diagnosis. We use xi,3 = Wi − 8.
• Deprivation score (Depscore): This variable measures the deprivation for the resi-
dential area of the patient. We use the Townsend deprivation index (TDI) (Townsend
et al., 1988). The scale of the variable is from -7 to 10 with lower values indicating
more severe deprivation.
We wish to use a piecewise constant hazard model for leukemia survival. Therefore, the
hazard function for patient i in interval Ik is exp{βk,0 +
∑4
j=1 βk,jxi,j}. For instance, if we
have a male patient with age 60, his white blood cell count is 8 and deprivation score 0,
then the hazard function in this case will be exp{βk,0 + βk,2} and so forth.
7.3.2 Exploratory plots in the leukaemia example
Figure 7.1 shows scatter plots of pairs of variables. When we compare Age and log(T ) in
Figure 7.1, we see that most of the people are in the age group [50-80] and the younger
people are tending to live longer than the older ones.
When we plot one covariate against another, that is plotting Age against log(WBC),
Age against Deprivation, log(WBC) against Deprivation, we can see that we have a ran-
dom scatter for points for both males and females.
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Figure 7.1: Exploratory plots for the covariates in leukaemia example. Black dots for males and
red dots for females.
When we plot log(WBC) against log(T ) and Deprivation against log(T ), there is no
suggestion that the variance changes. However, we will need to examine diagnostic plots
after fitting the model.
7.3.3 Wilson and Farrow approach
Wilson and Farrow (2017) applied Bayes linear kinematics to these data using a piecewise
constant hazards model with 10 time intervals. So, they define sk = −ν log(1 − uk), for
u = 0.1 and ν = 500 in order to give us these 9 cut-points which are (52.7, 111.6, 178.3,
255.4, 346.6, 458.1, 602.0, 804.7, 1151.3).
In order to make inference (i.e. posterior means, posterior variances and covariances)
about the collection of parameter values β
j
= (β0,j, β1,j, β2,j, β3,j, β4,j)T in the model, we
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need to specify our prior beliefs for these parameters.
Wilson and Farrow (2017) specified the prior moments for each of the parameters.
This prior specification is developed as follows. To obtain suitable prior moments for
β0,1, we assume a constant hazard with a wide range for the mean lifetime for “baseline”
patients. Therefore, we use the mean of -6 and standard deviation of 0.8 for β0,1. That can
give us ±2 standard deviations range which corresponds to a range for the mean lifetime
from 81 to 1998. See Wilson and Farrow (2017).
Now consider β1,1 which represents the coefficient of Age. The range of the Ages of
the patients is between 14 and 92. We expect that the hazard is increasing as the age
is increased. Wilson and Farrow (2017) elicited the mean and the variance for β1,1 by
assuming that the patient i is 10 years older than patient i′ . So, the ratio of the hazard




if patient i and i′ have the same values for the other covariates. We can suggest a
range 0.8 < hi(t)/hi′ (t) < 1.8. Suppose that these values give us an approximate 95%
interval for a normal prior distribution for β1,1. Therefore, we obtain E0(β1,1) = 0.02 and
Var0(β1,1) = 0.0004.
We can apply this process for the rest of the coefficients in the first time interval,
β2,1, β3,1 and β4,1. We apply this prior elicitation process to the other time intervals.
Table 7.1 gives the prior means and variances for β for the first time interval. The values
for the other time intervals are the same.
To complete the prior specification we need to specify prior correlations between the
parameters. Following Wilson and Farrow (2017) we make βr,j independent of βr′ ,j′ ,
unless r = r′ . That is, the coefficients of different covariates are independent of each
other. Again following Wilson and Farrow (2017), we construct the covariances between
βr,1, ..., βr,k using a stationary first order autoregressive process. We write, for j = 2, ..., k,
βr,j = Br + φ(βr,j−1 − Br) + εr,j
where εr,j is a zero-mean random variable with εr,j independent of εr′ ,j′ unless r = r
′ and
j = j ′ and Var(εr,j) = Vε,r.
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For stationarity, we choose |φ| < 1 and write
βr,1 = Br + ε?r
where ε?r is a zero-mean random variable with ε?r independent of ε?r′ unless r = r
′ and ε?r
independent of εr′ ,j for all r
′ and all j > 1, and set Var(ε?r) = Vε,r(1 − φ2)−1. The value
of φ is chosen to determine the temporal prior correlation in βr,1, ..., βr,k in conjunction
with the choice of Var(Br) (see Wilson and Farrow, 2017). Having chosen the values of
φ, Var(Br) and Var(βr,j), the value of Vε,r is determined since
Var(βr,j) = Var(Br) + Vε,r(φ2)−1.
The values chosen were those used by Wilson and Farrow (2017). Thus φ = 0.92,Var(Br) =
0 for r = 0, ..., 4 and the other choices are given in Table 7.1.
Effect Mean Variance
Baseline β0,1 -6.000 0.64
Age β1,1 0.020 0.0004
Sex β2,1 0.000 0.1225
WBC β3,1 0.005 0.000025
Deprivation score β4,1 0.000 0.01
Table 7.1: Prior means and prior variances for each of the effects. Adapted from Wilson and
Farrow (2017).
Wilson and Farrow (2017) used conjugate gamma prior distributions for the hazards
λi,j = exp(ηi,j). They considered three different methods for linking the moments of λi,j
to those of ηi,j, the log-mode, log-moment and lognormal methods. See Section 6.5.
In this thesis, we will use the same prior specifications as Wilson and Farrow (2017).
Then we will use our proposed method which depends upon using the non-conjugate
marginal prior (i.e. the non-conjugate method) to update our prior beliefs about β.
7.3.4 Use of non-conjugate updates in the leukaemia example
Our method of using the non-conjugate update might be regarded as an approximation to
a full-Bayes analysis. Wilson and Farrow (2017) compared the behaviour of Bayes linear
kinematic belief adjustments with full-Bayes posterior inferences in the case of a piecewise
constant hazard survival model and found that the results were generally close.
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Let us explain how our method works in this example. Suppose we have
ηi,k = log(λi,k) = xTi βk.
We are interested in finding the moments of β, (i.e. E1(β) and Var1(β)) using Bayes lin-
ear kinematics. To do that, we need to specify prior means and prior variance-covariance
for β which are E0(β) and Var0(β) respectively. Then, when we have observed patient i
in interval Ik, we can use the Laplace approximation method to gain a new mean and new
variance for ηi,k and propagate that through β and apply the proper BLK in the following
way.
We revise the mean and variance using
E1(β | Dη) = E0,β + V0,β,ηV −10,η,η(E1,η − E0,η), (7.5)
Var1(β | Dη) = V0,β,ηV −10,η,ηV1,η,ηV −10,η,ηV0,η,β
+V0,β,β − V0,β,ηV −10,η,ηV0,η,β. (7.6)
where Dη is a single observation, E0(β) is a vector of prior mean of β, V0,β,η is a vector
of the covariance between β and η, V −10,η,η is a scalar prior variance of η, V0,β,β is the prior
variance for β, E1(β | Dη) is the posterior mean of β updated by the single observation
Dη and Var1(β | Dη) is the posterior variance of β updated by a single observation Dη.
That is, we let η = log(λ) then we give η a normal prior distribution with mean E0(η)
and variance Var0(η). Then we obtain a Bayesian update using the numerical methods
such as the Laplace approximation method. See Section 6.5.3. Therefore, the update of
η will be non-conjugate. Hence, we obtain E1(η) and Var1(η). Then we use these E1(η)
and Var1(η) in (7.5) and (7.6) to find the posterior means and the posterior variances for
β.
To combine the updates from all observations, we use Bayes linear kinematics. When
a unique commutative update exists, it can be written as
P(β | D) =
J∑
j=1
P(β | Dj)− (J − 1)P(β), (7.7)
P(β | D)E(β | D) =
J∑
j=1
P(β | Dj)E(β | Dj)− (J − 1)P(β)E(β), (7.8)
where D = (D1, . . . , DJ)
′ and P(β) = Var(β)−1 is the prior precision matrix. See Section
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6.3.4 and equations (6.14) and (6.15).
Our use of non-conjugate updates allows our model to be closer to the corresponding
full-Bayes model. We can see from Figure 7.3 that the Bayes linear kinematic adjusted
expectations are even closer to the full-Bayes posterior means.
7.3.5 Full Bayes analysis for the leukaemia example
For comparison with the Bayes linear kinematic analysis we also carry out a conven-
tional full-Bayes analysis. In terms of the prior specification, we assume that all β
j
=
(β0,j, β1,j, β2,j, β3,j, β4,j)
′ have a multivariate normal distribution. There are 50 parameters
in this case ( 5 in each time interval). We represent the prior means and prior variances
in the first interval in Table 7.1.
To apply a full Bayes analysis, we need to specify our likelihood function which is
written in (7.4) in addition to the prior specification.
A Bayesian posterior update is done using the fully specified prior. We give a (non-
conjugate) normal prior for ηi,j. Therefore, the posterior update for ηi,j is non-conjugate.
The computations are done using MCMC. Specifically we used rjags (Plummer, 2017).
The rjags model specification is given in Appendix A.7.1.
7.3.6 Results in the leukaemia example
A preliminary analysis gave results which suggested that the hazard was not constant
over the first time interval. This was indicted by an excess of residuals close to the left
hand end of the histogram, in a residual plot made in the same way as Figure 7.4. To deal
with this problem, an extra cut-point was introduced at s1 = 10.5, giving eleven intervals
in total. The value of 11.5 was chosen by examination of histograms and Kaplan-Meier
plots (See Figure 7.2) of lifetimes in the affected region. Because the hazard appeared to
change rapidly in this region, we did not reduce the incremental variance Var0(β) in the
prior specification for β but kept it the same as for the other transitions.
We calculated posterior moments of the parameters using the Bayes linear Bayes
approach, with conjugate updates using both the log-mode and the log-normal methods
and with non-conjugate updates. We also calculated posterior distributions using a full-
Bayes analysis. The log-mode and log-normal methods were chosen because the log-mode
method was used by Wilson and Farrow (2017) and the lognormal method is closer to the
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Figure 7.2: Kaplan-Meier estimates Ŝ(t) with confidence intervals with several lifetime such as
15, 52, 300 and all the observations.
161
Chapter 7. Application to survival data
j τj βj1 × 102 βj2 × 10 βj3 × 103 βj4 × 102
1 10.5 4.352 (0.331) -0.199 (0.665) 4.625 (0.526) 3.275 (1.342)
2 52.7 3.692 (0.356) 0.252 (0.703) 3.072 (0.800) 4.262 (1.515)
3 111.6 3.126 (0.386) 0.263 (0.793) 2.882 (0.919) 2.540 (1.774)
4 178.3 2.502 (0.403) 0.310 (0.858) 3.465 (1.007) 1.266 (1.959)
5 255.4 2.345 (0.416) 0.589 (0.896) 3.564 (1.106) 1.147 (2.013)
6 346.6 1.823 (0.423) 0.420 (0.912) 2.589 (1.265) 0.747 (2.069)
7 458.1 1.557 (0.440) 0.090 (0.961) 2.595 (1.364) 1.137 (2.170)
8 602.0 1.590 (0.493) 0.425 (1.047) 3.449 (1.499) 0.033 (2.373)
9 804.7 1.495 (0.532) 1.106 (1.149) 1.762 (1.712) -2.322 (2.720)
10 1151.3 2.329 (0.580) 1.429 (1.254) -0.709 (2.063) -4.815 (2.983)
11 ∞ 2.887 (0.788) 1.523 (1.647) -1.179 (2.539) -4.548 (4.045)
Table 7.2: Posterior means and standard deviations for each of the parameters in each interval
using the non-conjugate method.
non-conjugate method.
We compare the results from four methods. Table 7.2 gives us the posterior means for
the effects of all the covariates in all the intervals and the posterior standard deviations
are given in brackets, using the non-conjugate method. When we look at Table 7.2, we
notice that all the posterior means of the effect of age are positive and most of those for
sex as well. That means increasing the age and the sex being male both increase the
hazard of death from leukaemia.
Furthermore, the age effect is decreasing over time and then eventually increasing
while the sex effect increases over the time. So, in general, all the covariates in the model
have an effect on the survival time for the patients with leukaemia.
Figure 7.3 shows the comparison between Bayes linear Bayes analysis using the con-
jugate prior based on the log-normal and log-mode method, full-Bayes analysis and the
non-conjugate method. We see that, the posterior means for the Bayes linear kinematic
method using the non-conjugate prior gives very similar results to the full-Bayes approach.
However, the computations for the non-conjugate BLK were much faster than those for
the full Bayes approach.
We have also noticed that the posterior means using the log-normal method are also
very close to our posterior means using the non-conjugate method.
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Figure 7.3: The effect of age and sex on the hazard functions of individuals with leukaemia.
Triangles represent the posterior means for the full Bayesian method, circles represent different
types of Bayes linear Bayes methods such as the black colour represents the posterior means
using the non-conjugate prior update method. The transformed time is [1− exp(−t/ν)]/u with
u = 0.1 and ν = 500. The posterior means are plotted at the mid-points of the time intervals on
the transformed scale.
7.3.7 Diagnostic checking in the leukaemia example
In this section, we produce some residual plots to check the validity of the assumptions
made in the leukaemia example.
7.3.7.1 Residuals in survival analysis
For a general, non-Bayesian, discussion of residuals in survival analysis see, for example,
Collett (1994). Several types of residuals have been defined for survival models. These
include Cox-Snell residuals (Cox and Snell, 1968).
In non-Bayesian analyses, the Cox-Snell residual for patient i is an estimate of
− logSi(ti), where Si(t) is the survival function for patient i and ti is that patient’s survival
time. In the case of a censored observation, the Cox-Snell residual is also censored.
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Clearly there is a 1−1 correspondence between − logSi(ti) and Fi(ti), where Fi(t) =
1 − Si(t) is the cumulative distribution function (cdf) of the lifetime distribution for
patient i. Given Fi(t) and that the lifetime Ti is a random value from this distribution,
then Fi(Ti) has a uniform U(0, 1) distribution. Furthermore Φ−1[Fi(Ti)] has a standard
normal distribution, where Φ() is the standard normal cumulative distribution function.
In the context of a model fitted to data, an observed lifetime ti is known but the
parameters of Fi(t) have a posterior distribution. Therefore Fi(ti) also has a posterior
distribution and we can compute summaries, such as quantiles, of this distribution. In the
case of a censored observation, the actual lifetime Ti is also unknown but we can compute
summaries of the posterior predictive distribution of Fi(Ti).
The two examples in this chapter, leukaemia and non-Hodgkin lymphoma, are prob-
lems of different kinds. The details of how residuals are calculated and used differ between
them.
7.3.7.2 Computing the residuals in the leukaemia example
The leukaemia example is a purely Bayes linear Bayes example in which the objective
is to make inferences about the values of the model parameters. Because the model
is a piecewise constant hazard model, all of the parameters are the coefficients β in a
linear model (including the baseline). The inferences are calculated using Bayes linear
kinematics (BLK). As no Markov chain Monte Carlo (MCMC) computations are involved,
we can not compute the residuals as a byproduct of the MCMC.
The Bayes linear Bayes model does not assign a distribution (either prior or posterior)
to β. However, for the purpose of computing residuals, as an approximation, we use a
multivariate normal distribution for the posterior distribution of β. We use the posterior
mean vector and variance-covariance matrix calculated by BLK. We draw a large number,
M , eg M = 1000, of random samples of β from this multivariate normal distribution. Let
these randomly sampled vectors be β1, ..., βM . For each sampled vector βm and each
patient i, we calculate a residual Rm,i as follows.
If the lifetime ti for patient i is observed (not censored) then we simply calculate
Rm,i = Fi(ti; βm) which is the cdf evaluated at time ti with the covariate values for
patient i and the parameter values β
m
.
If the observation for patient i is right-censored at time ci then we calculate Fi(ci; βm).
If the actual lifetime for patient i is Ti > ci, then Rm,i = Fi(Ti; βm) is uniformly distributed
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on the interval (Fi(ci; βm), 1). So we draw a random sample Um,i from the uniform distri-
bution U(0, 1) and set Rm,i = Fi(ci; βm) + Um,i[1− Fi(ci; βm)].
Having done this, for each patient i, we have a random sample of M draws from
the distribution of the patient’s residual. We can calculate summaries, such as the three
quartiles, from these values.
R code is shown in Appendix A.7.2 to compute the residuals and R a function to find
the cdf of a piecewise constant hazard model is shown in Appendix A.7.3. The number
of patients is n and the number of saved sets of parameter values is M . As a result, we
can compute the three quartiles of each residual.
For the purpose of the graphs which follow, the medians of the residuals are used.
7.3.7.3 Results
Figure 7.4 shows a histogram of the residuals in the leukemia example. This suggests that
these residuals have approximately a uniform distribution.
We also need to plot the residuals against the covariates. For example, we plot Age
against the residuals in Figure 7.5. It is clearly “random scatter” of points. There is no
particular pattern shown in this graph. So, our assumptions are plausible as the residuals
are distributed with constant variance for both males and females.
Figure 7.6 shows the scatter plot of log(WBC) and residuals. Again we do two plots,
one for males and one for females. Also, there is no concern about any particular changes
in the variance.
In Figure 7.7, we plot the Deprivation score against residuals for males and females,
again we need to assess the validity of the model assumptions. These residuals are in the
range (0,1) and show no dependence on the Deprivation score.
Figure 7.8 shows the scatter plot of the posterior means of η against residuals for
males and females. We can see a random pattern indicating a good fit for the model. As
a result, we conclude that there is no reason to reject the model assumptions.
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Figure 7.5: Scatter plots for Age against residuals for both sexes. The blue dots for males and
pink dots for females.
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Figure 7.6: Scatter plots for log(WBC) against residuals for both sexes. The blue dots for males











































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 7.7: Scatter plots for Deprivation score against residuals for both sexes. The blue dots
for males and pink dots for females.
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Figure 7.8: Scatter plots for the posterior mean of η against residuals for both sexes. The blue
dots for males and pink dots for females.
7.4 Bayes linear Bayes prognostic networks
7.4.1 Introduction
We now consider applications of a different type. We wish to build a system to calculate
prognostic index values for individual new patients. This calculation will be done using
Bayes linear kinematics. This makes the calculations very fast and, as we shall see, we
will be able to compute a value even when observations on some covariates are missing.
In Section 7.4.2, we will explain the use of a latent prognostic index and its advantages.
In Section 7.4.3, we will describe the general structure of a Bayes linear Bayes prognostic
network. In Section 7.5, we will describe how such networks are built, including the use
of historical data. In Section 7.6, we will apply these ideas to an example refering to
patients with non-Hodgkin lymphoma.
7.4.2 The use of a latent prognostic index
A traditional prognostic index measures the hazard of an individual relative to the baseline
in a proportional hazards model. Typically, it is the logarithm of the relative hazard. See
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Section 5.6. If we have a fixed list of covariates S = {X1, ..., XJ}, then the index must
be a function of the values x1, ..., xJ taken by these covariates. Conventionally, when
constructing a prognostic index, we try to choose a suitable function g(x1, ..., xJ). Suppose
now that we have a list Smax = {X1, ..., XJ} of covariates which can be observed but that
we might not always observe all of X1, ..., XJ but rather we observe some subset of Smax.
Suppose that the possible observed subsets are S1, ..., SM . We need a different function
gm for each possible subset Sm. To do this in a coherent and principled way, we introduce
the idea of a latent variable ZT . We will refer to this as a prognostic index but we will
not observe it. Instead, when we supply an index value to a user, we will give our current
expectation of ZT , given the information available to us. As in a traditional prognostic
index, ZT is a quantity on which the lifetime distribution depends. For example, in a
Weibull model with survival function exp{−λitα} for subject i, we can use ZT = ηi =
log(λi) as the prognostic index. If




where Xi,j is the value of covariate j for subject i, but not all of Xi,1, ..., Xi,k are observed
for subject i, then we use I = E(ηi | Si) where Si is the subset of observations made for
patient i. We refer to I as the predicted prognostic index value.
This allows us to compute a (predicted) prognostic index value given observations of
any subset of the possible covariates, for example when some values are missing or when
some variables are only measured in certain cases. Furthermore, the use of Bayes linear
kinematics and a Bayes linear Bayes model allows us to do this quickly and efficiently.
Additional flexibility is provided by modelling the joint distribution of ZT and the
covariates, often through latent variables associated with the covariates, so that ZT is not
known precisely even when all of the covariates are observed. In this way we always use
an expectation of ZT as our declared index value.
7.4.3 Prognostic networks
Suppose that the nodes X1, ..., XJ can represent covariates. With each covariate Xk we
associate a variable Zk which may be unobserved. The value, or more generally, the
distribution of Xk depends on the value of Zk. Just as Xk depends on Zk, suppose
that we have a lifetime T which depends on ZT . In general we can have covariates
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X1, ..., XJ depending on Z1, ..., ZJ respectively and then an additional dependent node T
depending on an element ZJ+1. The variables Z1, ..., ZJ+1 are related in a Bayes linear
structure. Then ZJ+1 represents our prognostic index. When we observe some or all of
the covariates this changes our expectation of ZJ+1 and therefore the index value which
we would report. See Figure 7.9. Notice that, in Figure 7.9, the red, undirected, edges














Figure 7.9: Bayes linear Bayes graphical model
The introduction of a latent variable Zk associated with the covariate Xk allows co-
variates of different types to be used such as ordinal variables and censored variables.
However, we are free to set Xk = Zk if this is appropriate.
We need to specify a mean vector and a variance-covariance matrix for the elements
of the Bayes linear structure, Z1, ..., ZJ , ZJ+1. The variance-covariance matrix might be
developed in a general, unstructured way as suggested by Figure 7.9. Alternatively, we
might impose some structure and exploit conditional independences, perhaps by intro-
ducing mediating nodes which induce correlation between related covariates. This might
be done by expert judgement. A subjective covariance structure might be developed us-
ing an approach similar to methods described in Farrow (2003). On the other hand we
might use an automatic method, using an algorithmic approach to determine a suitable
network structure. Methods for structure learning for Bayesian networks are discussed
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in, for example, Heckerman and Chickering (1995); Neapolitan (2003); Margaritis (2003)
and Wang et al. (2015). See Chapter 4.
We might also select certain important variables which are always observed and con-
dition the rest of the model on these.
However we determine the structure, we need to quantify it by specifying means,
variances and covariances. Again these might be chosen subjectively. More likely we will
use historical data and use an offline learning phase in which we fit an analogous model,
with a fully specified prior distribution, using, for example, Markov chain Monte Carlo
(MCMC) methods to compute posterior summaries. This latter approach is described in
our example in Section 7.6.3.
Once we have a fully specified model, in routine use with new patients, we compute
adjusted expectations of the prognostic index given observations of some or all of the
covariates. Because we can do the calculation when only a subset of the covariates is ob-
served, we can include a greater number of potential covariates in our model and therefore
use more information when it is available.
7.5 Construction of Bayes linear Bayes networks
7.5.1 General strategy
While, in some cases, we might construct our network using only the subjective judgements
of experts, more typically we might use historical data to learn values of parameters in
our model.
We have an offline learning phase and we use values that we infer from that model in
the network. In practice, we use the posterior expectation that we obtained from the offline
learning model to construct the Bayes linear Bayes prognostic network. At this stage in
our research, we use the posterior means of model parameters as values in our Bayes linear
Bayes model. The historical data are, however, independent of future patients, given the
model parameters. This raises the possibility, which we will pursue in future research,
that we can avoid any such compromise and obtain exactly the expectations which we
need. For example, in (6.14) and (6.15), clearly we can obtain the posterior expectations
of P(X) and P(X)E(X) directly from the MCMC computations in the learning phase.
However, further work is required to address the problem of parameter uncertainty in the
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adjusted expectations and precisions. Nevertheless, with a large historical data set, such
effects are likely to be small.
7.5.2 Specifying the covariance structure
First of all, we need to construct a variance-covariance matrix of the possibly latent
covariates Z. As an alternative to using an inverse-Wishart prior, we can use the following
approach.
Suppose that
Z = Gε+ µ.
where ε ∼ N(0, Vε), and, for example, when Z has five elements, Vε can be written as
Vε =

τ−11 0 0 0 0
0 τ−12 0 0 0
0 0 τ−13 0 0
0 0 0 τ−14 0
0 0 0 0 τ−15

.
So the matrix G will be
G =

1 0 0 0 0
γ21 1 0 0 0
γ31 γ32 1 0 0
γ41 γ42 γ43 1 0
γ51 γ52 γ53 γ54 1

Therefore, the variance-covariance matrix Var(Z) = GVεG
′ = Σ.
There are four reasons to use this approach rather than just use, for example, an
inverse Wishart prior.
1. This structure lends itself to using a more structured network, with some arcs miss-
ing.
2. This structure allows us to use a collection of univariate normal distributions rather
than a multivariate normal distribution. This avoids problems with standard MCMC
software such as JAGS when a multivariate normal vector is sometimes only par-
tially observed.
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3. The generalised autoregressive stucture automatically creates a missing-data model.
Ibrahim et al. (2001), Section 8.3, suggest a sequence of conditional distributions
for covariates. See also Zhao (2010).
4. The generalised autoregressive structure provides greater flexibility in specifying a
prior distribution for the variance-covariance matrix than an inverse-Wishart prior.
In an inverse-Wishart prior, once E(Σ) is specified, only one parameter is left to
specify the uncertainty. In contrast, in the generalised autoregressive structure, we
can give the regression coefficients γ21, γ31, γ32, . . . a multivariate normal prior and
also give, for example, a multivariate normal prior to the logarithms of the precisions
τ1, τ2, . . ..
Therefore, we use this structure, adapted from Pourahmadi (1999); Daniels and Pourah-
madi (2002). This structure uses a square-root-free Cholesky decompsition of Σ−1 as
follows.
The Cholesky decomposition of a symmetric positive definite matrix Q with dimension
p× p can be expressed in the following way
Q = S̃S̃ ′
where S̃ is non-singular and lower-triangular with elements ζ̃j,k. Suppose that for each k
we divide column k of S̃ by ζ̃k,k so that
Q = SDS ′ (7.9)
where D is diagonal with elements ζ̃1,1, ..., ζ̃p,p and S is lower triangular with elements
ζj,k = ζ̃j,k/ζ̃k,k for j > k and unit diagonal. This is a square-root-free Cholesky decompo-
sition of Q. See Watkins (2004).
The idea of using a “generalised autoregressive” representation was introduced by
Pourahmadi (1999), to provide a non-restrictive parameterisation of the covariance matrix.





where εj ∼ N(0, τ−1j ) and εj is independent of εj′ unless j = j
′ . The coefficients φj,i
are generalised autoregressive parameters. Therefore, ε = (ε1, ..., εj)
′ = PZ where P is
173
Chapter 7. Application to survival data
the lower triangular matrix with unit diagonal and, for j > k, elements −φj,k. So the
diagonal covariance matrix of ε is D−1 = PΣP ′ , where Σ is the covariance matrix of Z.
Rearranging this we obtain
Σ−1 = P ′DP.
where P ′ is upper triangular. By reversing the order of the elements of the vectors we
obtain (7.9).
7.5.3 Offline learning
Once we have determined a structure for our model we assume that Z has a multivariate
normal distribution and, with suitable prior distributions assigned, use MCMC to compute
posterior means for model parameters, as discussed in Section 7.5.1.
The assumption of a multivariate normal distribution for Z is convenient but, given
that we can choose a link function between the element of Z and the covariates X1, ..., XJ
and T , it is not restrictive.
Specifically we use a generalised autoregressive structure for Z in the model fitting.
So we set
Z1 = µ1 + ε1
where ε1 ∼ N(0, τ−11 ). Then, for j > 1, we set
Zj = µj +
j−1∑
k=1
γj,k(Zk − µk) + εj
where εj ∼ N(0, τ−1j ) and ε1, . . . , εJ are independent.
We then give multivariate normal priors to µ1, . . . , µJ+1 and to γ2,1, . . . , γJ+1,J . We also
give priors to the conditional precisions τ1, . . . , τJ+1. It is simple to give these parameters
independent gamma priors but we could also, for example, give a multivariate normal
prior to (log τ1, . . . , log τJ+1).
The mean vector for Z is just µ = (µ1, . . . , µJ+1)′ and the variance-covariance matrix
of Z is given by
Σ = GD−1G′ (7.10)
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where D is the diagonal matrix with diagonal elements τ1, . . . , τJ+1 and G is the lower
triangular matrix with diagonal elements gj,j = 1 and off-diagonal elements gj,k = γjk for
j > 1 and k < j.
7.6 Example: Non-Hodgkin lymphoma
7.6.1 Introduction
As an example we use patients with non-Hodgkin lymphoma. The historical data were
collected by the Scotland and Newcastle Lymphoma Group from patients in Scotland
and the North of England, UK, (Proctor and Taylor, 2000), See Section 2.2. Apart from
survival time, which is subject to right censoring, the variables include Age, Sex, Stage
(Ann Arbor Stage, Carbone et al., 1971), ECOG (Eastern Cooperative Oncology Group
performance status, Oken et al., 1982), the last two of which are both ordinal variables,
and a large number of other covariates, some of which may or may not be observed.
Some of these are binary and some are interval-censored, since the results were either
recorded as “normal”, if the measurement was inside the normal range, or as an actual
value if it was not. For further details, see, for example, Zhao (2010). See also Chapter
2. In our example, for illustration, we use a subset of these covariates. We use Age, Sex,
Haemoglobin (HB), White Blood Cell (WBC), Stage and Albumin. Of these, HB and
WBC are continuous variables, Stage is ordinal and Albumin is binary.
We chose to separate Age and Sex, which are always observed, and to condition the
rest of the model on these. Thus the means of Z1, ..., Zm, Zm+1, but not the variance and
covariances, depend via a linear model on age and sex.
We adopted a general covariance structure for the Bayes linear network and we impose
the order of the covariates in the following expression {hb, wbc, stage, albumin, T}, since
we always observed {hb, wbc} to form a generalised autoregression. In future work we
plan to investigate the use of more structure.
Thus our generalised autoregressive structure becomes the following. We set
Z1 = µ0,1 + µage,1xage + µsex,1xsex + ε1
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where ε1 ∼ N(0, τ−11 ). Then, for j > 1, we set
Zj = µ0,j + µage,jxage + µsex,jxsex +
j−1∑
k=1
γj,k(Zk − µk) + εj
where εj ∼ N(0, τ−1j ) and ε1, . . . , εJ are independent. Here xage is the patient’s age in
years minus 60 and xsex is 1 for a male patient and −1 for a female patient.
In our offline learning model, we suppose that the distribution of Ti, the lifetime of
patient i is a Weibull distribution with two parameters, α and λi, where log(λi) = Zt,i
and Zt,i is the prognostic index value for patient i.
Then we use the generalised autoregressive structure to relate each variable with oth-
ers in the model. All the variables that we use in the example have means which are
conditional on age and sex since we always observed age and sex.
As a result, we obtain the posterior distribution for all the parameters in the model
and then use the posterior means to produce a Bayes linear kinematic network.
We obtain the variance-covariance matrix for Z from the coefficients γj,k using (7.10).
7.6.2 Exploratory plots in the non-Hodgkin lymphoma example
Before constructing our model, we should look at some plots. So, we plot the covariates
used in the NHL example. These covariates are Age, Sex, HB, WBC, Stage and Albumin.
In Figure 7.10, we plot Age against Stage which has 4 levels and for both sexes. From
these boxplots, we notice that there is no change in the difference between male and
female in each stage. Similarly, the boxplots of log(HB) and Stage show no indication
that the difference in log(HB) between males and females depends on Stage.
Figure 7.11 shows the boxplots of plotting log(WBC) against Stage and for males
and females. This again suggests that the difference between log(WBC) does not depend
on the Stage. The same conclusion can be drawn from plotting log(T ) against Stage in
Figure 7.11.
Albumin is classified into two categories, Albumin 1 and Albumin 2. In Figure 7.12,
we plot Albumin against Age, log(HB), log(WBC) and for males and females. These plots
show no concern about the validity of the model assumptions.
Figure 7.13 shows scatter plots for the continuous variables in the data set, Age, HB
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Figure 7.10: Box plots for Stage and Age and box plots for Stage and log(HB).
and WBC. From these scatter plots, we can not see any pattern in the observations which
suggests a violation of the model assumptions, so we carry on the analysis.
7.6.3 Offline learning: Introduction
We use a full-Bayes specification and MCMC to learn the values of the parameters. As an
example, we use a data set containing 1391 patients with non-Hodgkin lymphoma. See
Chapter 2. A large proportion of these patients had at least some missing covariate values.
Therefore, it was necessary to include a missing-data model in our model specification.
So we construct a model for the joint distribution of all of the variables, including the
covariates. This is done using a generalised autoregressive structure. The main model was
the same as the Bayes linear Bayes model except that we specified a prior distribution for
the unknown model parameters, including the thresholds for ordinal covariates and the
means and variance-covariance matrix in the Bayes linear structure. The prior for the
parameters of the Bayes linear structure was specified using the generalised autoregressive
approach described in Section 7.6.1. This structure implies the missing-data model. The
coefficients and conditional precisions in the generalised autoregression were converted to
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Figure 7.12: Box plots for Age and Albumin, log(HB) and Albumin, log(WBC) and Albumin,
and Albumin and log(T).
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Figure 7.13: Scatter plots of covariates in non-Hodgkin lymphoma example against each other
(i.e. Age, HB, WBC) and the lifetime T . Black dots for males and red dots for females.
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give the variance-covariance matrix Σ for Z using (7.10).
7.6.4 Offline learning model with the direct method
In our example the computations were done using JAGS using the R package rjags
(Plummer 2017; R Core Team, 2018).
Suppose we use the direct method with the case of the ordinal variables. Then, it
is necessary to learn about the values of the thresholds, c1, ..., cK−1. However, since the
mean and variance of Z are both unknown, for identifiability we fix two thresholds. Thus
if K = 3, we can fix c1 = 0 and c2 = 1. If K = 4, then we can fix c1 = 0 and c3 = 2
and then give c2/2 a scaled beta prior distribution. For K > 4, we can fix c1 = 0 and
cK−1 = 1 and then give {u1, ..., uk−3} a Dirichlet prior distribution and let cj+1 =
∑j
i=1 ui.
For example, for ECOG, K = 5 for living patients.
In the case of Stage, K = 4. Without loss of generality we can fix c1 = 0 and
c3 = 2. We make inference about the second cut point. We give c2 a scaled beta prior
distribution. So c2/2 = c∗ where c∗ ∼ Beta(ac, bc). We also assume that the underlying
latent variable which is associated with this variable has a normal distribution with some
mean and unknown variance σ2z , so Z ∼ N(µz, σ2z) where the mean µz is also unknown.
See Appendix A.7.4 for the rjags model specification using the direct method.
In the offline-learning phase, we use full Bayes analysis with MCMC computations.
As a result, we learn about all the parameters that we need to produce the prognostic
index values. Then, we use these parameter values from the offline learning as the prior in
the BLK network. We use the generalised autoregressive structure as described in Section
7.6.1 and obtain posterior means for the mean vector and variance-covariance matrix of
Z to use in the BLK network.
Let us explain how we use the parameters of our generalised autoregression in Table 7.3
to obtain these mean parameters and variance covariance matrix. For the direct model,
we obtain the posterior means and posterior variances as described in Appendix A.7.4.
Then, we calculate E0(Z) from the following
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Table 7.3: Prior means and prior standard deviations for each of the parameters in the NHL
example.
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= (γsex.hb, γsex.wbc, γsex.stage, γsex.albumin, γsex.t)
′
.
Now, to obtain V0(Z), we have τz = (τz.hb, τz.wbc, τz.stage, 1, τz.t)
′ as we fixed τz.albumin to
be 1 and we have τz.hb ∼ Gamma(2, 300), τz.wbc ∼ Gamma(2, 30), τz.stage ∼ Gamma(2, 3)
and τz.t ∼ Gamma(1.5, 0.5).




1 0 0 0 0
γ21 1 0 0 0
γ31 γ32 1 0 0
γ41 γ42 γ43 1 0
γ51 γ52 γ53 γ54 1

where γ21 = γhb.wbc, γ31 = γhb.stage, γ32 = γwbc.stage, γ41 = γhb.albumin, γ42 = γwbc.albumin, γ43 =
γstage.albumin, γ51 = γhb.t, γ52 = γwbc.t, γ53 = γstage.t and γ54 = γalbumin.t.
Therefore, the variance-covariance matrix will be V0(Z) = GVεGT .
As a result, in the BLK network, we use the prior mean E0(Z) and prior variance-
covariance matrix V0(Z) as follows.




µ0(ZHB) µ0(ZWBC) µ0(ZStage) µ0(ZAlbumin) µ0(ZT )( )





µage(ZHB) µage(ZWBC) µage(ZStage) µage(ZAlbumin) µage(ZT )( )






µsex(ZHB) µsex(ZWBC) µsex(ZStage) µsex(ZAlbumin) µsex(ZT )( )
−4.9052 −0.0084 0.0500 0.0165 −0.0628
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Therefore,
E0(Zi) = µ0 + µagexage,i + µsexxsex,i.
where xage,i is the age in years of patient i, minus 60 and xsex,i is 1 for a male patient or
-1 for a female patient, and
V0(Z) =
ZHB ZWBC ZStage ZAlbumin ZT

ZHB 323.2214 −2.1272 −6.9139 −8.6734 −3.6989
ZWBC −2.1272 12.1289 0.0969 0.8100 0.3861
ZStage −6.9139 0.0969 1.8214 0.4274 0.2169
ZAlbumin −8.6734 0.8100 0.4274 1.3136 0.3980
ZT −3.6989 0.3861 0.2169 0.3980 0.4619
7.6.5 Offline learning model with the indirect method
In addition to the direct method, we introduce a novel method which is called the indirect
method. In this case we relate ordinal variables to the latent variables using ordinal logistic
regression. To specify this model (see Appendix A.7.11), suppose we have the variable X
which is an ordinal variable with K categories, say K = 4 with i = 1, ..., n. Then we have
probabilities that relate to each category as follows
pi,1 = 1− qi,1
pi,2 = qi,1 − qi,2
pi,3 = qi,2 − qi,3
pi,4 = qi,3.
This ensures that the sum of these probabilities is 1. We can represent q as
logit(qi,r) = Zi − cr.
where the cut-points are cr = (c1, c2, c3) since we have four categories.
We can deal with different sorts of covariates in this model exactly as we do with
the direct method. So, for example, in the case of a binary variable, since the binary
distribution has one parameter, we fix the variance of Z to be 1 and the cut-point to be 0.
To include an ordinal variable with K = 4 in this model, we should have three cut-points
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(0, c2, 1) where c2 ∼ Beta(a, b).
In the non-Hodgkin lymphoma example, after obtaining the posterior distribution for
all the parameters from the historical data, using a generalised autoregression, we then
convert the parameters to the form of E0(Z) and V0(Z). As a result, our prior means and
variances for use in the BLK network can be represented as
µ0 = (126.5844 , 8.0292 , 0.1596 , −0.8988 , 0.6034)
′
µage = (−0.1766 , 0.0087 , 0.0182 , 0.01910 , 0.0134)
′
and
µsex = (−4.9086 , −0.0080 , 0.0789 , 0.0157 , −0.0846)
′
Therefore,




323.2659 −2.1548 −10.5563 −8.9206 −4.3637
−2.1548 12.1275 0.1440 0.8379 0.4687
−10.5563 0.1440 1.3452 0.6220 0.7403
−8.9206 0.8379 0.6220 1.4024 0.4692
−4.3637 0.4687 0.7403 0.4692 0.7790

.
7.6.6 Offline learning: Diagnostic checking in the direct method
7.6.6.1 Introduction
The non-Hodgkin lymphoma (NHL) example concerns the construction and use of a Bayes
linear kinematic prognostic index calculator. There are two phases: the offline-learning
stage, which is a full-Bayes analysis with MCMC computations, and the Bayes linear
kinematic calculation of prognostic index values for new patients, based on a Bayes linear
Bayes network. The appropriate place to calculate and examine residuals in this case is in
the offline-learning stage as this is where the model is developed. Some covariate values
in this example are missing.
184
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Since we use MCMC to do the model-fitting calculations, it is possible to calculate
residuals within a rjags run. It is simpler to compute the residuals within rjags, espe-
cially as the lifetime distribution is Weibull and so the cdf has a simple form. At each
MCMC iteration the parameters are sampled and so are the lifetimes for censored ob-
servations. We thus obtain samples from the posterior distribution of the residuals as
discussed in Section 7.3.7.1. In particular for a censored observation, we obtain samples
from the posterior predictive distribution of Fi(Ti). We could use a separate R program
to deal with the missing covariate values, but there are some difficulties in doing that.
On the other hand, since there will be a large number of residuals, sampling the residuals
directly within rjags might cause difficulties with storage and with processing the results.
In fact, no such difficulties were encountered in this example. If they were, we could use
thinning to reduce the number of stored samples.
7.6.6.2 Results
In this section, we produce some residual plots in the non-Hodgkin lymphoma example in
order to support the selection of our model. In Figure 7.14, we notice that the distribution
in the histogram of these residuals is approximately uniform as required. In addition, to
check the model assumptions, we plot the residuals against the covariates in the example.
For instance, we plot Age against the residuals in Figure 7.15. It is clearly a “random
scatter” of points and there is no evidence of any pattern here. So, our assumption which
stated that the residuals are distributed with constant variance is plausible for both male
and female.
In Figure 7.16, we plot log(WBC) against the residuals. We can see that, there is no
concern about the relationship between log(WBC) and residuals. The points are randomly
scattered in this graph.
Figure 7.17 shows the scatter plot of HB and residuals. Again we do two plots, one for
males and one for females. Also, we can see random scatter with no evidence of changes
in the variance.
In Figure 7.18, we plot the Age against residuals but this time we ignore Sex. We
do a separate plot for each value of Albumin. Again, everything appears to be in order.
There is a random scatter of points. We also notice that there are more observations for
the value of Albumin 1 than the value of Albumin 2.
Figure 7.19 shows the scatter plots for residuals against Age. As we have 4 stages in
185



















Figure 7.14: Histogram of the posterior means of the residuals.
the variable Stage, we have 4 plots, one for each stage. These graphs raise no concerns
about the variability in the variance, which means we have a constant variance in all the
stages.
In Figure 7.20, we plot the posterior mean for η using two methods, full Bayes and
Bayes linear kinematics, against the residuals and for male and female using the direct
method. Again, we have scatter random observations for both methods and for male and
female. There is no clear pattern in these plots. As a result, there is no evidence against
the validity of our assumptions.
7.6.7 Diagnostic checking in the indirect method
Now we examine the residuals in the case of the indirect model.
Again, the histogram in Figure 7.21 shows approximately a uniform distribution. We
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Figure 7.15: Scatter plots for Age against residuals for both sexes. The blue dots for male and










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 7.16: Scatter plots for log(WBC) against residuals for both sexes. The blue dots for male
and the pink ones for female.
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Figure 7.17: Scatter plots for HB against residuals for both sexes. The blue dots for male and









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 7.18: Scatter plots for Age against residuals for Albumin 1 and Albumin 2. The blue
dots for Albumin 1 and the pink ones for Albumin 2.
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Figure 7.19: Scatter plots for Age against residuals for 4 stages in the covariate Stage.
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Figure 7.20: Scatter plots for posterior mean of η using full Bayes and Bayes linear kinematic
against residuals for both sexes. The blue dots for male and the pink ones for female.
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Figure 7.21: Histogram of the posterior means of the residuals in NHL example using the indirect
method.
also notice that all our Figures 7.22, 7.23, 7.24, 7.25, 7.26 and 7.27 are very similar graphs
to those produced for the direct method. In conclusion, there is no concern about the
validity of the model assumptions.
7.6.8 Prognostic index: Comparison with full Bayes analysis
We calculated the BLK prognostic index values for all of the patients in the dataset using
the direct method with parameter values obtained from the offline learning.
For comparison with the BLK prognostic index values, we used MCMC to calculate
“full Bayes” values. The missing-data ability can be achieved in a full-Bayes model by
modelling the joint distribution of all of the variables, rather than just the conditional
distribution of the lifetime given the covariates. To make the results comparable and
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Figure 7.22: Scatter plots for Age against residuals for both sexes in the indirect method. The








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 7.23: Scatter plots for log(WBC) against residuals for both sexes in the indirect method.
The blue dots for male and the pink ones for female.
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Figure 7.24: Scatter plots for HB against residuals for both sexes in the indirect method. The
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 7.25: Scatter plots for Age against residuals for Albumin 1 and Albumin 2 in the indirect
method. The blue dots for Albumin 1 and the pink ones for Albumin 2.
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Figure 7.26: Scatter plots for Age against residuals for 4 stages in the covariate Stage using the
indirect method.
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Figure 7.27: Scatter plots for posterior mean of η using full Bayes and Bayes linear kinematic
against residuals for both sexes in the indirect method. The blue dots for male and the pink
ones for female.
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represent routine use in practice, we fixed parameters in the “full Bayes” calculation at
the values obtained from the offline learning.
Figure 7.28 shows histograms of the “full Bayes” and BLK prognostic index values for
all the patients using the direct method. We notice from Figure 7.28 that both histograms
for the prognostic index values using MCMC and BLK are almost the same. The mean
“full Bayes” value is 0.5352, with standard deviation 0.3348 and the mean prognostic
index value using BLK is 0.5345 with standard deviation 0.3345. Now Figure 7.29 shows
that our adjusted means for the prognostic values are close to the posterior mean from
the full-Bayes analysis as we can see the straight line of equality is passing through the
points which means our BLK method fit the straight line very well. We also use another
graph to compare the two methods. This graph is called a “Bland and Altman plot”,
or agreement plot. This shows the agreement between two methods. Bland and Altman
(1986) described such plots which can be done by calculating the mean difference between








where ẐBLK,i is the prognostic index value calculated using the BLK network and ẐMCMC,i
is the “full-Bayes” value for patient i. The lower and the upper limit are md± 2Sd, where
Sd is the sample standard deviation of the differences. The sample standard deviation is
Sd = 0.167.
As we can see from Figure 7.30, there are 96% of the data points within the limits.
That indicates that our proposed method to construct Bayes linear kinematic network in
Figure 7.9 gives a reasonable result.
In Figure 7.31 the “full Bayes” values are again plotted against the BLK values.
However, this time cases where a particular covariate is missing are shown in red. There
is one plot for each of the covariates (other than Age and Sex). We see that in three
cases, the red dots appear to be fairly evenly distributed among the black dots. However,
in the case of the covariate Albumin, there is a distinct group of red dots where the BLK
index value is smaller than the corresponding “full Bayes” value. It is not clear why, for
example, any model misspecification with respect to Albumin would affect the BLK and
“full Bayes” results in distinctly different ways. This feature should be the subject of
further research.
The purpose of our Bayes linear Bayes prognostic network is the quick and easy routine
196
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(a)



















Figure 7.28: Histogram of prognostic index values from MCMC (a), Histogram of prognostic





































































































































































































































































































































































































































































































Figure 7.29: Adjusted mean using full-Bayes and BLK in direct method.
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Figure 7.30: Bland and Altman agreement plot for the direct method. The difference ẐBLK −
ẐMCMC is plotted against the mean (ẐBLK + ẐMCMC)/2 where ẐBLK and ẐMCMC are the
BLK and full Bayes posterior means of ZT respectively.
calculation of prognostic index values for new patients, potentially using a large number
of covariates but able to work when only some of these are observed. The missing-data
ability can be achieved in a full-Bayes model by modelling the joint distribution of all the
variables, rather than just the conditional distribution of the lifetime given the covariates.
However, in a full-Bayes model, we need to integrate over the joint distribution of the
missing covariates, conditional on the observed values, which may be computationally de-
manding. In our Bayes linear Bayes network, even with non-conjugate marginal updates,
we need, at most, a series of one-dimensional integrations which can usually be done very
quickly.
Furthermore, a full-Bayes analysis typically requires a lot of decisions to be made
about the forms of relationships between variables and these choices may have little basis
either in expert judgement or the analysis of historical data. In contrast, the Bayes linear
Bayes approach requires a more limited specification of relationships in terms of first and
second moments and focussing on these more limited judgements might lead to sounder
choices.
Our method might be regarded as an approximation to a full-Bayes analysis. Wilson
198

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 7.31: Predicted prognostic index values, Bayes linear against full Bayes in the non-
Hodgkin lymphoma example using the direct method. In each plot, cases where a particular
covariate is missing are shown in red.
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and Farrow (2017) compared the behaviour of Bayes linear kinematic belief adjustments
with full-Bayes posterior inference in the case of a piecewise constant hazard survival
model and found that the results were generally close. Our use of non-conjugate updates
allows our model to be closer to the corresponding full-Bayes model and we hope that this
will bring Bayes linear kinematic adjusted expectations even closer to full-Bayes posterior
means.
7.7 Comparison between the “direct” and the “indi-
rect” methods
We repeated the calculations using the indirect method and the corresponding indirect
model in the offline learning.
There are some differences between the direct and the indirect methods here.
In the indirect method, the support of the posterior is unbounded because the likeli-
hood is a function of all the values of the probability and for all the values of Z. As a
result, we obtain an unbounded posterior distribution rather than the bounded support
for the posterior in the direct method.
In the indirect method, in order to construct a Bayes linear kinematic network, we
need to specify three things, Z = (Z1, ..., Zn)
′ which represent a Bayes linear structure,
X = (X1, ..., Xn)
′ which represent what we observe and something between them which
is the probability P that depends deterministically on Z. For instance, in the case of
an ordinal variable, P is a vector of probabilities and those probabilities depend on the
values of Z. Notice that X is not determined by Z, but the probabilities of X depend on
Z. So, if we observe x, then the likelihood we obtain is the probability for the category
that X is in, and that probability is a function for all the values of Z.
Figure 7.32 shows a comparison between the full Bayes and Bayes linear kinematic
posterior means using the indirect method. We see that almost all of the observations lie
close to the line of equality which indicates that using the indirect method give us values
very close to these given by the full-Bayes method. Figure 7.33 shows that the histograms
of full-Bayes and BLK values look normally distributed which is slightly different from
the BLK in the direct method. In addition, the agreement plot in Figure 7.34 shows no
clear pattern of the trends of these observations.
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As for the direct method, in Figure 7.35 the “full Bayes” values are again plotted
against the BLK values of the indirect method. However, this time cases where a particular
covariate is missing are shown in red. There is one plot for each of the covariates (other
than Age and Sex). We see that, in all the cases, the red dots appear to be fairly evenly
































































































































































































































































































































Figure 7.32: Adjusted mean using full-Bayes and BLK in the indirect method.
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(a)





































Figure 7.33: Histogram of prognostic index values from MCMC (a), Histogram of prognostic



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 7.34: Bland and Altman agreement plot for the indirect method. The difference ẐBLK −
ẐMCMC is plotted against the mean (ẐBLK + ẐMCMC)/2 where ẐBLK and ẐMCMC are the
BLK and full Bayes posterior means of ZT respectively.
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Figure 7.35: Predicted prognostic index values, Bayes linear against full Bayes in the non-
Hodgkin lymphoma example using the indirect method. In each plot, cases where a particular
covariate is missing are shown in red.
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7.8 Prototype prognostic index calculator
In this section, we consider transformation of the adjusted means for the prognostic index
values that we calculate from BLK. We wrote a R function which prompts the user to
type in the information about the covariates and then gives the user the prognostic value
for that particular patient. This can help doctors to know about the current situation of
patients. Let the adjusted expectation of ZT for patient i be ẐT,i. We use transformed
index values in the range of (0,100) by using the percentiles of a normal distribution fitted







where Φ() is the standard normal cumulative distribution function and m and S are the
sample mean and sample standard deviation of the values of ẐT for patients in the data
base. So, for example, if a patient has an index value of 80, this means that this patient
has a high risk value. A R function is shown in Appendix A.7.10.
7.9 Summary
In this chapter, we have explained in detail two examples concerning leukaemia and non-
Hodgkin lymphoma. For the leukaemia example, we have reviewed the Wilson and Farrow
(2017) approach and extended that to our non-conjugate method and we compared our
method with three different methods.
We also have reviewed some aspects that relate to Bayes linear kinematics and Bayes
linear Bayes graphical models and then described the application of these ideas to the
routine calculation of prognostic index values in medical survival.
Initially, we have explained the general strategy of a novel method to construct a Bayes
linear Bayes prognostic network. In particular we introduced the idea of using a latent
prognostic index and presenting its expectation as a value to be used. We also made some
comparisons between full-Bayes and Bayes linear kinematics using the direct method and
between the direct and indirect methods. We found that the prognostic index values from
MCMC (full-Bayes) and BLK look similar. Our prototype prognostic network produces
prognostic index values using all, or some, of the possible covariates almost instantly and
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has the potential to be used, for example, as a Web-based calculator.
The general procedure has two phases. The first is to do some inference using past
data in an offline learning model. That can be done using MCMC and we obtain the pos-
terior distributions for all the parameters in the model. Secondly, we use these posterior
distributions to help us construct a Bayes linear kinematic network. These parameter
values are treated as fixed in the BLK network. In practice we might re-run the offline
learning from time to time, as new data become available, to obtain new parameter values.
This might also be necessary, for example, if a new treatment is introduced.
In conclusion, when using existing methods in more complicated networks, we might
have to use computationally intensive methods or some kind of approximations. However,
our proposed methods can do fast computations in networks which are not Gaussian, even
when not all covariate values are observed.
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Chapter 8
Simulation experiment in survival
analysis
8.1 Introduction
In this chapter, we investigate further the Bayes linear Bayes methods. We use some
simulation experiments to examine the behaviour of the direct and indirect methods. In
the following section, we will give more explanation about the way that we generated our
simulated data.
The main idea of this chapter is to predict the prognostic index ZT using three meth-
ods, BLK using the direct method, BLK using the indirect method and full-Bayes analysis
and to compare the results.
In Section 8.2, we will describe simulation experiments in which the data are generated
according to a model corresponding to the direct method. The R code for generating the
simulated data is given in Appendix A.8.1. These simulated data are then used to predict
the prognostic index using both the direct and indirect Bayes linear Bayes methods and
also the full-Bayes method assuming both a direct model and an indirect model. The
results are then compared. The R code for computing the predictions using BLK is given
in Appendix A.8.3 for the direct method and Appendix A.8.5 for the indirect method.
In the “full Bayes” method used for these comparisons, the population model parameters
are treated as known, as in the BLK methods but, unlike the BLK methods, a fully
probabilistic prediction, with a multivariate normal distribution for Z, is computed, using
MCMC, with rjags. The rjags code is given in Appendix A.8.2 for the direct method
207
Chapter 8. Simulation experiment in survival analysis
and Appendix A.8.4 for the indirect method.
In Section 8.3, the experiments are repeated except that, this time, the data are
generated according to a model corresponding to the indirect method. In Section 8.4,
conclusions are drawn.
8.2 Data simulated according to the direct model
8.2.1 Simulation method
The simulated data sets are based on the non-Hodgkin lymphoma example. We used the
same covariates as in Chapter 7, that is Age, Sex, Hb, Wbc, Stage and Albumin. We
have chosen the non-Hodgkin lymphoma as an example to apply our methods because it
contains an example of a continuous covariate, a binary covariate and an ordinal covariate.
To do the simulation, we generate the values of Z = (ZHb, ZWbc, ZStage, ZAlbumin, ZT )′
randomly from a multivariate normal distribution over Z. Then, given these Z, we gener-
ate randomly all the covariate values X. In other words, we draw samples from the con-
ditional distribution of X|Z. We use the vector of means E0(Z) and variance-covariance
matrix Var0(Z) as we described in Chapter 7, to do the generation. Therefore, the calcu-
lations to specify the prior mean vector for Z, E0(Z) for non-Hodgkin lymphoma will be
as follows:
µ0 = (126.6473 , 8.0231 , 1.2037 , −0.8868 , 0.5150)
′
µage = (−0.1777 , 0.0087 , 0.0121 , 0.0189 , 0.0098)
′
µsex = (−4.9052 , −0.0084 , 0.0500 , 0.0165 , −0.0628)
′
Therefore,
E0(Zi) = µ0 + µagexage,i + µsexxsex,i.
where xage,i is the age in years of patient i, minus 60 and xsex,i is 1 for a male patient or
-1 for a female patient.
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The prior variance-covariance matrix for Z, Var0(Z) is
Var0(Z) =

323.3027 −2.1272 −6.9139 −8.6734 −3.6989
−2.1272 12.1289 0.0969 0.8100 0.3861
−6.9139 0.0969 1.8214 0.4274 0.2169
−8.6734 0.8100 0.4274 1.3136 0.3980
−3.6989 0.3861 0.2169 0.3980 0.4619

.
When we do the simulation in the direct method (see Section 7.6.3), we simulate
(randomly) values for Z. These values can be positive or negative. If we have a binary
variable and the value of Z is positive, then X = 1 and if Z is negative, then X = 0.
In the case of ordinal variables, if the number of categories is K, we have K − 1
cut-points. For instance, if we have 4 categories as in the case of the covariate Stage
in the non-Hodgkin lymphoma example, then we have three cut-points. In general, if c
represents the cut-point, then X = k if and only if ck−1 ≤ Z < ck for a set of thresholds
{c1, ..., cK−1} where c0 → −∞ and cK →∞.
We also treated the covariates Hb and Wbc as normal random variables in the direct
model. We modelled Zhb = Xhb and Zwbc = Xwbc in the offline learning model. The actual
prediction values of ZT are generated normally with the prior mean and prior variance
that were obtained from offline learning with the real data.
Then we calculated predictions of the prognostic index using both the direct method
and the indirect method and also using full Bayes.
We have done three examples in this section. We generate 1200 simulated cases for
each of the three examples in this chapter.
In the first example, we are going to do all the simulations in terms of male patients
aged 60 to avoid unnecessary extra complications in these simulations.
We also applied our approach to a second example. In this example, we have different
ages and sexes. In particular, we have 1/3 of patients with age 50, 1/3 with age 60 and
1/3 with age 70. Therefore, we have 1/6 male aged 50, 1/6 female aged 50, 1/6 male aged
60, 1/6 female aged 60, 1/6 male aged 70 and 1/6 female aged 70. So, we have 1/2 of the
patients male and 1/2 female.
In the third example, we artificially increase the variance of ZT and we use exactly the
same age-sex groups from example 2. This has the effect of increasing the range of actual
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values somewhat. In order to increase the variance of ZT , we need to adjust Var0(Z).






where Vc is the variance matrix for the covariate Zc, c = (V1T , V2T , V3T , V4T )T and VTT =
Var(ZT ).
Then,
Var(Zc|ZT ) = Vc − cVar(ZT )−1cT , (8.1)
and
E(Zc|ZT ) = E(Zc) + cVar(ZT )−1[ZT − E(ZT )]. (8.2)
Alternatively, we can write (8.1) and (8.2) as follows
Zc = E(Zc) + cVar(ZT )−1[ZT − E(ZT )] + Uc
where Uc ∼ (0,Var[Zc|ZT ]).
Now, suppose that the new variance of ZT is Var∗(ZT ), then we can write the new
variance of Zc as
V ∗c = cVar(ZT )−1Var∗(ZT )Var(ZT )−1cT + Vc − cVar(ZT )−1cT ,






= Vc + ccT
{




and the new covariance is
c∗ = cVar(ZT )−1Var∗(ZT ).
In general, if Var∗(ZT ) = bVar(ZT ) then,
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and
c∗ = bc.
In summary, we used three sets of simulated data as follows. In each case 1200 cases
were generated
Example 1: all cases male, aged 60.
Example 2: 200 cases in each of 6 groups: male aged 50, male aged 60, male aged 70,
female aged 50, female aged 60, female aged 70.
Example 3: variance of ZT artificially increased, age-sex groups as in Example 2, b=3.
8.2.2 Results
Figure 8.1 shows scatter plots of predictions, i.e. posterior means, of ZT given the data,
against the true values of ZT for Example 1. Four methods are used: full Bayes assuming
a direct model, full Bayes assuming an indirect model, BLK using the direct method
(“BLK direct”) and BLK using the indirect method (“BLK indirect”).
When the direct method was used for prediction, the parameter values used were those
learned by fitting the direct model to the real data.
When the indirect method was used for prediction, the parameter values used were
those learned by fitting the indirect model to the real data.
In Figure 8.1, we have the predictions of the prognostic index values for the actual
values of ZT , direct and the indirect method and full-Bayes. These graphs show how suc-
cessful the methods are at predicting the actual values. The behaviour of the predictions
by all the methods is similar as all the points are spreading near the line of equality.
We notice from Figure 8.1 that the predictions are not going as far away from the
mean as the actual values do. This is because of “regression to the mean”. In addition,
we can see that the predictions from Bayes linear kinematics using the direct model are
very similar to the predictions from the full Bayes analysis.
Similarly, we can see the same pattern when we use the indirect method with parameter
values that we extracted from the offline learning model with the indirect model as the
observations lie close to the line of equality.
Figure 8.2 shows the comparison between the various full-Bayes and BLK methods.
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These figures show that the two BLK methods look very similar. In addition, the two
full-Bayes methods look similar as well.
We should also mention an important point here. The standard deviation for the
actual values is bigger than for the predictions (full Bayes and BLK). This is what we
would expect to happen because the data do not provide perfect information. If the data
were completely non-informative then the prediction would always be the prior mean and
the standard deviation of the predictions would be zero. If the data are more informative
then the predictions will be closer to the true values and the standard deviation of the
predictions will be closer to that of the true values.
From Figure 8.3 and Figure 8.4 in Example 2, Figure 8.5 and Figure 8.6 in Example
3, we can see that increasing the variance makes the relationship between actual and
predicted and, more so, between different prediction methods appear stronger.
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Figure 8.1: Different comparisons between predictions of the prognostic index and the actual
values of ZT , direct method and the indirect method and also using full Bayes, for data simulated
using the direct model. (a): actual ZT vs full Bayes direct. (b): actual ZT vs full Bayes indirect.
(c): actual ZT vs BLK direct. (d): actual ZT vs BLK indirect. (Example 1)
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Figure 8.2: Comparing one method with another method to predict the prognostic index using
both direct method and the indirect method for data simulated using the direct model. (a): full
Bayes direct vs full Bayes indirect. (b): full Bayes direct vs BLK direct. (c): full Bayes direct
vs BLK indirect. (d): BLK direct vs BLK indirect. (e): full Bayes indirect vs BLK indirect.
(f): full Bayes indirect vs BLK direct. (Example 1)
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Figure 8.3: Different comparisons between predictions of the prognostic index and the actual
values of ZT , direct method and the indirect method and also using full Bayes, for data simulated
using the direct model. (a): actual ZT vs full Bayes direct. (b): actual ZT vs full Bayes indirect.
(c): actual ZT vs BLK direct. (d): actual ZT vs BLK indirect. (Example 2)
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Figure 8.4: Comparing one method with another method to predict the prognostic index using
both direct method and the indirect method for data simulated using the direct model. (a): full
Bayes direct vs full Bayes indirect. (b): full Bayes direct vs BLK direct. (c): full Bayes direct
vs BLK indirect. (d): BLK direct vs BLK indirect. (e): full Bayes indirect vs BLK indirect.
(f): full Bayes indirect vs BLK direct. (Example 2)
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Figure 8.5: Different comparisons between predictions of the prognostic index and the actual
values of ZT , direct method and the indirect method and also using full Bayes, for data simulated
using the direct model with increasing the variance of ZT . (a): actual ZT vs full Bayes direct.
(b): actual ZT vs full Bayes indirect. (c): actual ZT vs BLK direct. (d): actual ZT vs BLK
indirect. (Example 3)
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Figure 8.6: Comparing one method with another method to predict the prognostic index using
both direct method and the indirect method for data simulated using the direct model with
increasing the variance of ZT . (a): full Bayes direct vs full Bayes indirect. (b): full Bayes direct
vs BLK direct. (c): full Bayes direct vs BLK indirect. (d): BLK direct vs BLK indirect. (e):
full Bayes indirect vs BLK indirect. (f): full Bayes indirect vs BLK direct. (Example 3)
218
Chapter 8. Simulation experiment in survival analysis
8.3 Data simulated according to the indirect model
8.3.1 Simulation method
In this section, we simulate data according to a model corresponding to the indirect
method (see Section 7.6.3). As with the direct simulations, we first generate a vector
Z using a multivariate normal distribution. The mean vector and variance matrix of
this distribution are those determined following the offline-learning phase with the non-
Hodgkin’s lymphoma data in Chapter 7. Thus
µ0 = (126.5844 , 8.0292 , 0.1596 , −0.8988 , 0.6034)
′
µage = (−0.1766 , 0.0087 , 0.0182 , 0.0191 , 0.0134)
′
µsex = (−4.9086 , −0.0080 , 0.0789 , 0.0157 , −0.0846)
′
Therefore,




323.2659 −2.1548 −10.5563 −8.9206 −4.3637
−2.1548 12.1275 0.1440 0.8379 0.4687
−10.5563 0.1440 1.3452 0.6220 0.7403
−8.9206 0.8379 0.6220 1.4024 0.4692
−4.3637 0.4687 0.7403 0.4692 0.7790

.
As in the direct model, we generate all the values of Z randomly from a multivariate
normal distribution over Z. From these Z values, we compute the covariates X, this time
according to the indirect model. Then, we use the different methods, full-Bayes and BLK
in order to calculate the predictions of the prognostic index values using the simulated
covariate values. We use three examples, as in Section 8.2. The details of these examples
are given respectively as follows
• Example 1: all cases male, aged 60.
• Example 2: 200 cases in each of 6 groups: male aged 50, male aged 60, male aged
219
Chapter 8. Simulation experiment in survival analysis
70, female aged 50, female aged 60, female aged 70.
• Example 3: variance of Zt artificially increased, age-sex groups as in Example 2,
b=3.
We generate 1200 simulated cases. In the BLK methods, we use the non-conjugate
prior update to obtain the predictions for the prognostic index values. The results are
shown in Figures 8.7-8.12 which correspond to Figures 8.1-8.6 for the direct data.
8.3.2 Results
Figure 8.7 shows scatter plots of predictions, i.e. posterior means, of ZT given the data,
against the true values of ZT for Example 1. Four methods are used: full Bayes assuming
a direct model, full Bayes assuming an indirect model, BLK direct and BLK indirect.
As in Section 8.2, parameter values obtained from the offline learning with the real
data were used. When the direct method was used for prediction, the values used were
those from fitting the direct model. When the indirect method was used for prediction,
the values used were those from fitting the indirect model.
We notice from Figure 8.7 that the predictions are reasonably good and the predictions
from Bayes linear kinematics using the indirect model follow a similar pattern to the
predictions from the full Bayes analysis.
Figure 8.8 represents the comparison between the various full-Bayes and BLK methods.
These figures show that the two BLK methods look very similar. In addition, the two full-
Bayes methods look similar as well. The relationship between the full-Bayes predictions
and BLK predictions is not quite as strong.
We notice also from Figure 8.9 and Figure 8.10 in Example 2, having different age
groups can make the relationship fairly stronger between the actual and different predicted
values.
For Example 3, Figures 8.11 and 8.12 (for the indirect model) show that when we
increased the variance of ZT , we have obtained results which appear better than when we
use a small variance of ZT . We set up the new variance of Zt to be Var∗(Zt) = bVar(Zt),
where b = 3 in this example.
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Figure 8.7: Different comparisons between predictions of the prognostic index and the actual
values of ZT , direct method and the indirect method and also using full Bayes, for data simulated
using the indirect model. (a): actual ZT vs full Bayes direct. (b): actual ZT vs full Bayes
indirect. (c): actual ZT vs BLK direct. (d): actual ZT vs BLK indirect. (Example 1)
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Figure 8.8: Comparing one method with another method to predict the prognostic index using
both direct method and the indirect method for data simulated using the indirect model. (a):
full Bayes direct vs full Bayes indirect. (b): full Bayes direct vs BLK direct. (c): full Bayes
direct vs BLK indirect. (d): BLK direct vs BLK indirect. (e): full Bayes indirect vs BLK
indirect. (f): full Bayes indirect vs BLK direct. (Example 1)
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Figure 8.9: Different comparisons between predictions of the prognostic index and the actual
values of ZT , direct method and the indirect method and also using full Bayes, for data simulated
using the indirect model. (a): actual ZT vs full Bayes direct. (b): actual ZT vs full Bayes
indirect. (c): actual ZT vs BLK direct. (d): actual ZT vs BLK indirect. (Example 2)
223














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 8.10: Comparing one method with another method to predict the prognostic index using
both direct method and the indirect method for data simulated using the indirect model. (a):
full Bayes direct vs full Bayes indirect. (b): full Bayes direct vs BLK direct. (c): full Bayes
direct vs BLK indirect. (d): BLK direct vs BLK indirect. (e): full Bayes indirect vs BLK
indirect. (f): full Bayes indirect vs BLK direct. (Example 2)
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Figure 8.11: Different comparisons between predictions of the prognostic index and the actual
values of ZT , direct method and the indirect method and also using full Bayes, for data simulated
using the indirect model with increasing the variance of ZT . (a): actual ZT vs full Bayes direct.
(b): actual ZT vs full Bayes indirect. (c): actual ZT vs BLK direct. (d): actual ZT vs BLK
indirect. (Example 3)
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Figure 8.12: Comparing one method with another method to predict the prognostic index using
both direct method and the indirect method for data simulated using the indirect model with
increasing the variance of ZT . (a): full Bayes direct vs full Bayes indirect. (b): full Bayes direct
vs BLK direct. (c): full Bayes direct vs BLK indirect. (d): BLK direct vs BLK indirect. (e):
full Bayes indirect vs BLK indirect. (f): full Bayes indirect vs BLK direct. (Example 3)
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8.4 Conclusion
In conclusion, the Bayes linear Bayes approach produced solutions more quickly than the
full Bayes method. For example, the time that we need to obtain the results for 1200
simulated patients on a desk-top computer using full-Bayes analysis is about 544 seconds,
while the time we need to produce the results using the Bayes linear kinematic method
is about 3.3 seconds, which is very much faster than the full Bayes method.
The Bayes linear kinematic predictions appeared to be only slightly less close to the
true values than the full-Bayes predictions. Whether the simulated data were generated
using the direct or the indirect model, it seemed to make little difference whether the
predictions were calculated according to the direct or indirect method.
Importantly, the Bayes linear kinematic methods can easily be used if only some of
the covariates are observed.
Following the results that we have obtained so far from the simulations, we may
recommend the use of either method, the direct or the indirect, as they both give very close
results to each other. Both methods are faster and easier to use once we have obtained
the parameter values that we extract from the offline learning. The indirect method may
be preferred as it gives unbounded posterior support rather than the bounded posterior
in the direct methods.
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Chapter 9
Conclusion and Future Work
9.1 Summary of the project
In this thesis we have been concerned with methods that use Bayesian inference and par-
ticularly Bayes linear Bayes methods for different types of distribution, such as binomial,
Poisson, etc. Firstly, in Chapter 1 we reviewed some literature related to our work such as
using structure learning in Bayesian networks and Bayesian networks in survival analysis.
Chapter 2 described two data sets that we used in this thesis which are non-Hodgkin
lymphoma (NHL) and leukemia data. We have explained in detail the covariates in each
data set.
We consider full-Bayes analysis methods such as MCMC techniques in Chapter 3.
Initially, we gave an introduction to Bayesian inference. We have discussed some numerical
integration methods that we need in this thesis such as Laplace approximation and the
trapezoidal rule. Various types of MCMC algorithms have been illustrated in this chapter,
for example, Monte Carlo integration, importance sampling and, of course, the three
most important algorithms in Bayesian analysis, Gibbs sampling, Metropolis-Hastings
algorithm and Metropolis within Gibbs. We also mentioned how we can obtain samples
from the posterior distributions using MCMC and check the convergence of the chains.
The second part of this chapter dealt with generalised linear models (GLMs) with common
link functions such as logit and probit. We then gave the theory of some variable selection
methods and how we can use Bayesian analysis to select the most important variables
in the model. We used an illustrative example of a Bayesian logistic regression model.
We also explained some variable selection methods which depend on various forms of
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prior distribution, such as spike and slab prior and Zellner’s g prior. In many data sets,
some values are missing. This chapter has described the problem of missing data and the
related method of data augmentation. We use the lung transplant example with many
covariates and a logistic regression model to illustrate the idea of variable selection from a
Bayesian perspective with some results showing that the posterior predictive probabilities
are close to the observed values of the dependent variable.
In Chapter 4, we reviewed a special type of probabilistic graphical models called a
Bayesian network (BN). Then we gave some important terms and definitions in Bayesian
networks. We explained the main points of difference between Bayesian networks and
regression models. In particular, in regression model we do not specify a probability dis-
tribution for the covariates. However, in a BN, we specify the joint probability distribution
for all of the variables so we can use it even when we observe only some of these variables.
We may wish to learn about the parameter of a Bayesian network from data. This is
called parameter learning in BN. We explained, in brief, learning the parameters in both
cases, with complete data and incomplete data. We gave different examples of learning
from data in different cases, such as a categorical network and a Gaussian network. We
used an R package called “bnlearn”, which stands for Bayesian network learning, to learn
about the structure of BNs. We focused on using two algorithms to construct the network
which are the “Grow-Shrink” (GS) algorithm and the “Hill-Climbing” algorithm. These
algorithms depend on a score function such as the Bayesian information criterion (BIC)
to specify the optimal Bayesian network. We explained both algorithms in a motivational
example. Finally, we used a proposed method to construct a Bayesian network. The
method is called “arc-deletion” method. This method requires that we impose the order
of the nodes in the network. Then we used MCMC to select the most likely configuration
and that depends on the posterior probability of the coefficients being non-zero in the
model. We applied this method to the non-Hodgkin lymphoma data set. We found that
the most likely structure from this method had fewer arrows, i.e. we dropped some of
the arcs as the posterior probability for them was close to zero. That is beneficial as we
do not need as many calculations to compute the joint probability distributions as in a
fully-connected network.
We gave general background on survival analysis in Chapter 5. We illustrated some
useful models that relate the survival lifetime distribution to some covariates in the model.
These models are proportional hazard models, piecewise constant hazard models and
accelerated failure time models. We described a prognostic index which is used to predict
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the outcome in patients with a certain disease. We showed for example, how to calculate
this index by fitting the Weibull lifetime distribution. In this chapter, we demonstrated
how we can calculate the posterior distribution for the parameters in survival analysis for
exponential and Weibull distributions. We used the software called “rjags” to compute
all the posterior means and variances for the parameters of interest in the model. We
showed some results and graphs showing that our sampler mixed well and the chains
converged.
The main contribution of the thesis is in Chapters 6 and 7. In Chapter 6 we inves-
tigated Bayes linear methods with some theoretical aspects of this approach. In Bayes
linear methods, we do not need to specify the prior in a probabilistic way as in full-Bayes
analysis. We explained the idea of Bayes linear analysis using a motivational example. We
explained Bayes linear kinematics (BLK) and mentioned the concept of “commutativity”
and how to do multiple updates using BLK.
We explained Bayes linear Bayes graphical models as a combination of Bayesian net-
works and Bayes linear structure. We use the idea of transformation of the parameters for
different reasons. However, an important reason is that, when a quantity θ has a bounded
range, this makes the use of Bayes linear methods less attractive.
After transforming the parameters, we can use the mode and log-curvature method
that we explained in Section 6.5.3 to relate the distribution of the parameters to moments
on the transformed scale. We apply the mode and curvature method to construct the
mean and variance for the transformed parameters. We use an example for illustration.
In this chapter we introduced a new method for updating our means and variances which
depends on non-conjugate prior updates in order to calculate Bayes linear kinematics. In
the case of a non-conjugate prior, we need to use some numerical integration methods such
as Laplace approximation, Gauss-Hermite quadrature and the trapezoidal rule. However,
the integrations are typically one-dimensional in contrast to the multi-dimensional in-
tegrations often required in a full-Bayes analysis. The use of non-conjugate priors also
extends the range of types of variable which we can use in a Bayes linear Bayes model.
We used two examples to demonstrate the idea of using non-conjugate prior updates.
Finally, we illustrated briefly various sorts of variables that we can deal with, such as
binary, ordinal, unordered categorical and interval censored variables.
Chapter 7 reviewed two examples, using data on patients with leukaemia and non-
Hodgkin lymphoma. For the leukaemia example, we reviewed the Wilson and Farrow
approach using a piecewise constant hazards model. Then we used our non-conjugate
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updates in this example in order to compare the results with Wilson and Farrow (2017).
We did some diagnostic checking in the leukaemia example to assess the validity of the
assumptions in our model.
For the non-Hodgkin lymphoma example, firstly, we introduced Bayes linear Bayes
prognostic networks and then applied this idea to the NHL example. Secondly, we intro-
duced the novelty of the model relating T to a latent prognostic index.
Initially, we have explained the general strategy of offline learning to construct a Bayes
linear Bayes network and then Bayes linear kinematics in the routine use of a Bayes linear
Bayes prognostic network. We described the offline learning model using rjags and how
we can use the posterior means of the parameters in the model. We introduced two
different structures for the Bayes linear Bayes model, called the direct method and the
indirect method. Then we used BLK and did some comparisons between full-Bayes and
Bayes linear kinematics. We found that the prognostic index values from MCMC (full-
Bayes) and BLK look similar. A Bland and Altman agreement plot showed that only 4%
of the prognostic index values were outside the limits. Our prototype prognostic network
produces prognostic index values using all, or some, of the possible covariates almost
instantly and has the potential to be used, for example, as a Web-based calculator.
We also set out some advantages and disadvantages of using the direct and the indirect
method.
In summary, the indirect method is preferable to the direct method as the latter has
bounded support for the posterior and the indirect method give us posterior means which
are closer to the MCMC values than those which the direct method gives.
Since, at present, we use a separate, offline, full-Bayes model to choose parameter
values for the Bayes linear Bayes model, in practice, from time to time, after we have
observed new data, we might run the offline learning again with the addition of new cases
and update the Bayes linear kinematic network.
Finally, in Chapter 8, we implemented a simulation experiment to compare the direct
and the indirect methods based on the results of these methods in Chapter 7. So we
generated repeated simulations when the direct model is correct but both direct and
indirect methods are used to generate the prognostic index distributions. We used full
Bayes and BLK methods to compute predictions. We repeated this for the indirect model
as well.
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9.2 A review of the objectives of the project
In Chapter 1 of this thesis, we stated the aim of the project with some listed points. These
were as follows
1. Develop Bayesian methods for selecting, fitting and using models with appropriate
conditional independence structures, i.e. graphical models, in the context of medical
diagnosis and prognosis problems. In addition, we are looking for improvements to
some existing methods.
2. Investigate methods for a wider class of conditional distributions.
3. Build probabilistic models for diagnosis and prognosis with various Bayesian network
learning algorithms to help the physicians and others to make decisions about their
patients more accurately and efficiently.
4. Propose the novelty of using the non-conjugate prior update in order to obtain the
posterior moments using Bayes linear kinematics.
5. Construct a Bayes linear kinematic network which can be used when we observe
only some of the covariates. Develop methods for incorporating different kind of
covariates in such a network.
6. Propose two new methods, the direct and the indirect methods to compute the
prototype prognostic network and has the potential to be used, for example, as a
Web-based calculator.
We have achieved some of these objectives of the study. For instance, in Chapter 4 we
have constructed a Bayesian network with a Weibull lifetime distribution for the leukemia
data. We made imposed an order on the covariates in the model and we put the covariates
that we always observed first in the network. We also introduced a method to construct
a Bayesian network which depends on selecting the most likely configuration and that
depends on the posterior probability of the coefficients being non-zero.
The main way in which we achieved the objectives was by the extension of methods
for Bayes linear Bayes graphical models to allow non-conjugate marginal updates and the
application of this to a Bayes linear Bayes prognostic index.
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In Chapter 6, we gave the general theory and some examples where we showed that
the adjusted moments from Bayes linear kinematics and the posterior moments from
full-Bayes analysis were close to each other. We discussed examples such as binomial ob-
servations and Poisson observations. We developed methods for incorporating variables of
different types into a Bayes linear Bayes network. All these examples used non-conjugate
prior updates which is an extension of the work done by Wilson and Farrow (2010, 2017).
Chapter 7 showed problems of different kinds using the leukaemia example and the
non-Hodgkin lymphoma example. In the leukaemia example we demonstrated the use of
Bayes linear kinematics to fit a survival model and make inferences about the values of
parameters, using our novel non-conjugate marginal updates. In the non-Hodgkin lym-
phoma example, we showed the idea of constructing a Bayes linear Bayes prognostic index
which depends on fitting an offline learning model for a Weibull survival time and making
inferences about the parameters in the model and then using Bayes linear kinematics to
update our beliefs about Z = (Z1, ..., ZJ , ZJ+1)
′ in routine use with new patients. We are
particularly interested to predict ZJ+1 which is linked with the survival time. We com-
pared the posterior moments with full Bayes analysis which gave us reasonable results. We
also compared the direct and the indirect method and we found that the indirect method
is more accurate than the direct method and the reason is that, in the indirect method,
we have an unbounded support for the posterior distribution with ordinal variables rather
than the bounded posterior support in the direct method.
In Chapter 8, we did some simulation experiments in survival analysis in order to
compare the direct and the indirect methods motivated by the results in the non-Hodgkin
lymphoma example in Chapter 7.
9.3 Future work
There is further work to do on selecting Bayesian network structure. Our idea is to use
a score criterion the expectation of a suitable utility function. Similarly work can be
done which applies this idea to variable selection methods. The idea is to use the more
important covariates in the model again depending upon the maximisation of the expected
utility.
We have investigated an “arc-deletion” method, which can calculate the posterior
mean of the indicators, in other words the posterior probability that those coefficients are
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non-zero. This method can drop some of the arrows from the network and that leads to
simplifying the calculation of the joint probability distribution. We can do more work
to improve this method by changing the directions of the arrows to obtain the optimal
structure. That is, we can apply a utility function as a score function in algorithms such
as “Hill-Climbing” and “Grow-Shrink”. Further work is also required on the choice of
suitable utility functions.
In our Bayes linear Bayes graphical models we used a general, that is fully-connected,
covariance structure. There is a need for further research on using structures which are
not fully-connected and which exploit conditional independence.
In our Bayes linear kinematic prognostic index calculation we used the posterior means
of model parameters produced in the offline learning phase. Ideally we would use posterior
expectations of the functions of model parameters which are needed in the Bayes linear
kinematic calculation. Further work is needed to develop this.
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In this thesis, we use the software called jags, which stands for “Just Another Gibbs
Sampler” (Plummer, 2017). It uses MCMC to fit many different kinds of models specified
using a model specification language based on the BUGS language (Spiegelhalter et al.,
1996). To run jags we use the rjags package (Plummer, 2013) within R (R Core Team,
2018).
A.2 Appendix to Chapter 2
A.2.1 Few observations of SNLG data
t died age sex albumin ap bsy . . .
0.016438356 1 72 1 2 2 2 . . .
0.250228311 1 63 1 1 1 2 . . .
0.084018265 1 70 1 1 2 1 . . .
0.168949772 0 58 2 1 1 2 . . .
Table A.1: Few observations of SNLG data.
237
Appendix A. Appendix
A.2.2 Few observations of leukaemia data
t t.cen age sex wbc depsc
1 0 61 1 13.3 -1.96
1 0 76 1 450.0 -3.39
1 0 74 1 154.0 -4.95
1 0 79 2 500.0 -1.40
1 0 83 2 160.0 -2.59
Table A.2: Few observations of leukaemia data.
A.3 Appendix to Chapter 3
A.3.1 R function to generate samples from the posterior distri-






























A.3.2 Rjags specification for the logistic regression model of





































































































A.4 Appendix to Chapter 4
A.4.1 Rjags specification to compute the posterior probabilities


















































































































for( c in 1:N)
{pmat[,c]<-1






A.5 Appendix to Chapter 5
A.5.1 R function to generate samples from the posterior distri-































A.5.2 Rjags model specification to fit the exponential survival

























A.5.3 Rjags model specification to calculate the survival prob-
















Explanation of calculation of the survival probability
Suppose we consider a new patient. That means we are interested in plotting the sur-
vival function for one particular patient, say, for example, male and age 63, etc. Therefore,
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we have λ for that patient denoted λ∗. If the posterior median for λ∗ is λ∗m and the lower
and upper limits of the 95% interval are λ∗0.025 and λ∗0.975 respectively, then the corre-
sponding quantities for the survival probability at time t are exp(−λ∗mt), exp(−λ∗0.025t)
and exp(−λ∗0.975t).







A.6 Appendix to Chapter 6


















A.6.2 R function for sulfinpyrazone example using logits
function(theta1,theta2,n,x,prior)
{# Evaluates posterior density for logit example.





























A.6.3 R function to find the posterior mean and variance for η1































A.6.4 Posterior correlation matrix for η for both areas and sexes
in surgical death example using Bayes linear kinematic
See Table A.3−A.7.
A.6.5 R function to make adjustment for both binary and ordi-























1 2 3 4 5 6 7 8
1 1.0000 0.2246 0.0742 0.0332 0.0197 0.0082 0.0024 0.0008
2 0.2246 1.0000 0.2088 0.0662 0.0352 0.0140 0.0039 0.0010
3 0.0742 0.2088 1.0000 0.1726 0.0653 0.0244 0.0070 0.0016
4 0.0332 0.0662 0.1726 1.0000 0.1917 0.0564 0.0152 0.0034
5 0.0197 0.0352 0.0653 0.1917 1.0000 0.1701 0.0408 0.0090
6 0.0082 0.0140 0.0244 0.0564 0.1701 1.0000 0.1204 0.0236
7 0.0024 0.0039 0.0070 0.0152 0.0408 0.1204 1.0000 0.1023
8 0.0008 0.0010 0.0016 0.0034 0.0090 0.0236 0.1023 1.0000
9 0.0010 0.0007 0.0007 0.0011 0.0025 0.0057 0.0224 0.1334
10 0.0017 0.0010 0.0007 0.0008 0.0012 0.0023 0.0081 0.0463
11 0.1330 -0.0840 -0.0377 -0.0264 -0.0175 -0.0071 -0.0015 -0.0005
12 -0.0779 0.3824 -0.0001 -0.0403 -0.0305 -0.0127 -0.0026 -0.0007
13 -0.0735 -0.0643 0.2788 -0.0442 -0.0564 -0.0243 -0.0051 -0.0012
14 -0.0366 -0.0517 -0.0137 0.2466 -0.0548 -0.0366 -0.0083 -0.0018
15 -0.0157 -0.0231 -0.0174 -0.0173 0.2417 -0.0434 -0.0128 -0.0027
16 -0.0068 -0.0102 -0.0087 -0.0260 -0.0533 0.1307 -0.0433 -0.0117
17 -0.0019 -0.0027 -0.0016 -0.0066 -0.0173 -0.0484 0.1057 -0.0388
18 -0.0006 -0.0006 -0.0002 -0.0012 -0.0030 -0.0112 -0.0317 0.0660
19 -0.0005 -0.0003 -0.0001 -0.0002 -0.0004 -0.0019 -0.0059 -0.0321
20 -0.0005 -0.0004 -0.0001 -0.0001 -0.0002 -0.0007 -0.0020 -0.0118
21 0.1264 -0.0321 -0.0621 -0.0255 -0.0119 -0.0060 -0.0022 -0.0006
22 -0.0312 0.3860 -0.0562 -0.0415 -0.0220 -0.0113 -0.0040 -0.0009
23 -0.0465 -0.0225 0.2157 -0.0420 -0.0423 -0.0216 -0.0070 -0.0015
24 -0.0218 -0.0297 -0.0530 0.2459 -0.0349 -0.0333 -0.0114 -0.0022
25 -0.0075 -0.0110 -0.0387 -0.0148 0.2371 -0.0331 -0.0170 -0.0032
26 -0.0035 -0.0055 -0.0214 -0.0258 -0.0361 0.1340 -0.0493 -0.0114
27 -0.0011 -0.0015 -0.0065 -0.0076 -0.0135 -0.0400 0.1001 -0.0400
28 -0.0003 -0.0003 -0.0013 -0.0013 -0.0017 -0.0080 -0.0345 0.0625
29 -0.0003 -0.0002 -0.0005 -0.0002 0.0000 -0.0012 -0.0065 -0.0364
30 -0.0002 -0.0002 -0.0005 -0.0002 -0.0001 -0.0005 -0.0024 -0.0145
31 0.1123 -0.0143 -0.0196 -0.0233 -0.0317 -0.0100 -0.0045 -0.0015
32 0.0058 0.2251 0.0041 -0.0285 -0.0416 -0.0134 -0.0058 -0.0019
33 -0.0166 -0.0076 0.1837 -0.0257 -0.0603 -0.0204 -0.0083 -0.0025
34 -0.0105 -0.0211 0.0002 0.2095 -0.0657 -0.0304 -0.0127 -0.0037
35 -0.0029 -0.0098 -0.0099 -0.0053 0.2079 -0.0287 -0.0202 -0.0060
36 -0.0010 -0.0045 -0.0057 -0.0208 -0.0606 0.1324 -0.0427 -0.0139
37 -0.0002 -0.0015 -0.0015 -0.0078 -0.0279 -0.0330 0.1008 -0.0381
38 0.0000 -0.0004 -0.0003 -0.0019 -0.0074 -0.0093 -0.0322 0.0696
39 0.0000 -0.0002 -0.0001 -0.0005 -0.0019 -0.0020 -0.0078 -0.0304
40 0.0002 -0.0001 -0.0001 -0.0004 -0.0011 -0.0009 -0.0029 -0.0123
Table A.3: Posterior correlation matrix for η for both areas and sexes in surgical death example
using Bayes linear kinematic and for the columns 1−8
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9 10 11 12 13 14 15 16
1 0.0010 0.0017 0.1330 -0.0779 -0.0735 -0.0366 -0.0157 -0.0068
2 0.0007 0.0010 -0.0840 0.3824 -0.0643 -0.0517 -0.0231 -0.0102
3 0.0007 0.0007 -0.0377 -0.0001 0.2788 -0.0137 -0.0174 -0.0087
4 0.0011 0.0008 -0.0264 -0.0403 -0.0442 0.2466 -0.0173 -0.0260
5 0.0025 0.0012 -0.0175 -0.0305 -0.0564 -0.0548 0.2417 -0.0533
6 0.0057 0.0023 -0.0071 -0.0127 -0.0243 -0.0366 -0.0434 0.1307
7 0.0224 0.0081 -0.0015 -0.0026 -0.0051 -0.0083 -0.0128 -0.0433
8 0.1334 0.0463 -0.0005 -0.0007 -0.0012 -0.0018 -0.0027 -0.0117
9 1.0000 0.2145 -0.0007 -0.0004 -0.0005 -0.0005 -0.0005 -0.0027
10 0.2145 1.0000 -0.0010 -0.0006 -0.0005 -0.0004 -0.0004 -0.0012
11 -0.0007 -0.0010 1.0000 0.3101 0.1676 0.0790 0.0386 0.0176
12 -0.0004 -0.0006 0.3101 1.0000 0.3477 0.1474 0.0700 0.0312
13 -0.0005 -0.0005 0.1676 0.3477 1.0000 0.3009 0.1326 0.0581
14 -0.0005 -0.0004 0.0790 0.1474 0.3009 1.0000 0.2249 0.0867
15 -0.0005 -0.0004 0.0386 0.0700 0.1326 0.2249 1.0000 0.1858
16 -0.0027 -0.0012 0.0176 0.0312 0.0581 0.0867 0.1858 1.0000
17 -0.0098 -0.0040 0.0059 0.0103 0.0189 0.0274 0.0547 0.1586
18 -0.0450 -0.0192 0.0017 0.0027 0.0047 0.0068 0.0135 0.0362
19 0.0939 -0.0549 0.0012 0.0011 0.0015 0.0018 0.0033 0.0078
20 -0.0429 0.2034 0.0020 0.0014 0.0014 0.0012 0.0014 0.0027
21 -0.0006 -0.0009 0.1272 -0.0296 -0.0655 -0.0347 -0.0200 -0.0106
22 -0.0006 -0.0008 -0.0299 0.3519 -0.0598 -0.0486 -0.0305 -0.0169
23 -0.0005 -0.0006 -0.0178 0.0285 0.2380 0.0067 -0.0186 -0.0141
24 -0.0005 -0.0005 -0.0200 -0.0236 -0.0260 0.2264 -0.0075 -0.0243
25 -0.0004 -0.0004 -0.0162 -0.0245 -0.0475 -0.0228 0.2045 -0.0370
26 -0.0019 -0.0010 -0.0089 -0.0139 -0.0278 -0.0280 -0.0322 0.1321
27 -0.0079 -0.0036 -0.0028 -0.0043 -0.0088 -0.0090 -0.0135 -0.0335
28 -0.0386 -0.0184 -0.0008 -0.0011 -0.0023 -0.0023 -0.0034 -0.0112
29 0.0992 -0.0465 -0.0005 -0.0005 -0.0008 -0.0006 -0.0007 -0.0026
30 -0.0337 0.1927 -0.0006 -0.0006 -0.0008 -0.0005 -0.0005 -0.0012
31 -0.0013 -0.0008 0.1198 -0.0020 -0.0166 -0.0230 -0.0324 -0.0126
32 -0.0013 -0.0008 0.0155 0.2199 0.0093 -0.0229 -0.0394 -0.0154
33 -0.0015 -0.0008 0.0116 0.0408 0.2069 0.0167 -0.0358 -0.0137
34 -0.0018 -0.0007 0.0000 -0.0013 0.0313 0.2038 -0.0329 -0.0208
35 -0.0025 -0.0008 -0.0055 -0.0130 -0.0122 -0.0065 0.1836 -0.0306
36 -0.0051 -0.0014 -0.0030 -0.0074 -0.0086 -0.0194 -0.0514 0.1321
37 -0.0144 -0.0038 -0.0010 -0.0027 -0.0029 -0.0079 -0.0254 -0.0259
38 -0.0512 -0.0139 -0.0004 -0.0010 -0.0011 -0.0028 -0.0084 -0.0122
39 0.0850 -0.0241 -0.0002 -0.0004 -0.0004 -0.0009 -0.0024 -0.0036
40 -0.0467 0.2231 -0.0002 -0.0004 -0.0004 -0.0006 -0.0014 -0.0017
Table A.4: Posterior correlation matrix for η for both areas and sexes in surgical death example
using Bayes linear kinematic and for the columns 9−16
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17 18 19 20 21 22 23 24
1 -0.0019 -0.0006 -0.0005 -0.0005 0.1264 -0.0312 -0.0465 -0.0218
2 -0.0027 -0.0006 -0.0003 -0.0004 -0.0321 0.3860 -0.0225 -0.0297
3 -0.0016 -0.0002 -0.0001 -0.0001 -0.0621 -0.0562 0.2157 -0.0530
4 -0.0066 -0.0012 -0.0002 -0.0001 -0.0255 -0.0415 -0.0420 0.2459
5 -0.0173 -0.0030 -0.0004 -0.0002 -0.0119 -0.0220 -0.0423 -0.0349
6 -0.0484 -0.0112 -0.0019 -0.0007 -0.0060 -0.0113 -0.0216 -0.0333
7 0.1057 -0.0317 -0.0059 -0.0020 -0.0022 -0.0040 -0.0070 -0.0114
8 -0.0388 0.0660 -0.0321 -0.0118 -0.0006 -0.0009 -0.0015 -0.0022
9 -0.0098 -0.0450 0.0939 -0.0429 -0.0006 -0.0006 -0.0005 -0.0005
10 -0.0040 -0.0192 -0.0549 0.2034 -0.0009 -0.0008 -0.0006 -0.0005
11 0.0059 0.0017 0.0012 0.0020 0.1272 -0.0299 -0.0178 -0.0200
12 0.0103 0.0027 0.0011 0.0014 -0.0296 0.3519 0.0285 -0.0236
13 0.0189 0.0047 0.0015 0.0014 -0.0655 -0.0598 0.2380 -0.0260
14 0.0274 0.0068 0.0018 0.0012 -0.0347 -0.0486 0.0067 0.2264
15 0.0547 0.0135 0.0033 0.0014 -0.0200 -0.0305 -0.0186 -0.0075
16 0.1586 0.0362 0.0078 0.0027 -0.0106 -0.0169 -0.0141 -0.0243
17 1.0000 0.1306 0.0264 0.0084 -0.0041 -0.0065 -0.0062 -0.0110
18 0.1306 1.0000 0.1277 0.0386 -0.0012 -0.0018 -0.0017 -0.0028
19 0.0264 0.1277 1.0000 0.1790 -0.0006 -0.0007 -0.0004 -0.0006
20 0.0084 0.0386 0.1790 1.0000 -0.0009 -0.0009 -0.0005 -0.0005
21 -0.0041 -0.0012 -0.0006 -0.0009 1.0000 0.3729 0.1715 0.0907
22 -0.0065 -0.0018 -0.0007 -0.0009 0.3729 1.0000 0.3524 0.1684
23 -0.0062 -0.0017 -0.0004 -0.0005 0.1715 0.3524 1.0000 0.2607
24 -0.0110 -0.0028 -0.0006 -0.0005 0.0907 0.1684 0.2607 1.0000
25 -0.0210 -0.0052 -0.0008 -0.0006 0.0493 0.0891 0.1215 0.2390
26 -0.0481 -0.0144 -0.0026 -0.0012 0.0250 0.0446 0.0591 0.1064
27 0.1064 -0.0345 -0.0069 -0.0031 0.0082 0.0145 0.0189 0.0336
28 -0.0358 0.0660 -0.0324 -0.0157 0.0023 0.0037 0.0044 0.0077
29 -0.0094 -0.0432 0.0974 -0.0570 0.0017 0.0019 0.0017 0.0023
30 -0.0040 -0.0190 -0.0554 0.2044 0.0025 0.0024 0.0016 0.0015
31 -0.0060 -0.0021 -0.0013 -0.0007 0.1172 0.0353 0.0053 -0.0130
32 -0.0075 -0.0026 -0.0014 -0.0008 0.0391 0.2332 0.0341 -0.0123
33 -0.0077 -0.0029 -0.0014 -0.0006 -0.0029 0.0129 0.1712 -0.0081
34 -0.0120 -0.0043 -0.0018 -0.0006 -0.0023 -0.0052 0.0265 0.1977
35 -0.0237 -0.0081 -0.0029 -0.0009 -0.0026 -0.0078 -0.0040 0.0068
36 -0.0406 -0.0162 -0.0055 -0.0014 -0.0028 -0.0070 -0.0078 -0.0178
37 0.1078 -0.0319 -0.0129 -0.0027 -0.0020 -0.0044 -0.0054 -0.0116
38 -0.0329 0.0743 -0.0444 -0.0099 -0.0007 -0.0014 -0.0018 -0.0037
39 -0.0107 -0.0369 0.0816 -0.0324 -0.0002 -0.0005 -0.0005 -0.0010
40 -0.0045 -0.0168 -0.0713 0.2374 -0.0001 -0.0004 -0.0004 -0.0007
Table A.5: Posterior correlation matrix for η for both areas and sexes in surgical death example
using Bayes linear kinematic and for the columns 17−24
255
Appendix A. Appendix
25 26 27 28 29 30 31 32
1 -0.0075 -0.0035 -0.0011 -0.0003 -0.0003 -0.0002 0.1123 0.0058
2 -0.0110 -0.0055 -0.0015 -0.0003 -0.0002 -0.0002 -0.0143 0.2251
3 -0.0387 -0.0214 -0.0065 -0.0013 -0.0005 -0.0005 -0.0196 0.0041
4 -0.0148 -0.0258 -0.0076 -0.0013 -0.0002 -0.0002 -0.0233 -0.0285
5 0.2371 -0.0361 -0.0135 -0.0017 0.0000 -0.0001 -0.0317 -0.0416
6 -0.0331 0.1340 -0.0400 -0.0080 -0.0012 -0.0005 -0.0100 -0.0134
7 -0.0170 -0.0493 0.1001 -0.0345 -0.0065 -0.0024 -0.0045 -0.0058
8 -0.0032 -0.0114 -0.0400 0.0625 -0.0364 -0.0145 -0.0015 -0.0019
9 -0.0004 -0.0019 -0.0079 -0.0386 0.0992 -0.0337 -0.0013 -0.0013
10 -0.0004 -0.0010 -0.0036 -0.0184 -0.0465 0.1927 -0.0008 -0.0008
11 -0.0162 -0.0089 -0.0028 -0.0008 -0.0005 -0.0006 0.1198 0.0155
12 -0.0245 -0.0139 -0.0043 -0.0011 -0.0005 -0.0006 -0.0020 0.2199
13 -0.0475 -0.0278 -0.0088 -0.0023 -0.0008 -0.0008 -0.0166 0.0093
14 -0.0228 -0.0280 -0.0090 -0.0023 -0.0006 -0.0005 -0.0230 -0.0229
15 0.2045 -0.0322 -0.0135 -0.0034 -0.0007 -0.0005 -0.0324 -0.0394
16 -0.0370 0.1321 -0.0335 -0.0112 -0.0026 -0.0012 -0.0126 -0.0154
17 -0.0210 -0.0481 0.1064 -0.0358 -0.0094 -0.0040 -0.0060 -0.0075
18 -0.0052 -0.0144 -0.0345 0.0660 -0.0432 -0.0190 -0.0021 -0.0026
19 -0.0008 -0.0026 -0.0069 -0.0324 0.0974 -0.0554 -0.0013 -0.0014
20 -0.0006 -0.0012 -0.0031 -0.0157 -0.0570 0.2044 -0.0007 -0.0008
21 0.0493 0.0250 0.0082 0.0023 0.0017 0.0025 0.1172 0.0391
22 0.0891 0.0446 0.0145 0.0037 0.0019 0.0024 0.0353 0.2332
23 0.1215 0.0591 0.0189 0.0044 0.0017 0.0016 0.0053 0.0341
24 0.2390 0.1064 0.0336 0.0077 0.0023 0.0015 -0.0130 -0.0123
25 1.0000 0.2124 0.0645 0.0148 0.0039 0.0019 -0.0260 -0.0325
26 0.2124 1.0000 0.1661 0.0354 0.0084 0.0033 -0.0116 -0.0146
27 0.0645 0.1661 1.0000 0.1206 0.0267 0.0092 -0.0061 -0.0077
28 0.0148 0.0354 0.1206 1.0000 0.1368 0.0451 -0.0020 -0.0025
29 0.0039 0.0084 0.0267 0.1368 1.0000 0.2041 -0.0012 -0.0013
30 0.0019 0.0033 0.0092 0.0451 0.2041 1.0000 -0.0005 -0.0006
31 -0.0260 -0.0116 -0.0061 -0.0020 -0.0012 -0.0005 1.0000 0.3297
32 -0.0325 -0.0146 -0.0077 -0.0025 -0.0013 -0.0006 0.3297 1.0000
33 -0.0478 -0.0227 -0.0113 -0.0035 -0.0017 -0.0008 0.2494 0.3341
34 -0.0328 -0.0230 -0.0135 -0.0044 -0.0019 -0.0008 0.1801 0.2334
35 0.1801 -0.0172 -0.0199 -0.0067 -0.0026 -0.0009 0.1129 0.1447
36 -0.0414 0.1344 -0.0326 -0.0133 -0.0050 -0.0014 0.0591 0.0753
37 -0.0285 -0.0325 0.1027 -0.0350 -0.0140 -0.0037 0.0245 0.0311
38 -0.0090 -0.0127 -0.0349 0.0697 -0.0497 -0.0137 0.0079 0.0097
39 -0.0023 -0.0031 -0.0091 -0.0313 0.0864 -0.0245 0.0037 0.0040
40 -0.0014 -0.0016 -0.0042 -0.0166 -0.0621 0.2242 0.0048 0.0046
Table A.6: Posterior correlation matrix for η for both areas and sexes in surgical death example
using Bayes linear kinematic and for the columns 25−32
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33 34 35 36 37 38 39 40
1 -0.0166 -0.0105 -0.0029 -0.0010 -0.0002 0.0000 0.0000 0.0002
2 -0.0076 -0.0211 -0.0098 -0.0045 -0.0015 -0.0004 -0.0002 -0.0001
3 0.1837 0.0002 -0.0099 -0.0057 -0.0015 -0.0003 -0.0001 -0.0001
4 -0.0257 0.2095 -0.0053 -0.0208 -0.0078 -0.0019 -0.0005 -0.0004
5 -0.0603 -0.0657 0.2079 -0.0606 -0.0279 -0.0074 -0.0019 -0.0011
6 -0.0204 -0.0304 -0.0287 0.1324 -0.0330 -0.0093 -0.0020 -0.0009
7 -0.0083 -0.0127 -0.0202 -0.0427 0.1008 -0.0322 -0.0078 -0.0029
8 -0.0025 -0.0037 -0.0060 -0.0139 -0.0381 0.0696 -0.0304 -0.0123
9 -0.0015 -0.0018 -0.0025 -0.0051 -0.0144 -0.0512 0.0850 -0.0467
10 -0.0008 -0.0007 -0.0008 -0.0014 -0.0038 -0.0139 -0.0241 0.2231
11 0.0116 0.0000 -0.0055 -0.0030 -0.0010 -0.0004 -0.0002 -0.0002
12 0.0408 -0.0013 -0.0130 -0.0074 -0.0027 -0.0010 -0.0004 -0.0004
13 0.2069 0.0313 -0.0122 -0.0086 -0.0029 -0.0011 -0.0004 -0.0004
14 0.0167 0.2038 -0.0065 -0.0194 -0.0079 -0.0028 -0.0009 -0.0006
15 -0.0358 -0.0329 0.1836 -0.0514 -0.0254 -0.0084 -0.0024 -0.0014
16 -0.0137 -0.0208 -0.0306 0.1321 -0.0259 -0.0122 -0.0036 -0.0017
17 -0.0077 -0.0120 -0.0237 -0.0406 0.1078 -0.0329 -0.0107 -0.0045
18 -0.0029 -0.0043 -0.0081 -0.0162 -0.0319 0.0743 -0.0369 -0.0168
19 -0.0014 -0.0018 -0.0029 -0.0055 -0.0129 -0.0444 0.0816 -0.0713
20 -0.0006 -0.0006 -0.0009 -0.0014 -0.0027 -0.0099 -0.0324 0.2374
21 -0.0029 -0.0023 -0.0026 -0.0028 -0.0020 -0.0007 -0.0002 -0.0001
22 0.0129 -0.0052 -0.0078 -0.0070 -0.0044 -0.0014 -0.0005 -0.0004
23 0.1712 0.0265 -0.0040 -0.0078 -0.0054 -0.0018 -0.0005 -0.0004
24 -0.0081 0.1977 0.0068 -0.0178 -0.0116 -0.0037 -0.0010 -0.0007
25 -0.0478 -0.0328 0.1801 -0.0414 -0.0285 -0.0090 -0.0023 -0.0014
26 -0.0227 -0.0230 -0.0172 0.1344 -0.0325 -0.0127 -0.0031 -0.0016
27 -0.0113 -0.0135 -0.0199 -0.0326 0.1027 -0.0349 -0.0091 -0.0042
28 -0.0035 -0.0044 -0.0067 -0.0133 -0.0350 0.0697 -0.0313 -0.0166
29 -0.0017 -0.0019 -0.0026 -0.0050 -0.0140 -0.0497 0.0864 -0.0621
30 -0.0008 -0.0008 -0.0009 -0.0014 -0.0037 -0.0137 -0.0245 0.2242
31 0.2494 0.1801 0.1129 0.0591 0.0245 0.0079 0.0037 0.0048
32 0.3341 0.2334 0.1447 0.0753 0.0311 0.0097 0.0040 0.0046
33 1.0000 0.3250 0.1931 0.0995 0.0409 0.0125 0.0044 0.0043
34 0.3250 1.0000 0.2965 0.1426 0.0578 0.0173 0.0053 0.0042
35 0.1931 0.2965 1.0000 0.2554 0.0988 0.0290 0.0078 0.0046
36 0.0995 0.1426 0.2554 1.0000 0.2152 0.0613 0.0153 0.0071
37 0.0409 0.0578 0.0988 0.2152 1.0000 0.1702 0.0405 0.0167
38 0.0125 0.0173 0.0290 0.0613 0.1702 1.0000 0.1586 0.0621
39 0.0044 0.0053 0.0078 0.0153 0.0405 0.1586 1.0000 0.2440
40 0.0043 0.0042 0.0046 0.0071 0.0167 0.0621 0.2440 1.0000
Table A.7: Posterior correlation matrix for η for both areas and sexes in surgical death example
using Bayes linear kinematic and for the columns 33−40
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A.6.6 R function to make adjustment for both binary and ordi-
nal variables in the indirect method
function(y,E0,V0,cuts,tol=1E-5,n=20)
{#
# y is an ordinal variable with possible values 1,2,...,m.













































# Tierney and Kadane numerator for E(Z+C)
z1<-z0
d<-1

























# Tierney and Kadane approximation to E(Z+C) and E(Z)
E1<-eta1/eta0
postmean<-E1-C
# Tierney and Kadane numerator for E([Z+C]ˆ2)
z2<-z1
d<-1






























A.7 Appendix to Chapter 7
A.7.1 Rjags model specification for the leukaemia data using a
piecewise constant hazards model
model



























for (j in 2:11)


























































A.7.4 Offline learning model for non-Hodgkin lymphoma data
in the direct method
##########################################################################
#### Offline learning model for non-Hodgkin lymphoma data in the ####




for (i in 1:1391){





























alpha ˜ dgamma(4, 4)# prior for alpha





































A.7.5 R function to adjust the mean and the variance of the
Gaussian random variables in non-Hodgkin lymphoma
data
##### posterior mean and variance for hb ######
function(y,E0,V0)













######## posterior mean and variance for wbc #######
function(y,E0,V0)











A.7.6 R function to update the mean and the variance of the
ordinal and the categorical random variables























######## posterior mean and variance for Z.albumin #########
function(y,E0,V0,cuts,nstep=100)
























A.7.7 R function to adjusted the mean and the variance for stage



















A.7.8 R function to compute the posterior mean using BLK in

















































































A.7.10 R function for prototype prognostic index calculator
function(params)
{
mean <- mean(out) ### out: is the posterior expectation of prognostic index values.
std.dev <- sd(out)
############### AGE
write(file="","Please enter the Age in years of the patient at time of diagnosis.")
age<-scan(n=1)
############### SEX
write(file="","Please enter the Sex of the patient.
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Enter 1 for male or 2 for female.")
sex<-scan(n=1)
############### STAGE
write(file="","Please enter the Clinical Stage of the patient (1, 2, 3 or 4).")
stage<-scan(n=1)
############### HB
write(file="","Please enter the Haemoglobin (g/l) measurement for the patient.")
hb<-scan(n=1)
################ WBC
write(file="","Please enter the White Blood Cell count for the patient.")
wbc<-scan(n=1)
################ ALBUMIN
write(file="","Please enter 1 if the Serum Albumin
measurement for the patient is normal")







write(file="","The index is on a scale from 0 to 100,
Greater index values indicate greater risk.")
}
A.7.11 Offline learning model for non-Hodgkin lymphoma data
in the indirect method
##########################################################################
#### Offline learning model for non-Hodgkin lymphoma data in the ####















































alpha ˜ dgamma(4, 4)# prior for alpha


































A.7.12 R functions to do the adjustment by the categorical ran-























# Tierney and Kadane numerator for E(Z+C)
z1<-z0
d<-1
















# Tierney and Kadane approximation to E(Z+C) and E(Z)
E1<-eta1/eta0
postmean<-E1-C
# Tierney and Kadane numerator for E([Z+C]ˆ2)
z2<-z1
d<-1





















A.8 Appendix to Chapter 8
A.8.1 R code for simulation from the direct model with direct







sex<-rep(1,n) # all male
age<-rep(0,n) # because each case aged 60 and we centred
# them as 60-60=0
# We use E0(Z) and V0(Z) that we obtained from the
# offline learning model to generate n=1200 samples
# from a multivariate normal distribution for Z.
Z<- mvrnorm(n, E0, V0)
hb<-Z[,1]
wbc<-Z[,2]










# Actual values of Z_T
actual_Z<-Z[,5]
# Then we have the matrix Z with dimension 1200X5 where
# for example Z[,1] is the generated values for the covariate
# Hb and Z[,2] is the generated values for the covariate Wbc
# and so on. The last column of the matrix Z, Z[,5] represents
# the actual values for Z_T. Afterwards, we use the model
# comparison (in rjags) in Appendix A.8.1. to compute the posterior
# means of Z_T using MCMC. Then we use Bayes linear
# kinematic to compute the posterior means for Z_T and
# compare the results between the two methods.
A.8.2 Rjags model specification for model comparison for non-
Hodgkin lymphoma data in the direct method
##########################################################################
##### model comparison for non-Hodgkin lymphoma data in the #####































A.8.3 Computing the predictions of ZT using Bayes linear kine-






















########## posterior mean and variance for wbc ##########
adjbynorm<-function(y,E0,V0)

































########## posterior mean and variance for Z.albumin ########## adjalbumin
adjalbumin<-function(y,E0,V0,cuts,nstep=100)



























































































































A.8.4 Rjags model specification for model comparison for non-
Hodgkin lymphoma data in the indirect method
##########################################################################
##### model comparison for non-Hodgkin lymphoma data in the #####








































A.8.5 Computing the predictions of ZT using Bayes linear kine-







########## posterior mean and variance for hb ##########
adjbynorm<-function(y,E0,V0)











########## posterior mean and variance for wbc ##########
adjbynorm<-function(y,E0,V0)













### function to find posterior mean and variance for










































# Tierney and Kadane approximation to E(Z+C) and E(Z)
E1<-eta1/eta0
postmean<-E1-C
# Tierney and Kadane numerator for E([Z+C]ˆ2)
z2<-z1
d<-1


























































































































A.9 List of abbreviations and notations
Table A.8: Glossary of abbreviation
Symbols Meaning
AP Alkaline phosphatase.
BLK Bayes linear kinematic.
BN Bayesian network.
bnlearn Bayesian network learning.
Bsy B-symptoms.
BUGS Bayesian inference using Gibbs sampler.
BVS Bayesian variable selection.
CPT Conditional probability table.
DA Data augmentation.
DAG Directed acyclic graph.
DBN Dynamic Bayesian network.
Depscore Deprivation score.
DLBCL Diffuse large B-cell lymphoma.
DLBCL-NOS Diffuse large B-cell lymphoma- Not Otherwise Specified.
ECOG Eastern Co-operative Oncology Group.
Extranod Extranodal without bone marrow.
EVLP Ex vivo lung perfusion.
FCD Full conditional distribution.
GLM Generalised Linear Model.
GVS Gibbs variable selection.
HB Haemoglobin.
i.i.d. Independent and identically distributed.
INLA Integrated nested Laplace approximation.
JAGS Just another Gibbs sampler.
LDH Serum lactate dehydrogenase.
MAR Missing at random.




Table A.9: Glossary of abbreviation
Symbols Meaning
MCAR Missing completely at random.
MCMC Markov chain Monte Carlo.
MNAR Missing not at random.
NHL Non-Hodgkins Lymphoma.
NRHG Northern Regional Haematology Group.
PACE Population Adjusted Clinical Epidemiology.
PCH Piecewise constant hazard.
PGM Probabilistic graphical model.
SNLG Scotland Newcastle Lymphoma Group.
SSVS Stochastic search variable selection.
TDI Townsend deprivation index.
Urea Blood urea nitrogen.
WBC White blood cell.
297
Appendix A. Appendix
Table A.10: Glossary of notations
Symbols Meaning
π(θ) Prior distribution of parameter θ
L(θ|y) Likelihood function.
π(θ|y) Posterior distribution of parameter θ given data y.
g(θ) Arbitrary function of θ.
g(·) Link function.
θ(xi) The probability of the event for subject i.
Yobs The observed data.
Ymiss The missing values.
ψ Unknown quantity for the missing data mechanism.
F (t) Lifetime distribution function.
S(t) Survival function.
f(t) Lifetime probability density function.
h(t) Hazard function.
H(t) Cumulative hazard function.
tf Posterior predictive density of future observation.
A Acceptance probability.
Φ Standard normal cumulative distribution function.
P0 Probability that the lung be used.
P01,P03 Lower and upper quartiles for the proportion.
f0(y | x) Prior predictive distribution.
f1(y | x) Posterior predictive distribution.
D = {x1, ..., xj} Observed data.
θ1, ..., θP Multinomial probability distribution.
π(θ | D) Posterior distribution of θ.
S? Best structure in Bayesian network.
ε1, ..., εp Autoregression innovations for transformed parameters.
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Table A.11: Glossary of notations
Symbols Meaning
E0,Var0,Cov0 Prior expectation, variance, covariance.
E1,Var1,Cov1 Posterior expectation, variance, covariance.
γ Regression coefficients in autoregression model.
{X1, ..., XJ} Covariates in the model.
R(Y |D) Error terms from the Bayes linear fit.
ψ(·) Digamma function.
ψ1(·) trigamma function.
Ik Interval k in a piecewise constant hazard model where k = 1, ..., K.
s1, ..., sk−1 Cut-points in a piecewise constant hazard model.
η = (η1, ..., ηn)
′ Transformed parameters.
Zm+1 = ZT Prognostic index.
ẐBLK,i Prognostic index value calculated using BLK.
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Studenỳ, M. (1998). Bayesian networks from the point of view of chain graphs. Proceedings
of the Fourteenth Conference on Uncertainty in Artificial Intelligence, 496–503.
Tanner, M. A. and W. H. Wong (1987). The calculation of posterior distributions by data
augmentation. Journal of the American Statistical Association 82 (398), 528–540.
Tian, G.-L., M. T. Tan, and K. W. Ng (2009). Bayesian Missing Data Problems: EM,
Data Augmentation and Noniterative Computation. Chapman and Hall/CRC.
Tierney, L. and J. B. Kadane (1986). Accurate approximations for posterior moments and
marginal densities. Journal of the American Statistical Association 81 (393), 82–86.
Townsend, P., P. Phillimore, and A. Beattie (1988). Health and Deprivation: Inequality
and the North. Routledge.
312
References
Verdurmen, N. (2003). A model for Credit Scoring: Combining Bayesian Networks with
Survival Analysis Techniques. Master’s thesis, Utrecht University.
Walli, G. M. (2010). Bayesian Variable Selection in Normal Regression Models. Master’s
thesis, Johannes Kepler Universitat Linz.
Wang, H. et al. (2015). Scaling it up: Stochastic search structure learning in graphical
models. Bayesian Analysis 10 (2), 351–377.
Watkins, D. S. (2004). Fundamentals of Matrix Computations. John Wiley & Sons.
Wei, L.-J. (1992). The accelerated failure time model: a useful alternative to the Cox
regression model in survival analysis. Statistics in Medicine (14-15), 1871–1879.
West, M., P. J. Harrison, and H. S. Migon (1985). Dynamic generalized linear models
and Bayesian forecasting. 80, 73–83.
Wilkinson, D. J. (2007). Bayesian methods in bioinformatics and computational systems
biology. Briefings in Bioinformatics 8 (2), 109–116.
Wilson, K. J. (2011). Belief Representation for Counts in Bayesian Inference and Ex-
perimental Design. Ph. D. thesis, University of Newcastle upon Tyne, Newcastle upon
Tyne, NE1 7RU, UK.
Wilson, K. J. and M. Farrow (2010). Bayes linear kinematics in the analysis of failure rates
and failure time distributions. Proceedings of the Institution of Mechanical Engineers,
Part O: Journal of Risk and Reliability 224, 309–321.
Wilson, K. J. and M. Farrow (2017). Bayes linear kinematics in a dynamic survival model.
International Journal of Approximate Reasoning 80, 239–256.
Wilson, K. J., J. Quigley, T. Bedford, and L. Walls (2013). Bayes linear Bayes graphical
models in the design of optimal test strategies. International Journal of Performability
Engineering 9, 715–728.
Witteveen, A., G. F. Nane, I. M. Vliegen, S. Siesling, and M. J. IJzerman (2018). Com-
parison of logistic regression and Bayesian networks for risk prediction of breast cancer
recurrence. Medical Decision Making, 1–12.
313
References
Yadav, C., A. Ahmad, B. D’Souza, A. Agarwal, M. Nandini, K. A. Prabhu, and
V. D’Souza (2016). Serum lactate dehydrogenase in non-Hodgkin’s lymphoma: A prog-
nostic indicator. Indian Journal of Clinical Biochemistry 31 (2), 240–242.
Zellner, A. (1986). On assessing prior distributions and Bayesian regression analysis with
g-prior distributions. Goel, P. and Zellner, A., Eds., Bayesian Inference and Decision
Techniques: Essays in Honor of Bruno de Finetti, 233–243. Elsevier, New York.
Zhang, Z. and J. Sun (2010). Interval censoring. Statistical Methods in Medical Re-
search 19 (1), 53–70.
Zhao, X. (2010). Bayesian Survival Analysis for Prognostic Index Development with Many
Covariates and Missing Data. Ph. D. thesis, Newcastle University, Newcastle upon
Tyne, NE1 7RU, UK.
Zhou, M. (2015). Empirical Likelihood Method in Survival Analysis. CRC Press.
314
